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Abstract 
Early embryogenesis in metazoa is controlled by maternally synthesized 
products. Among these products, the mature egg is loaded with transcripts 
representing approximately two thirds of the genome. A subset of this maternal 
RNA pool is degraded prior to the transition to zygotic control of development. 
This transfer of control of development from maternal to zygotic products is 
referred to as the midblastula transition (or MBT). It is believed that the 
degradation of maternal transcripts is required to terminate maternal control of 
development and to allow zygotic control of development to begin. 
Until now this process of maternal transcript degradation and the subsequent 
timing of the MBT has been poorly understood. I have demonstrated that in the 
early embryo there are two independent RNA degradation pathways, either of 
which is sufficient for transcript elimination. However, only the concerted action 
of both pathways leads to elimination of transcripts with the correct timing, at 
the MBT. The first pathway is maternally encoded, is triggered by egg 
activation, and is targeted to specific classes of mRNAs through cis-acting 
elements in the 3' untranslated region (UTR}. The second pathway is activated 
2 hr after fertilization and functions together with the maternal pathway to 
ensure that transcripts are degraded by the MBT. In addition, some transcripts 
fail to degrade at select subcellular locations adding an element of spatial 
control to RNA degradation. The spatial control of RNA degradation is achieved 
by protecting, or masking, transcripts from the degradation machinery. The 
RNA degradation and protection events are regulated by distinct cis-elements 
in the 3' untranslated region (UTR). These results provide the first systematic 
dissection of this highly conserved process in development and demonstrate 
that RNA degradation is a novel mechanism used for both temporal and spatial 
control of development. 
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Chapter 1 
RNA localization in development 
With permission, from the Annual Review of Biochemistry, 
Volume 67, copyright 1998, by Annual Reviews 
www.AnnuaiReviews.org 
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ABSTRACT 
Cytoplasmic RNA localization is an evolutionarily ancient mechanism for produc-
ing cellular asymmetries. This review considers RNA localization in the context 
of animal development. Both mRNAs and non-protein-coding RNAs are local-
ized in Drosophila, Xenopus, ascidian, zebrafish, and echinoderm oocytes and 
embryos, as well as in a variety of developing and differentiated polarized cells 
from yeast to mammals. Mechanisms used to transport and anchor RNAs in the 
cytoplasm include vectorial transport out of the nucleus, directed cytoplasmic 
transport in association with the· cytoskeleton, and local entrapment at particu-
lar cytoplasmic sites. The majority of localized RNAs are targeted to particular 
cytoplasmic regions by cis-acting RNA elements; in mRNAs these are almost 
always in the 3' -untranslated region (UTR). A variety of trans-acting factors-
many of them RNA-binding proteins-function in localization. Developmental 
functions of RNA localization have been defined in Xenopus, Drosophila, and 
Saccharomyces cerevisiae. In Drosophila, localized RNAs program the antero-
posterior and dorso-ventral axes of the oocyte and embryo. In Xenopus, localized 
RNAs may function in mesoderm induction as well as in dorso-ventral axis spec-
ification. Localized RNAs also program asymmetric cell fates during Drosophila 
neurogenesis and yeast budding. 
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INTRODUCTION 
Since the early days of experimental embryology it has been suggested that the 
asymmetric distribution of substances in the egg cytoplasm might confer par-
ticular fates to cells that receive that cytoplasm (reviewed in 1)0 However, it is 
only in the past 13 years that specific maternally synthesized, asymmetrically 
distributed RNA and protein molecules have been identified in oocytes and 
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early embryos of Xenopus, Drosophila, ascidians, zebrafish, and echinoderms. 
This review focuses largely on RNAs that are localized to specific cytoplasmic 
regions in eggs and early embryos. It addresses both the mechanisms of cyto-
plasmic RNA localization and the developmental functions of this localization. 
Some consideration is also given to RNA localization later in development, in 
differentiating or differentiated cells. However, since both the mechanisms and 
the functions of this later localization are not well understood, the emphasis 
here is on RNA localization in oocytes. 
This review considers only RNAs that are asymmetrically distributed in the 
cytoplasm. Examples of RNAs that are localized to and within the nucleus-
even to specific chromosomes or regions of chromosomes (2-4 )-are covered 
elsewhere. The first maternally synthesized cytoplasmically localized RNAs 
were identified in Xenopus in a molecular screen for RNAs enriched in either 
the vegetal (V g RNAs) or animal (An RNAs) hemisphere of the Xenopus oocyte 
(5). Shortly thereafter, an RNA was discovered that is localized to the anterior 
pole of the Drosophila oocyte and early embryo (6). This RNA is encoded by 
the bicoid maternal effect locus (7), which plays a crucial role in specifying 
cell fates in the anterior half of the early Drosophila embryo (8). The facile 
combination of genetics and molecular biology in Drosophila led to bicoid 
becoming the first case in which it was demonstrated that RNA localization 
per se was important for normal development. Delocalization of bicoid RNA 
led to defects in anterior cell fate specification (7). Over 75 cytoplasmically 
localized RNAs have now been identified, and many of these are localized in 
eggs, early embryos, or differentiating cells (Table 1). 
To date, it has been possible to address both the mechanisms and the de-
velopmental functions of RNA localization almost exclusively in Drosophila 
and Xenopus. The large size of the Xenopus oocyte has allowed mapping of 
sequences necessary and sufficient for RNA localization through injection of 
in vitro synthesized transcripts engineered to contain an exogenous reporter 
sequence and part or all of the localized RNA. Further, in some cases inactiva-
tion, delocalization, or degradation of specific RNAs has been induced through 
microinjection of antisense RNA or DNA. The ability to manipulate Xenopus 
oocytes and to apply various cytoskeleton-destabilizing drugs or other inhibitors 
has demonstrated the importance of the cytoskeleton in RNA localization. 
Drosophila oocytes and early embryos are also large and have also been used 
for drug and inhibitor studies. In contrast to Xenopus, however, the ability to 
generate transgenic lines that express reporter-tagged transcripts during ooge-
nesis has obviated the need for micronjection studies, although some of these 
pave been conducted. Finally, the ability to obtain mutations in the endoge-
nous gene that encodes the localized RNA or in factors that function in trans in 
its localization or in its translational regulation, has facilitated analyses of the 
4 
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Table 1 Localized RNAs 
Transcript Protein Localization 
Species name product pattern Cell Reference 
Ascidians 
Actin Cytoskeletal Myoplasm and Oocyte 249 
component ectoplasm 
PCNA Auxilary protein Ectoplasm Oocyte 100 
of DNA 
polymerase 
Ribosomal Ribosomal Myoplasm Oocyte 102 
proteinL5 component 
YCRNA Noncoding RNA Myoplasm Oocyte 101 
Drosophila 
Add-hts Cytoskeletal Anterior Oocyte and 16,17 
component embryo 
Bicaudal-C Signal Anterior Oocyte 18 
transduction/ 
RNA-binding 
protein 
Bicaudal-D Cytoskeleton Anterior Oocyte 19 
interacting 
protein(?) 
bicoid Transcription Anterior Oocyte and 7,32 
factor embryo 
crumbs Transmembrane Apical Cellular 67 
protein blastoderm 
Cyclin B Cell cycle Posterior and Oocyte and 59,62 
regulator perinuclear embryo 
egalitarian Novel Anterior Oocyte 20 
even-skipped Transcription Apical Cellular 69 
factor blastoderm 
fushi tarazu Transcription Apical Cellular 64 
factor blastoderm 
germ cell-less Nuclear pore Posterior Oocyte and 57,239 
associated embryo 
protein 
gurken Secreted growth Anterior-dorsal Oocyte 21 
factor 
hairy Transcription Apical Cellular 65 
factor blastoderm 
Hsp83 Molecular Posterior Embryo 63 
chaperone 
inscuteable Novel Apical Neuroblast 127 
KJO Novel Anterior Oocyte 22 
mtlrRNA Noncoding RNA Posterior Oocyte and 61 , 134 
embryo 
(Continued) 
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Table 1 (Continued) 
Transcript Protein Localization 
Species name product pattern Cell Reference 
nanos RNA binding Posterior Oocyte and 28,43 
protein embryo 
orb RNA binding Posterior Oocyte and 23 
protein embryo 
oskar Novel Posterior Oocyte and 24,25 
embryo 
Pgc Noncoding Posterior Oocyte and 26 
RNA embryo 
prospero Transcription Apical/basal Neuroblast 127 
factor 
pumilio RNA binding Posterior Embryo 250 
protein 
runt Transcription Apical Cellular 66 
factor blastoderm 
sevenless Transmembrane Apical Eye imaginal 126 
receptor Epithelial cells 
tudor Novel Posterior Oocyte 27 
wingless Secreted ligand Apical Cellular 68 
blastoderm 
yemanuclein-a Transcription Anterior Oocyte 251 
factor 
Echinoderms 
SpCOUP-TF Hormone Lateral to Oocyte 103 
receptor animal-
vegetal axis 
Mammals 
fJ-actin Cytoskeletal Specialized Fibroblasts, 123-125 
component periphery myoblasts, 
and epithelial 
cells 
Arc Cytosketal Somatodendritic Neurons 104 
component 
BC-1 Noncoding Somatodentritic Neurons 107, Ill 
RNA and axonal 
BC-200 Non coding Somatodendritic Neurons 108 
RNA 
CaMK/la Signalling Somatodendritic Neurons 109 
component 
Fl/GAP43 PKC substrate Somatodendritic Neurons 104 
lnsP3 receptor Integral Somatodendritic Neurons 110 
membrane 
receptor 
(Continued) 
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Table 1 (Continued) 
Transcript Protein Localization 
Species name product pattern Cell Reference 
MAP2 Cytosketal Somatodendritic Neurons 106 
component 
MBP Membrane Myelinating Oligodendrocyte 120 
protein membrane and Schwann 
cells 
Myosin heavy Cytoskeletal Peripheral Muscle 252 
chain component 
OMP/odorant Integral Axonal . Neurons 118,119 
receptors membrane 
receptor 
Oxytocin Neuropeptide Axonal Neurons 115 
Prodynorphin Neuropeptide Axonal Neurons 116,117 
RC3 PKC substrate Somatoden- Neurons 104 
dritic 
tau Cytoskeletal Axon hillock Neurons 112 
component 
Tropomyosin-5 Cytoskeletal Pre-axonal Neurons 113 
component pole 
V-ATPase Membrane Specialized Osteoclasts 122 
subunits protein membrane 
Vassopressin Neuropeptide Axonal Neurons 253 
Xenopus 
Actin Cytoskeletal Peri plasmic Oocyte 254 
component 
Anl (a and b) Cyoplasmic Animal Oocyte 5,81 
protein 
(ubiquitin-
like) 
An2 mtATPase Animal Oocyte 5,82 
subunit 
An3 RNA binding Animal Oocyte 5 
protein 
An4 (a and b) Novel Animal Oocyte 83 
fJTrCP Signaling Animal Oocyte 83 
molecule 
{JTrCP-2 Signaling Vegetal Oocyte 83 
molecule 
fJTrCP-3 Signaling Vegetal Oocyte 83 
molecule 
B6 NR3 Vegetal Oocyte 70 
B7 NR Vegetal Oocyte 70 
B9 NR Vegetal Oocyte 70 
B12 NR Vegetal Oocyte 70 
CJO NR Vegetal Oocyte 70 
(Continued) 
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Table 1 (Continued) 
Transcript Protein Localization 
Species name product pattern Cell Reference 
G-proteins Signaling Animal Oocyte 84 
molecule 
Oct60 Transcription Animal Oocyte 85 
factor 
PKCa Signaling Animal Oocyte 86 
molecule 
a-tubulin Cytoskeletal Peri plasmic Oocyte 254 
component 
VegT Transcription Vegetal Oocyte 91,92 
(Antipodean) factor 
Vgl Signaling Vegetal Oocyte 5 
molecule 
Xcat-2 RNA-binding Vegetal Oocyte 78,79 
protein 
Xcat-3 RNA-binding Vegetal Oocyte 95 
protein 
Xcat-4 NR Vegetal Oocyte 70 
xl-21 Transcription Animal Oocyte 87 
factor(?) 
Xlan4 P-rich and PEST Animal Oocyte 88 
sequences 
Xlcaax-1 Membrane Animal Oocyte 89 
protein 
Xlsirt Noncoding RNA Vegetal Oocyte 97 
Xwnt-11 Secreted ligand Vegetal Oocyte 98 
Yeast 
ASH1 Transcription Budding site Mother cell 128,129 
factor 
Zebrafish 
Vasa RNA-binding Cleavage plane Early embryo 209 
protein 
8NR, Not reported. 
mechanisms of RNA localization, the developmental functions of these RNAs, 
and of their localization per se. 
This review begins with a description of patterns of cytoplasmic RNA lo-
calization with an emphasis on Xenopus and Drosophila. To help explain the 
patterns and their significance, brief descriptions of the structure and develop-
ment of Xenopus and Drosophila oocytes and/or early embryos are included. 
After considering the patterns of RNA localization, the focus switches to mech-
anisms. First, the dynamics of RNA localization are considered, including the 
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role of the cytoskeleton in RNA transport and anchoring. Then specific com-
ponents of the localization mechanism are dissected; these include cis-acting 
sequences and trans-acting factors that function either in localization per se or 
in control of RNA stability or translation during and after localization. Finally, 
developmental functions of RNA localization are discussed. 
PATTERNS OF RNA LOCALIZATION 
All cells are nonhomogeneous since they are compartmentalized into organelles 
with distinct functions and locations. These inhomogeneities can result in sev-
eral forms of cellular symmetry and asymmetry. For example, positioning of 
the nucleus in the center of an otherwise quite homogeneous spherical cell pro-
duces spherical symmetry. In such a cell (and there are few if any examples, 
with the possible exception of some oocytes), certain RNAs might be local-
ized close to the nucleus (perinuclear) while others might be positioned more 
peripherally. More complex cellular asymmetries result from variations in cell 
shape and the position of the nucleus and other subcellular organelles. Cells 
can be radially symmetric or even further polarized in two or three axes. In 
these cases, RNA localization can occur relative to one, two, or three axes (e.g. 
to the dorsal anterior pole). Regardless of cell shape or size, RNA distribution 
patterns are usually based on preexisting asymmetries and can, in tum, lead to 
the establishment of further asymmetries. 
This section describes the dynamics and patterns of subcellular distribution 
of cytoplasmically localized RNAs. It provides a cellular and developmental 
context for consideration of the mechanisms and functions of RNA localization 
in subsequent sections. The emphasis here is on the best understood of the 
examples listed in Table 1. 
Drosophila Oocytes and Early Embryos 
STRUCTURE AND DEVELOPMENT OF THE NURSE CELL-OOCYTE COMPLEX 
The two bilaterally symmetric Drosophila ovaries each consist of about 16 
ovarioles. At the anterior tip of the ovariole is the germarium. Here the oogo-
nial stem cells divide asymmetrically producing a stem cell and a comrnited 
cell, which is called a cystoblast. Each cystoblast divides four times with in-
complete cytokinesis to form 16 cystocyte cells interconnected by cytoplasmic 
bridges that run through specialized membrane cytoskeletal structures called 
ring canals. Only 1 of the 16 cystocytes becomes the oocyte, and the remain-
ing 15 become nurse cells. Each 16-cell germarial cyst becomes surrounded 
by somatically derived follicle cells to form a stage 1 egg chamber. The more 
posterior part of the ovariole comprises a connected series of progressively 
older egg chambers ordered such that the youngest is most anterior and the 
9 
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oldest (stage 14) most posterior relative to the body axis of the female. It takes 
three days for an egg chamber to produce a mature egg. Except during the 
final six hours, the nurse cells synthesize large amounts of RNA and protein 
that are transported into the developing oocyte. Many of these molecules are 
required during the first two hours of embryonic development prior to the onset 
of zygotic transcription. 
Selection of the oocyte from among the 16 cystocytes is not random. Of the 
16 cells, 2 are connected to 4 others and 1 of these always becomes the oocyte 
(9). A large cytoplasmic structure-called the fusome-containing several cy-
toskeletal proteins, runs through the ring canals that connect cystocytes and 
has been implicated in oocyte determination (10-13). The only microtubule 
organizing center (MTOC) in the 16-cell complex is localized to the pro-oocyte, 
and microtubule arrays connect all 16 cells through the ring canals (reviewed in 
14, 15). Because the MTOC nucleates the minus ends of the microtubules, the 
microtubule-based cytoskeleton that connects the 16 cells is polarized. This has 
important consequences for RNA transport from the nurse cells into the oocyte 
as well as for RNA localization within the oocyte itself. 
RNA LOCALIZATION IN STAGE 1-6 EGG CHAMBERS Many RNAs that are later 
localized within the growing oocyte are first transcribed in all16 germline cells 
but accumulate specifically in the pro-oocyte. These include the Adducin like-
huli tai shao (Add-hts) (16, 17), Bicaudal-C (18), Bicaudal-D (19), egalitarian 
(20), gurken (21), KJO (22), orb (23), oskar (24, 25), Polar granule component 
(Pgc) (26), and tudor (27) transcripts. Other RNAs that will later be localized 
within the oocyte are transcribed at very low levels in the nurse cells at this early 
stage and so cannot be visualized easily. For example, nanos is transcribed at 
low levels, and oocyte accumulation can be seen only later (28). Additional 
transcripts, such as ovarian tumor (29) and cytoplasmic tropomyosin II (cTmll) 
(30), also accumulate in the oocyte at this and later stages but are not localized. 
Therefore oocyte-specific accumulation is not unique to RNAs that will be 
localized within the oocyte during later stages of oogenesis but is a property of 
many RNAs synthesized in the germline of early egg chambers. The fact that 
many RNAs that accumulate in the early oocyte appear to do so with higher 
concentrations at the posterior cortex-the site of the only MTOC in the egg 
chamber (31)-is an early indication of the role of the polarized microtubule 
network in RNA transport and localization (see below). 
The exact stage at which transcription of different localized RNAs com-
mences (or at least the stage at which the transcripts can first be detected) 
varies. For example, bicoid is first transcribed in the nurse cells of stage 5 egg 
chambers and then accumulates in the oocyte (32), whereas oskar (24, 25) and 
KJO (22) RNAs already accumulate in the oocyte in the germarium over a day 
10 
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earlier. Interestingly, the dynamics of accumulation of these RNAs is identical 
if they are intentionally transcribed at the same time (33). Thus temporal differ-
ences in patterns of oocyte accumulation of different RNAs are a consequence 
of variation in time of transcription and are not indicative of a difference in 
underlying transport mechanism, which in fact is similar for different RNAs 
transcribed at distinct stages. 
REORGANIZATION OF THE CYTOSKELETON AND RNA LOCALIZATION DURING 
STAGE 7 The process of nurse cell transcription and oocyte accumulation of 
RNAs continues through stage 6. During this time oocyte-follicle cell inter-
actions establish anterior-posterior polarity within the oocyte and in the sur-
rounding follicle cells (34, 35). Reciprocal signaling between the follicle cells 
and the oocyte results in a reorganization of the cytoskeleton such that, by the 
end of stage 7, the MTOC disappears from the posterior of the oocyte and 
microtubules become concentrated at the anterior oocyte margin (31, 34, 35). 
Concomitant with this change in cytoskeletal organization, RNAs that previ-
ously accumulated at the posterior of the oocyte localize in a ring-like pattern 
at the anterior oocyte margin (Figure 1) (e.g. Bicaudal-C. Bicaudal-D, bicoid, 
egalitarian, gurken, KJO, nanos, orb, oskar, and Pgc) (18-26). At this stage 
several proteins are also seen in an anterior ring-like pattern (e.g. Egalitarian 
and Bicaudal-D) (20). This redistribution of RNA and protein is likely a con-
sequence of the reorganization of the microtubule network such that the minus 
ends of microtubules move from the posterior pole to the anterior. Consistent 
with this, a ,8-galactosidase fusion to the minus-end-directed microtubule mo-
tor, Nod, relocalizes from the posterior pole of the oocyte at stage 6 to a ring 
around the anterior margin by the end of stage 7 (36). Thus RNAs that are trans-
ported into and within the oocyte by minus-end-directed microtubule motors 
would be expected to accumulate at the anterior rather than the posterior pole. 
As expected, the transient anterior localization of transcripts (e.g. Bicaudal-D. 
bicoid, KJO, orb) is colchicine sensitive (37), and microtubules are required for 
anterior Egalitarian protein localization (20). 
Mutations in genes involved in oocyte-follicle cell signaling during stages 6 
and 7 cause defects in oocyte polarity (see below) and in the microtubule-based 
cytoskeleton (e.g. Delta, gurken, Notch, PKA) (34, 35, 38, 39). For example, 
double-anterior oocytes can form in which microtubules have their minus ends 
at both oocyte poles and their plus ends at its center. Mutations in homeless 
cause a similar disorganization of micro tubules ( 40). Such disorganization 
results in bicoid RNA localization at both poles of the oocyte while oskar 
RNA and plus-end-directed kinesin-,8-galactosidase fusion protein localize in 
the middle (38, 41, 42). These data emphasize that microtubule polarity directs 
intraoocyte transcript localization. 
1 1 
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Figure 1 Localization of transcripts during Drosophila oogenesis. Transcript distribution patterns 
are shown in black or gray shading for bicoid, gurken, nanos, and oskar RNAs in stage 8 (top row), 
9 (middle row), and lOB (bottom row) egg chambers. A, anterior; P, posterior; D, dorsal; V, ventral. 
Drawings of egg chambers are after King (9). 
RNA LOCALIZATION AT STAGES 8- 9 Further changes in RNA localization pat-
terns occur at stages 8 and 9. Certain RNAs localize in a general anterior 
cortical pattern. These include Bicaudal-C (18), Bicaudal-D (19), bicoid (7), 
KJO (22), nanos (28,43), orb (23), and Pgc (26). In contrast, Add-hts RNA 
shifts from a general cortical pattern to an anterior cortical pattern (16, 44, 45; 
KL Whittaker, D Ding, WW Fisher, HD Lipshitz, manuscript in preparation) 
whereas gurken RNA localizes in a dorso-anterior pattern around the nucleus 
(21). Others such as egalitarian RNA delocalize from the anterior and become 
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uniformly distributed (20). Still others begin to relocalize to the posterior: Pgc 
RNA spreads posteriorly along the oocyte cortex (26) while oskar RNA grad-
ually moves away from the anterior and begins to accumulate at the posterior 
pole of the oocyte (24, 25). 
During this same period a kinesin-,8-galactosidase fusion protein localizes 
to the posterior (41). This observation suggests that, even though it has not 
been possible to visualize microtubules that traverse antero-posterior axis of 
the oocyte at this stage (31), they must be present. RNAs that enter the oocyte 
at this stage or that were previously localized to the anterior of the oocyte 
in association with minus-end-directed microtubule motors, must dissociate 
from these motors and associate with plus-end-directed motors in order to 
be translocated to the posterior pole. One such RNA is oskar, which by the 
end of stage 9, is present only at the posterior pole of the oocyte (24, 25). 
oskar RNA plays a key role in nucleating formation of the polar granules at 
the posterior pole of the oocyte. The polar granules, which are involved in 
germ-cell specification (see below), gradually assemble during stages 9-14 of 
oogenesis (reviewed in 47). 
NURSE CELL "DUMPING" AND RNA LOCALIZATION FROM STAGES 10-14 Dur-
ing stages 9 and 10 nurse cells increase synthesis of RNA and protein, dump 
their contents into the oocyte starting at stage lOB, and degenerate by the end 
of stage 12. This massive transfer of material is aided by contraction of the 
actin cortex of nurse cells. "Dumpless" mutants affect this process as well as 
ring canal structure. These genes, chickadee (encoding a profilin homolog), 
singed (encoding a fascin homolog), and quail (encoding a vilin homolog), are 
involved in F-actin crosslinking, indicating a major role for the actin-based cy-
toskeleton (48-50). Moreover, these studies demonstrate that the actin-based 
cytoskeleton is involved in anchoring the nurse cell nuclei so that they do not 
plug the ring canals during the dumping process. Interestingly, bicoid is lo-
calized apically in nurse cells during this phase (32). This apical distribution 
of bicoid RNA indicates a preexisting asymmetry within the nurse cells, but 
whether this transient bicoid localization in nurse cells serves any function is 
unclear. A similar apical nurse cell RNA localization pattern is observed for 
ectopically expressed oskar and KJO transcripts at this stage (33). 
During stage lOB, microtubules rearrange into subcortical parallel arrays in 
the oocyte, and a microtubule-based process called ooplasmic streaming begins. 
Capuccino and Spire proteins are required for control of ooplasmic stream-
ing (51, 52). During stages lOB-12 the dumping of large amounts of RNA 
into the oocyte along with ooplasmic streaming make it difficult to distinguish 
delocalization of previously localized RNA on the one hand, from a transient 
stage during which the dumped RNA is becoming localized (i.e. is joining the 
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previously localized RNA at its intracellular target site) on the other. This is fur-
ther complicated by the release of many transiently anteriorly localized RNAs, 
followed by their gradual translocation toward the posterior in some cases, or 
their complete delocalization in others. As a result, many RNAs appear to be 
generally distributed in the stage 11 oocyte. These include Bicaudat-e (18), 
Bicaudal-D (19), egalitarian (20), nanos (28), and orb (23). Other previously 
localized transcripts such as Kl 0 and gurken disappear by stage 11 (21, 22). 
In contrast, the anterior localization pattern of bicoid and Add-hts transcripts 
is maintained throughout these stages (7, 16, 32). Maintenance of this pattern 
is likely the result of two factors: (a) anteriorly localized RNAs are trapped 
as they enter the oocyte from the nurse cells (WE Theurkauf, TI Hazelrigg, 
personal communication) and (b) previously anchored bicoid andAdd-hts RNA 
is not released from the anterior pole during dumping and so does not have the 
opportunity to become generally distributed throughout the oocyte (16, 32). 
After ooplasmic streaming is completed (stage 12), subcortical microtubules 
are replaced by randomly oriented short cytoplasmic filaments, and F-actin 
reorganizes from a dense cortical filament network to an extensive deep cy-
toplasmic network (31, 54, 55). At this stage, several newly localized RNAs 
can be seen at the posterior of the oocyte. These include nanos (28, 56), germ 
cell-less (57), and probably orb (23). In addition, oskar and Pgc transcripts 
exhibit a posteriorly enriched pattern (24-26). bicoid and Add-hts transcripts 
remain localized at the anterior pole of late oocytes (7, 16, 32). 
RNA LOCALIZATION IN EARLY EMBRYOS After egg activation, the cytoskele-
ton reorganizes once again with actin and tubulin concentrated in the cortex and 
deeper filamentous networks of microtubules (31, 54, 55). Some longitudinal 
actin fibers may also be present in the early embryo. The Drosophila zygote 
undergoes 13 synchronous nuclear divisions without cytokinesis, forming a 
syncytial embryo containing several thousand nuclei that share the same cy-
toplasm (58). This syncytial state persists until the end of the 14th cell cycle 
when approximately 6000 nuclei reside at the cortex. Subsequently, invagina-
tion of membranes forms individual cells to give the cellular blastoderm. At 
this point the antero-posterior and dorso-ventral positional fates of the cells are 
specified. 
The two anteriorly localized maternal RNAs- bicoid (Figures 1 and 2) and 
Add-hts~persist in early cleavage embryos. Add-hts is released and diffuses 
posteriorly (16), while bicoid appears to remain anchored at the anterior cortex 
(7, 32). By the cellular blastoderm stage both RNAs are gone. 
Three RNAs that are posteriorly localized in the oocyte-oskar, nanos 
(Figures 1 and 2), and Pgc- retain posterior localization in early cleavage 
stage embryos. By nuclear cycle 6/7 oskar RNA is gone (24), whereas Pgc and 
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Figure 2 Localized maternal transcripts in early Drosophila embryos. A: bicoid RNA; B: nanos 
RNA. Images are of whole mount RNA tissue in situ hybridizations to stage 2 embryos using 
digoxigenin-labeled probes. Anterior is to the left and dorsal toward the top of the page. 
nanos RNAs are associated with polar granules and are taken up into pole cells 
together with these granules (26, 56). Some maternal RNAs do not become 
posteriorly localized until late in oogenesis or early embryogenesis. Examples 
are Cyclin B (59-62) and Hsp83 (60, 61, 63) transcripts. By the cellular blas-
toderm stage, maternal transcripts of Cyclin B, germ cell-less, Hsp83, nanos, 
orb, and Pgc can be detected only in pole cells. 
During the syncytial and cellular blastoderm stages, zygotic synthesis of 
RNA commences. Several of these zygotically synthesized transcripts, includ-
ing crumbs, even-skipped,fushi tarazu, hairy, runt, and wingless are apically 
localized in the blastoderm (64-69), an epithelium surrounding the syncytial 
yolk mass of the zygote. 
Xenopus Oocytes 
As in Drosophila, maternally synthesized gene products play a key role in the 
development of the Xenopus embryo (reviewed in 70). Zygotic transcription 
initiates at the 4000-cell mid blastula stage. Unlike in Drosophila, however, 
synthesis of maternal molecules occurs in the oocyte itself. Thus the issue of 
transport into the oocyte from interconnected nurse cells does not arise. 
DEVELOPMENT OF THE OOCYTE The Xenopus oocyte is initially a small 
spherical cell of 30 J.Lm diameter when it is produced by mitosis of a stem 
cell, the oogonium (71). However, even at this stage, its nucleus and organelles 
are asymmetrically distributed (72, 73). Unlike Drosophila oogenesis, which 
lasts just over a week, Xenopus oogenesis lasts three years, although most of the 
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synthesis of oocyte contents occurs in the third year (71). The oocyte reaches 
a final diameter of approximately 1.5 mm (71). 
An early indicator of asymmetry is the mitochondrial cloud or Balbiani body 
(71). It is composed of clumps of mitochondria, rough endoplasmic reticulum, 
and dense granules that initially are evenly distributed around the periphery of 
the germinal vesicle in early stage I oocytes ( "'-'80 f.Lm diameter). By the end of 
stage I these components condense on one side of the germinal vesicle as a cap-
like structure that grows and assumes a spherical shape. Beginning in stage II, 
the mitochondrial cloud moves toward the future vegetal pole initially changing 
shape to become disk-like and then reorganizing into a wedge-like shape (late 
stage 11/early stage III). Subsequently its components become localized to the 
vegetal cortex of the oocyte during stage III/IV. 
The mitochondrial cloud probably functions in the accumulation and local-
ization of material needed for the formation of germ plasm at the vegetal pole 
of the early embryo (reviewed in 70, 74). In structure and function the Xeno-
pus germ plasm is comparable to the Drosophila posterior polar plasm, and it 
contains germinal granules that function in germ-cell determination. However, 
while Drosophila polar granules are sufficient for the induction of germ cells 
(75, 76), Xenopus primordial germ cells are not irreversibly determined (77). 
Preliminary evidence indicates that certain RNA and protein components of 
the Drosophila and Xenopus germinal granules are evolutionarily conserved 
(70, 78, 79) and that in both cases RNA localization is an important mechanism 
used to locally assemble these structures. 
The oocyte cytoskeleton is symmetric early in oogenesis. Until stage II the 
germinal vesicle appears to serve as the only MTOC with microtubules emanat-
ing radially toward the plasma membrane (80). This array loses its symmetry as 
the germinal vesicle moves toward the future animal pole and the mitochondrial 
cloud starts condensing at the opposite (vegetal) side. At this time microtubules 
start to concentrate at the vegetal side of the germinal vesicle, co localizing with 
the wedge-shaped mitochondrial cloud by late stage II (77). The germinal vesi-
cle completes movement to the animal hemisphere by stage VNI and at this 
time the microtubule array disappears. 
RNA LOCALIZATION PA1TERNS The first collection of localized RNAs was re-
ported for Xenopus oocytes. Three animal hemisphere-enriched RNAs (Ani, 
An2, An3) and one vegetal hemisphere-localized RNA (Vgl; Figures 3 and 4) 
were identified in a molecular screen for cDNAs representing mRNAs differ-
entially distributed along the animal-vegetal axis (5). 
The animal hemisphere (An)-enriched RNAs are not tightly localized within 
the animal hemisphere but are at least fourfold enriched in this hemisphere 
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Figure 3 Localization of transcripts during Xenopus oogenesis. Transcript distribution patterns 
are shown in black, on the left for transcripts that show a Vgl-like pattern and on the right for 
transcripts that show an Xcat-2-like distribution pattern. Oocytes from stages I-IV are schematized. 
An, animal pole; Vg, vegetal pole. The germinal vesicle (oocyte nucleus) is shown in gray and the 
METRO as a white circle (stage I) or ellipsoid (stage II). Drawings of oocytes are after Kloc & 
Etkin (90). 
relative to their vegetal concentration. Generally distributed maternal RNAs 
are twice as abundant in the animal than in the vegetal hemisphere (5). Thus 
the An RNAs are enriched in the animal hemisphere at least twofold versus other 
maternal RNAs. There are over a dozen known examples of An RNAs, all with 
similar distribution patterns: An1a (5, 81), An1b (5, 81), An2 (5, 82), An3 (5), 
An4a (83), An4b (83), {3-TrCP (83), G protein (84), oct60 (85), PKC-a (86), 
xl-21 (87), Xlan-4 (88), andXlcaax-1 (89). Unfortunately, reported in situ RNA 
hybridization data are lacking, making detailed comparisons of distribution 
patterns impossible. 
In contrast to the An RNAs, the vegetally localized RNAs exhibit highly re-
stricted distribution patterns. Careful observations ofthe patterns oflocalization 
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Figure 4 Localized transcripts in Xenopus oocytes. A: Vgl RNA; B: Xcat-2 RNA; C: Xlsirt RNA. 
All images are of whole mount RNA tissue in situ hybridizations to either late stage III (A) or early 
stage II (B, C) oocytes. In A, the vegetal pole points toward the top right; in B and C the-vegetal 
tip of the oocyte is at the center of the transcript distribution (i.e. the oocytes are viewed from the 
vegetal side). The small patches of Xcat-2 RNA that are radially symmetrically distributed around 
the vegetal ring of transcripts are in the islands of germ plasm. 
in situ in whole mounts have suggested two or three distinct patterns (70, 90-92) 
exemplified by Vgl, Xcat-2, and, possibly, VegT/Antipodean. 
Four RNAs show the V g J-like pattern of localization: V g 1 (Figures 3 and 4); 
andXcat-4, Bl2, andB9 (70). Vgl RNA is initially distributed uniformly in the 
oocyte cytoplasm and is excluded from the mitochondrial cloud during stages 
I and II (93). During late stage Illearly stage III, Vgl transcripts accumulate 
in a wedge-like pattern toward the vegetal pole before becoming restricted to 
the vegetal cortex by late stage III (93-95). Finally, at stage IV, Vgl RNA is 
tightly localized to the cortex of the entire vegetal hemisphere (94, 96). This 
localization pattern correlates with the dispersion of the mitochondrial cloud 
(see above). 
The second pattern of RNA localization is exhibited by seven RNAs: Xcat-2, 
Xwnt-11, Xcat-3, B6, B7, CJO, and the Xlsirts (Figures 3 and 4) (70, 78, 79, 95, 
97, 98). This localization process includes passage through what has been called 
a message transport organizer (METRO) within the mitochondrial cloud (Fig-
ure 3) and occurs in three distinct steps (90): (a) movement from the germinal 
vesicle to the mitochondrial cloud, (b) sorting within the METRO, and (c) 
translocation and anchoring to vegetal cortex. Localization begins during early 
oocyte stage I when transcripts appear to be distributed throughout the cyto-
plasm at low levels with slightly higher concentrations around the germinal 
vesicle. As the mitochondrial cloud condenses into a sphere during mid stage 
I, these transcripts are transported to the METRO. For Xcat-2 this change in 
pattern is not the result of a reduction of RNA elsewhere, as the total amount 
of RNA in the oocyte remains constant or even increases (79). Within the 
METRO the transcripts are sorted such that, for example, Xcat-2 is localized 
first, followed by Xlsirts, and then Xwnt-11 (70, 79, 90, 99). By late stage I, 
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when the METRO is disc-like, Xcat-2 RNA is in the periphery of the disc, 
Xwnt-11 RNA is in the center, and Xlsirts reside between these two (Figure 3). 
The METRO moves vegetally such that by stage IV, all three RNAs are local-
ized at the tip of the vegetal pole (70, 79, 90, 99). At this stage, the Vg1 RNA 
pattern is quite distinct as it is distributed throughout the vegetal cortex (70, 79, 
90, 99). 
The third type of localization, typified by VegT (Antipodean), appears to 
deviate from both of these patterns, although there is some discrepancy in the 
distributions described in two reports (91, 92). VegT/Apod maternal transcripts 
are initially uniform in the cytoplasm in stage I. Later they appear to move 
to the vegetal pole with a timing and pattern similar to Xlsirts, Xcat-2, and 
Xwnt-11 transcripts. One report describes a distribution at late stage III/early 
stage IV similar to that of Vg1 (92), while another describes a novel final 
pattern predominantly in the vegetal yolk (91). The latter distribution would 
imply a target of localization that is distinct from all other vegetally localized 
transcripts. 
After fertilization, the B7 transcripts disappear, the Xlsirt, Xcat-2, and Xcat-3 
transcripts are associated with the germ plasm in the primordial germ cells, 
and the other transcripts (B9, B12, CJO, Vg1, Xcat-4, and Xwnt-11) are all 
located in the vegetal blastomeres (70, 79, 90, 93, 98, 99; L Etkin, personal 
communication). 
Ascidian Oocytes 
Several RNAs are localized in ascidian (Styela) oocytes (Table 1). These in-
clude YC RNA, PCNA mRNA, and ribosomal protein L5 mRNA. PCNA mRNA 
is initially uniformly distributed throughout the previtellogenic oocyte (100). 
During maturation, PCNA mRNA becomes concentrated in the central ecto-
plasm and cortical regions surrounding the myoplasm but is absent from the 
myoplasm per se (100). While PCNA mRNA can be observed in both the 
ectoplasm and the myoplasm after the first phase of ooplasmic segregation, 
which restricts the ectoplasm and myoplasm to the vegetal hemisphere, PCNA 
mRNA is absent from the myoplasm in the two-cell embryo (100). YC RNA is 
distributed throughout the cytoplasm of previtellogenic oocytes (101). How-
ever, during early vitellogenesis, YC transcripts are localized around the nu-
cleus. They gradually move away from the nucleus as the oocyte increases 
in size, until they become restricted to the cortex of postvitellogenic oocytes 
(101). After the first phase of ooplasmic segregation shortly after fertiliza-
tion, YC transcripts are localized in the vegetal cap ofmyoplasm (101). A third 
pattern of localization is exhibited by L5 transcripts, which are concentrated 
in the cortical myoplasm (except at the animal pole) during oogenesis (102). 
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After fertilization, L5 transcripts become restricted to the vegetal myoplasm 
(102). 
Echinoderm Oocytes 
There is one example of a maternally synthesized mRNA that is localized in the 
echinoderm (Strongylocentrotus purpuratus) oocyte and early embryo (103). 
This SpCO UP-TF mRNA, which encodes an "orphan" nuclear steroid hormone 
receptor, is localized subcortically in one hemisphere of the sea urchin oocyte 
and mature egg. Since there are no markers of the animal-vegetal axis of the 
egg, the location of SpCOUP-TF transcripts in the egg was inferred from their 
distribution in cleavage stage embryos where the animal-vegetal and oral-aboral 
axes are evident morphologically. From this inference it was concluded that 
SpCOUP-TF transcripts are localized such that they are restricted to one of 
the two cells produced by the first cleavage (i.e. lateral to the animal-vegetal 
axis) and, thus, are fixed at a 45° angle relative to the future oral-aboral axis 
(103). 
Zebrafish Embryos 
There is one example of a maternally synthesized mRNA that is localized 
within the cells of the zebrafish (Brachydanio rerio) embryo (209). This mRNA 
encodes a fish homolog of Drosophila Vasa, a DEAD-box RNA helicase that is 
known to function in germ plasm assembly (see below). Maternally synthesized 
zebrafish vasa transcripts localize to the inner (yolk-most) edges of the cleavage 
furrows at the first embryonic cell division (209). This localization pattern is 
maintained through the four-cell stage. From the 8- to the 1000-cell stage, the 
vasa transcripts remain in only four cells (the presumptive primordial germ 
cells) and are found in intracellular clumps that likely represent the assembling 
germ plasm. Subsequently, vasa transcripts are found in all primordial germ 
cells and germ cells. 
Polarized Somatic Cells 
Many cells in addition to oocytes are polarized. Epithelial cells have an apical-
basal polarity. Differentiated neurons have dendritic arbors and an axon. Fibro-
blasts have specialized moving membranes (lamellopodia) at defined surfaces. 
These classes of cells also show asymmetric distributions of RNAs. However, 
in most cases, the developmental significance of RNA localization is unknown 
or, alternatively, transcript localization serves a function in the fully differen-
tiated cell rather than during its development or differentiation. Several RNA 
localization patterns in these polarized cells are described here. 
Although neurons can exhibit very complex and quite varied cytoarchitec-
tures, they are classic examples of polarized cells and generally have an axon 
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on one side of the cell body (soma) and dendrites on the other. Most neuronal 
RNAs are present only in the soma and are excluded from dendrites and axons. 
At least 12 localized neuronal RNAs have been reported (1, 104, 105). These 
RNAs can be classified into two different patterns. The first is somatodendritic: 
MAP2 (106); BC-1 (107); BC-200 (108); CaMKII-a (109); IP3 receptor (110); 
and Arc, Fl/GAP43, and RC3 (104) RNAs. The second is axonal: BC-1 (111), 
tau (112), tropomyosin-5 (113), vasopressin/oxytocin (114, 115), prodynorphin 
(116, 117), and odorant receptor (118, 119) RNAs. In almost all cases these 
RNAs are localized in differentiated neurons. The exception, tropomyosin-5 
(Tm5) RNA, is localized prior to any structural polarities at the future axonal 
pole of differentiating neurons (113). In mature neurons Tm5 RNA is present 
only in the soma (113). 
Several types of cells have defined areas of membrane devoted to a particular 
function. Myelinating membranes of oligodendrocytes and Schwann cells have 
associated myelin basic protein (MBP) mRNA (120, 121). mRNA for vacuolar 
H+ -ATPase subunits is localized to the bone resorption membranes of osteo-
clasts (122). Lamellopodia of fibroblasts (123) and myoblasts (124) contain 
localized cytoplasmic {> -actin mRNA. Apical ends of villar epithelial cells also 
have high concentrations of actin mRNA (125). In these cases, the distribu-
tion of mRNA likely follows the differentiation of these cell types rather than 
playing a role during their differentiation. 
In Drosophila the location of plus-end (kinesin)- and minus-end (Nod)-
directed microtubule motors provides a readout of the polarities of various 
cell types. Localization of these motors within oocytes was mentioned ear-
lier. In addition, these motors localize to opposite ends of polarized cells 
(36): epithelia (Nod is apical and kinesin is basal), mitotic spindles (Nod is 
at the poles), neurons (Nod is dendritic and kinesin is axonal), and muscle 
(Nod is at the center and kinesin at attachment sites). As mentioned previ-
ously, several mRNAs (e.g. crumbs, even-skipped, fushi tarazu, hairy, runt, 
and wingless) are apically localized within undifferentiated epithelia such as 
the embryonic blastoderm (64-69). In addition, mRNAs (e.g. sevenless) are lo-
calized within the developing epithelium of imaginal discs such as the eye disc 
(126). 
It has been reported that prospero and inscuteable mRNAs are localized 
within embryonic Drosophila neuroblasts (127). The inscuteable transcripts are 
apically localized during interphase of the neuroblast cell divisions, while pros-
pero transcripts are apically localized at interphase but are basal from prophase 
to telophase. Basal prospero RNA is segregated into one daughter cell (the 
ganglion mother cell). 
The S. cerevisiae ASHJ mRNA is localized within yeast cells at the site of 
the future bud and is segregated into the daughter cell (128, 129). 
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MECHANISMS OF RNA LOCALIZATION 
This section focuses on general classes of RNA localization mechanisms. Spe-
cific details of cis-acting sequences and trans-acting factors that function in 
RNA localization are reviewed in the following section. 
Nucleo-Cytoplasmic Transport 
An obvious way to achieve cytoplasmic RNA localization is to export transcripts 
vectorially from only one side of the nucleus and then to transport or anchor 
them in the cytoplasm on that side of the nucleus. Substantial progress has 
been made recently in understanding the mechanisms of nucleo-cytoplasmic 
transport (130); however, studies of vectorial aspects of transport from the 
nucleus are in their infancy. 
In general, it has been difficult to establish vectorial nucleo-cytoplasmic 
transport for particular transcripts due to experimental limitations. An excep-
tion is the case of pair-rule gene transcripts (hairy and fushi tarazu) in the 
cellularizing blastoderm of Drosophila (65, 131). Here it was possible to use 
mutations to produce two layers of nuclei (or displaced nuclei) in the cortex of 
the syncytial blastoderm and, thus, to show-for the inner nuclei- that tran-
scripts are vectorially exported even in the absence of normal apical cytoskeletal 
structures. The fact that this is possible suggests that the nuclei themselves have 
a polarity independent of the cytoplasmic cytoskeleton. Moreover, this directed 
export depends on the 3'-UTR (65), suggesting that it is specific to these tran-
scripts (see below for a discussion of the role of 3'-UTRs). 
A second example of vectorial nucleo-cytoplasmic export may be the Droso-
phila gurken mRNA that is localized dorso-anterior to the nucleus in stage 
8 oocytes. The gurken transcripts are synthesized in the oocyte nucleus itself 
(R Cohen, personal communication), and the KlO and Squid proteins may 
function in vectorial transport of the gurken mRNA (see below). 
Transport from One Cell Type into Another 
A second class of localization mechanism applies during Drosophila oogene-
sis. As outlined previously, RNAs are transported from the nurse cells into the 
oocyte through intercellular bridges known as ring canals. Nurse cells connect 
only to the presumptive anterior pole of the oocyte, so that the imported RNAs 
first arrive at the oocyte's anterior pole. It is likely that anteriorly localized 
RNAs (e.g. bicoid) are trapped at the anterior pole when they enter the oocyte 
(WE Theurkauf, TI Hazelrigg, personal communication). The fact that mutants 
in which nurse cells connect to the oocyte at both poles result in bipolar trans-
port into the oocyte and trapping of bicoid RNA at both poles (42) supports this 
hypothesis. Recent experiments in which so-called localization particles were 
followed by time-lapse confocal microscopy supports this hypothesis further 
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(WE Theurkauf, TI Hazelrigg, personal communication). In contrast to the 
entrapment seen for anterior-localized RNAs, those that are localized to the 
posterior pole are actively transported there in association with the cytoskele-
ton or are localized there by other mechanisms such as degradation-protection 
(see below). 
Transport Out of Mitochondria 
The posterior polar plasm of Drosophila oocytes and early embryos contains 
large, non-membrane-bound organelles known as polar granules, which are in-
volved in germ cell formation and specification (see below). Mitochondria are 
found in close association -with the polar granules. One of the more remarkable 
examples of a localized RNA is the Drosophila 16S mitochondrial large ribo-
somal RNA (mtlrRNA), which is encoded by the mitochondrial genome (132). 
This RNA appears to be exported from the mitochondria into the cytoplasm 
within the posterior polar plasm and to be associated with polar granules (61, 
133-137). Indeed, given the apposition of polar granules and mitochondria, the 
mtlrRNA may in fact be exported vectorially out of mitochondria directly into 
or onto the polar granules. The function of the mtlrRNA in the polar granules 
is unclear, although it has been implicated in pole cell formation (133 ). There 
is some disagreement, however, about whether a high local concentration of 
mtlrRNA is indeed necessary for pole cell formation (135-137). 
Generalized Degradation with Localized Protection 
It was postulated several years ago that one mechanism by which a generalized 
RNA distribution could be converted to a restricted pattern was through degrada-
tion of the RNA throughout the cell except at the site of localization (138). Sev-
eral Drosophila transcripts represent variants of this type of process. For exam-
ple, while the bulk of maternally synthesized nanos and cyclin B transcripts are 
concentrated in the posterior polar plasm of the early embryo, a subset of these 
transcripts remains unlocalized (62, 139- 141). The posteriorly localized tran-
scripts are taken up into the pole cells when they bud, while the unlocalized tran-
scripts are degraded (62, 139-141). Similarly, maternally synthesized Hsp83 
transcripts are generally distributed in the early embryo (61, 63, 142; SR Halsell, 
A Bashirullah, RL Cooperstock, WW Fisher, A Karaiskakis, HD Lipshitz, 
manuscript in preparation). Hsp83 transcripts in the posterior polar plasm 
also are taken up into the pole cells when they bud, while the remaining tran-
scripts are degraded (61, 63, 142; SR Halsell, A Bashirullah, RL Cooperstock, 
WW Fisher, A Karaiskakis, HD Lipshitz, manuscript in preparation). There is 
a close correlation between translational repression of unlocalized nanos tran-
scripts and their degradation (reviewed in 144). Under normal conditions, the 
polar granules are necessary and sufficient for protection of nanos, cyclin B, 
and Hsp83 transcripts from degradation at the posterior (56, 60, 63). 
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Another example of transcript destabilization and localization may be ma-
ternally synthesized PCNA mRNA in the ascidian oocyte. There is sequence 
complementarity between a non-protein-coding RNA, YC, whose 3' end is 
complementary to the 3'-UTR of the PCNA RNA (100) as well as to the 5'-
UTR of ribosomal protein L5 RNA (ScYC26a) (1 02). During oogenesis the YC 
RNA is perinuclear, gradually moving to the cortex, and after fertilization the 
RNA segregates to the myoplasm and associates with the cytoskeleton (101). 
Uniformly expressed maternal PCNA RNA initially overlaps with YC RNA but 
later becomes depleted in the myoplasm (100). Investigators have suggested 
that the double-stranded YC-PCNA RNA hybrid in the myoplasm might some-
how destabilize PCNA RNA, thus representing an example of RNA localization 
by degradation-protection. The hypothesis that such double-stranded RNA hy-
brids destabilize specific RNAs in the myoplasm is, however, confounded by the 
data for the L5 ribosomal protein maternal RNA. Although there is substantial 
sequence complementarity between YC and L5 RNAs, L5 RNA is concentrated 
in myoplasm along with YC RNA, rather than destabilized there (102). In 
this case, the YC RNA has been postulated to aid the anchoring of L5 RNA. 
Whether PCNA RNA localizes by a mechanism that involves hybrid-induced 
degradation remains an open question. 
Directed Cytoplasmic Transport of RNA 
Asymmetries in cytoskeletal organization have been described earlier for both 
Xenopus and Drosophila oocytes. Further, there is colocalization of specific 
RNAs with either a minus-end-directed microtubule motor (Nod) or a plus-
end-directed motor (kinesin), in particular regions of the Drosophila oocyte's 
cytoplasm (see above). There is now substantial evidence that cytoplasmic 
RNA transport to specific intracellular destinations is accomplished by both the 
microtubule- and the microfilament-based cytoskeleton. The following section 
reviews evidence for a role of the cytoskeleton in anchoring localized RNAs 
at their intracellular destinations. Here the role of the cytoskeleton in directed 
cytoplasmic transport is reviewed. 
Analysis of intracellular transport mechanisms requires the ability to system-
atically perturb normal cytoskeletal function. These studies have been aided in 
Xenopus and Drosophila by drugs that specifically perturb either the microtu-
bule-based (colchicine, nocodazole, or taxol) or the microfilament-based (cy-
tochalasins) cytoskeleton. In addition, mutations that affect components of the 
cytoskeleton have led to informative results in Drosophila and Saccharomyces. 
THE ROLE OF THE CYTOSKELETON IN RNA TRANSPORT DURING DROSOPHILA 
OOGENESIS Localized RNAs have several characteristic and sequential pat-
terns of expression during Drosophila oogenesis that correlate with particular 
aspects of the cytoskeleton, particularly the microtubules (see above). 
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Over a dozen transcripts are synthesized in the nurse cells and specifically 
accumulate in the oocyte within early egg chambers prior to their localization 
[bicoid (7), nanos (28), orb (23), oskar (24, 25),Add-hts (16), Bicaudal-C (18), 
Bicaudal-D (19), gurken (21), Pgc (26), KJO (22), egalitarian (20), and tu-
dor (27)]. Transport of these RNAs into the oocyte is likely to be carried out 
by minus-end-directed microtubule motors since the MTOC is located in the 
oocyte during these stages (see above). Although no specific motors have been 
demonstrated to be involved in this process, the kinesin-like minus-end-directed 
motor-Nod-localizes first to the oocyte and then to its posterior at the same 
stages as many of these RNAs are transported into the oocyte and then accu-
mulate at its posterior pole (36). Dynein (a minus-end-directed motor) is also 
localized to the oocyte at these stages (145) but does not appear to be involved 
in RNA transport and localization (146). During these stages, several RNAs are 
present in detergent insoluble fractions (e.g. bicoid, oskar, Bicaudal-D. KJO, 
orb) indicating association with the cytoskeleton (147). Moreover, the associ-
ation of bicoid, oskar, and Bicaudal-D RNAs with the cytoskeleton is sensitive 
to colchicine and not to cytochalasins, indicating that microtubules but not 
microfilaments are involved in their transport and localization (37, 147). 
The phenotypes of orb, egalitarian, and Bicaudal-D mutants suggest a role 
in oocyte specific RNA accumulation. Egalitarian and Bicaudal-D proteins are 
made in nurse cells and are transported to the posterior of the oocyte presum-
ably along minus-directed microtubules (20). The distribution of Egalitarian 
and Bicaudal-D proteins parallels that of the RNAs that are transported into 
the oocyte at these stages. Microtubule inhibitors result in delocalization of 
Egalitarian protein (20). Moreover, in egalitarian mutants oskar and orb RNA 
are no longer associated with the cytoskeleton (147). This indicates that 
Egalitarian and Bicaudal-D proteins may be involved--directly or indirectly-
in transporting localized RNAs along microtubule networks into and to the 
posterior of the oocyte. 
Mutations in genes required for early localization also perturb oocyte po-
larity; egalitarian and Bicaudal-D mutations cause all 16 cells of the cyst to 
become polyploid nurse cells; thus oocyte-specific accumulation of transcripts 
cannot occur because there is no oocyte (20, 148). Orb is required for oocyte 
polarity, and in orb mutants, oocytes are located at ectopic positions within 
the egg chamber (149). In orb mutant oocytes certain RNAs (orb, oskar) are 
still localized-albeit at abnormal positions-whereas others are not localized 
at all (Add-hts, Bicaudal-D, KJO) (149). It is possible that Orb protein is re-
quired to establish microtubule polarity, whereas Egalitarian and Bicaudal-D 
are necessary for its maintenance. 
As described above, the majority of RNAs transported into and localized in 
the oocyte have in common early transport from the nurse cells (stage 1-5), 
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transient localization to the posterior (stage 6), and subsequent localization to 
the anterior (stages 7-8). In addition, oskar and Pgc transcripts move back to 
the posterior pole of the oocyte at stage 9, whereas the bicoid and Add-hts 
RNAs never show the early posterior localization but are either always an-
teriorly localized (bicoid) or are initially localized throughout the cortex and 
subsequently localize to the anterior (Add-hts). These data suggest that a default 
transport and localization mechanism is carried out by minus-end-directed mi-
crotubule motors, and that certain RNAs (bicoid, Add-hts, oskar, Pgc) initially 
use this mechanism to enter the oocyte but then engage a different localization 
machinery. Since bicoid and oskar RNA transport and localization are best 
understood and exemplify distinct localization mechanisms, they are discussed 
below. 
bicoid RNA is localized at the anterior pole of the oocyte by stage 8 of 
oogenesis and remains anterior until the late cleavage stage of embryogene-
sis when it is degraded. During its translocation from the nurse cells into the 
oocyte, it is apically localized within the nurse cells (32). Both apical nurse 
cell localization and anterior oocyte localization are sensitive to microtubule de-
polymerizing drugs (colchicine, nocodazole, tubulozole C) but not to inhibitors 
ofF-actin polymerization (cytochalasin D and B) (150). Recent evidence sug-
gests that transport of bicoid RNA into the oocyte actually involves several 
distinct steps that might be mediated by distinct localization mechanisms; for 
example, two distinct microtubule-dependent steps drive bicoid RNA localiza-
tion particles within the nurse cell cytoplasm (WE Theurkauf, TI Hazelrigg, 
personal communication), but transport through the ring canals into the oocyte 
is resistant to both microtubule and actin filament inhibitors (WE Theurkauf, 
TI Hazelrigg, personal communication). The Exuperantia protein may medi-
ate this microtubule-independent transport (151). The cytoskeletal association 
of bicoid transcripts is stage specific (147). During early oocyte accumula-
tion, bicoid transcripts are associated with the cytoskeleton (i.e. the detergent-
insoluble fraction). However, during stages 8-11, when bicoid transcripts are 
at the anterior margin of the oocyte, they are not cytoskeleton associated. This 
observation supports the idea that anchoring at the anterior pole at these stages 
is accomplished by some other structures. ·Later, during stage 14, bicoid RNA is 
localized in a tight cap at the anterior, is again associated with the microtubule-
based cytoskeleton, and its localization is again sensitive to colchicine. In early 
embryos, bicoid RNA is no longer restricted to the cortex and is not associated 
with the cytoskeleton (147). 
A kinesin-,B-galactosidase fusion protein localizes to the posterior (41) at 
stages 8-9, indicating that micro tubules traverse the antero-posterior axis of the 
oocyte at these stages and are oriented with their plus ends at the posterior (41). 
This localization coincides with the initiation of oskar and Pgc translocation 
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from the anterior pole of the oocyte to its posterior. Thus it is likely that oskar 
and Pgc switch from the use of minus-end-directed microtubule motors to the 
use of plus-end-directed ones in order to achieve transport to the posterior. 
Posterior localization of the kinesin-,8-galactosidase fusion protein is lost 
once ooplasmic streaming begins (stage 10) and is absent in capuccino and 
spire mutant oocytes that undergo premature streaming (41, 52). In capuccino 
and spire mutants oskar RNA is not localized to the posterior during stages 8 
and 9, but instead oskar RNA is uniformly distributed throughout the oocyte 
(24, 25). These mutants cause an early cytoplasmic streaming during stage 7 and 
8 instead of lOB (52), suggesting that premature assembly of microtubules into 
the parallel arrays in the subcortex drives cytoplasmic streaming (52). In other 
words, oskar RNA does not localize to the posterior in capuccino and spire 
mutants because these mutants omit the stage during which antero-posterior 
axial organization of microtubules is used for directed transport of oskar RNA 
to the posterior. 
Evidence suggests a role for the actin-based cytoskeleton at the anterior of 
the oocyte in transfer of RNAs to the microtubules that run from the ante-
rior to the posterior pole. In oocytes that are mutant for a component of the 
actin-based cytoskeleton--cytoplasmic (nonmuscle) tropomyosin II (cTmii)-
oskar RNA remains anteriorly localized at stage 9 and never localizes posteri-
orly (152, 153). This observation suggests a role for cTmii-and possibly the 
actin-based cytoskeleton-in transfer of oskar RNA to the axial microtubules. 
Staufen protein similarly fails to translocate posteriorly in cTmll mutants (152), 
suggesting that the entire transport particle containing Staufen protein and oskar 
RNA fails to be transferred to the posterior translocation apparatus. 
THE ROLE OF THE CYTOSKELETON IN RNA TRANSPORT DURING XENOPUS 
OOGENESIS As discussed above, the dynamics of transcript localization to 
the vegetal pole of Xenopus oocytes can largely be classified into two different 
patterns exemplified by Vg1 and Xcat-2 RNAs. 
Xcat-2 transcripts are distributed uniformly in early Xenopus oocytes (79) 
and are then sequestered into the METRO region of the mitochondrial cloud 
along with Xwnt-11, Xlsirt, and other RNAs (70, 90). This step appears to be 
mediated by selective entrapment of these RNAs, possibly similar to posterior 
polar-granule-localized RNAs in Drosophila (see below). Once localized to 
the METRO, Xcat-2 accompanies the mitochondrial cloud to the vegetal pole 
(90). Xcat-2 RNA then relocates to form a disc-like pattern at the tip of the 
vegetal pole (90). 
Vgl RNA is initially generally distributed in the oocyte and later localizes 
in the wedge-shaped pattern that overlaps but differs from that of Xcat-2 RNA 
at the vegetal pole (90). Accumulation of Vgl to the vegetal pole requires 
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functional microtubules but not actin microfilaments (94). Later Vgl RNA is 
found throughout the cortex of the vegetal hemisphere, unlike Xcat-2, which is 
localized to a more restricted area at the vegetal pole (90). During this late stage, 
Vgl RNA is enriched 30- to 50-fold in the detergent-insoluble fraction (96). 
Moreover, this association and cortical Vgl RNA localization are not sensitive 
to microtubule-depolymerizing drugs (nocodazole and colchicine) but rather 
to microfilament-disrupting agents (cytochalasin B) (94). This is an indication 
of a two-step localization mechanism for Vgl RNA where microtubules are 
required for translocation and actin filaments for anchoring (94). Recent ev-
idence indicates that Vgl RNA is associated with the endoplasmic reticulum 
(ER) and that Vgl RNA-ER complexes move to the vegetal pole along with the 
mitochondrial cloud in a microtubule-dependent fashion (154). 
Xcat-2 RNA injected into later oocytes is able to localize cortically without 
prior association with the METRO (99). This localization is dependent on mi-
crotubules and cannot occur in late oocytes (stage VI) when microtubules are 
no longer present (99). Moreover, the cis-acting elements within the Xcat-2 
3' -UTR that are required for METRO localization and cortical localization are 
different but overlapping (79, 99) (see below). In addition, injectedXcat-2 tran-
scripts that localize to the vegetal cortex without METRO do so in a pattern 
similar to Vgl (throughout the vegetal hemisphere) but different from that of 
endogenous Xcat-2 transcripts (99). Thus the differences in Vgl and Xcat-2 
localization patterns are a consequence of the fact thatXcat-2 is normally asso-
ciated with the METRO, rather than in some inherent difference in their ability 
to associate with the microtubule-based cytoskeleton. 
ROLE OF THE CYTOSKELETON IN RNA TRANSPORT IN OTHER CELL TYPES Ob-
servations of localized RNAs in living neurons in culture have suggested that 
they are present in particles composed of several RNAs and proteins including 
polyribosomes (155). These particles translocate inside the cell in a micro-
tubule- but not microfilament-dependent manner (155). Similar studies with 
MBP RNA injected into oligodendrocytes in culture indicate that the initially 
homogeneous MBP RNA becomes organized into granules that align on mi-
crotubule tracks in the peripheral processes (156). Endogenous MBP RNA is 
seen in granules and fractionates with the insoluble fraction in cell extracts, 
consistent with an association of "transport" granules with the cytoskeleton 
(156). 
Mammalian tau mRNA is localized to the proximal hillock of axons (112). 
This localization is mediated by the tau 3'-UTR (see below) and depends on 
microtubules (157). Interestingly, in vitro synthesized tau 3'-UTR injected into 
Xenopus oocytes localizes to the vegetal pole in a pattern identical to Vgl RNA 
(158). Moreover, this localization is dependent first on microtubules and then on 
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actin microfilaments, as for Vg 1 RNA (158). This observation demonstrates that 
once an RNA associates with the cytoskeletal transport apparatus, it localizes 
according to the type of cell in which it is. This occurs even if that RNA normally 
would not be present in this cell type. Thus the role of the cytoskeleton in RNA 
localization is highly conserved across evolution (see below). 
RNA localization also occurs in the yeastS. cerevisiae. In this budding yeast, 
ASHJ mRNA is localized first to the future bud site and then to the daughter 
cell by a mechanism involving actin microfilaments (128, 129). The role of 
microfilaments was demonstrated genetically using mutants in actin, myosin, 
profilin, and tropomyosin (which form part of the microfilament network). 
In contrast, disruption of microtubules by tubulin mutants, or disruption of 
the process of budding with MY02 mutants, has no effect on ASHJ transcript 
localization. 
In various somatic cells (e.g. fibroblasts and myoblasts) {3 -actin mRNA is 
localized to moving membranes (123, 124). This localization is not depen-
dent on microtubules or intermediate filaments but on microfilaments (123). 
Both RNA transport and anchoring are dependent on the actin cytoskeleton 
(123). 
The data described above indicate a key role for microtubules in directed 
mRNA transport, especially in Drosophila and Xenopus oocytes but also in po-
larized cells such as neurons and glia. In several cases, micro filaments also play 
a crucial role in RNA localization. However, it is unclear whether the instances 
of microfilament-based RNA localization indicate a role in directed RNA trans-
port versus in entrapment/anchoring of the RNA at the site of localization (see 
below). 
Entrapment/ Anchoring of RNA at the Site of Localization 
At stage 1 OB of Drosophila oogenesis, the micro tubules in the oocyte assem-
ble into subcortical arrays that direct circumferential ooplasmic streaming (see 
above). Thus at these stages, RNAs cannot be localized to the posterior by di-
rected transport on axial microtubules. Localized RNAs most likely are trapped 
at the posterior as they circulate through the oocyte cortex along with unlocal-
ized components of the cytoplasm. In support of this hypothesis, it has been 
shown that, while long-range transport of injected oskar RNA to the posterior 
requires microtubules (159), local injection of oskar RNA near the posterior 
pole of large (stage 10-11) oocytes or anywhere in smaller (stage 9) oocytes 
results in posterior localization in a microtubule-independent process. This ob-
servation suggests that short-range RNA transport and/or local entrapment of 
RNA is not dependent on microtubules. Trapping of injected oskar transcripts 
at the posterior pole fails in cTmll mutant oocytes (159), consistent with a role 
for the actin-based cytoskeleton in this process. 
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Egalitarian and Bicaudal-D may also be required for posterior anchoring or 
trapping ofRNAs such as oskar. In a situation where Bicaudal-Dis eliminated 
during late oogenesis (160), oskar RNA is initially localized normally but then 
is lost from the posterior pole. In these mutant oocytes kinesin-_8-galactosidase 
protein localizes normally to the posterior; therefore, the microtubule-based 
cytoskeleton involved in posterior transport is not disrupted. Posterior RNA 
localization occurs independent of Bicaudal-D, but maintenance of localization 
is dependent on Bicaudal-D function . Bicaudal-D may be involved in anchoring 
of RNA at the posterior pole of the oocyte, where it may function in a complex 
with Egalitarian (20). 
Anchoring of RNAs at the posterior pole of the Drosophila oocyte also re-
quires the integrity of the polar granules. These are large non-membrane-bound 
organelles composed of RNA and protein. Many posteriorly localized RNAs 
are either components of the polar granules or are associated with the granules 
(reviewed in 142). Mutations that disrupt the posterior polar granules (e.g. 
capuccino, oskar, spire, staufen, tudor, valois, and vasa) cause delocalization 
of posteriorly localized RNAs while ectopic assembly of polar granules at the 
anterior pole of the oocyte results in anterior localization of RNAs normally 
localized to the posterior (reviewed in 142), with the possible exception of the 
mtlrRNA (137). Developmental functions of the posterior polar granules and 
their associated localized RNAs are considered below. 
In Xenopus oocytes, anchoring of V g 1 RNA to the vegetal cortex of stage IV 
oocytes requires rnicrofilaments (94), which as for Drosophila, implicates the 
actin-based cytoskeleton in anchoring of RNA. Anchoring of Vg1 RNA also 
involves other-non-protein-coding-localized RNAs, Xlsirts (161). Injection 
of oligonucleotides complementary to Xlsirt transcripts causes delocalization of 
anchored Vg1 RNA in a manner similar to delocalization by P-actio-disrupting 
drugs ( 161 ). This observation indicates a connection between Xlsirt RNA, V g 1 
RNA, and F-actin; however, no direct interactions have been demonstrated. A 
role for the noncoding YC RNA in anchoring L5 RNA in the myoplasm of the 
ascidian oocyte and early embryo has also been postulated (102). However, no 
experimental evidence supports this hypothesis. 
Finally, for ASH1 RNA in yeast (128, 129) as well as for .8-actin mRNA 
in mammalian somatic cells (123), the actin-based cytoskeleton is necessary 
for localization (see above). However, the mechanism of localization of these 
RNAs is not clear; it has not yet been determined whether localization is by 
selective entrapment or by directed transport. 
RNA Transport/Anchoring Particles 
Specific trans-acting factors that interact with localized RNAs are discussed 
later in a separate section. Large ribonucleoprotein RNA transport particles 
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have been visualized at the light microscope level in several systems. For 
example, bicoid RNA is transported from the nurse cells into the oocyte in 
particles that contain Exuperantia protein (162; WE Theurkauf, TI Hazelrigg, 
personal communication). Maintenance of bicoid transcripts at the anterior 
pole, as well as transport of oskar RNA to the posterior pole, likely involves 
particles that contain Staufen protein (163, 164). In Xenopus, RNA-contain-
ing transport particles have been visualized (90, 99). In neurons and glia, large 
transport particles containing tau RNA (157) and MBP RNA (156), respectively, 
have been identified. Particles containing ASHJ mRNA have been detected in 
S. cerevisiae (129). The polar granules of Drosophila and the germinal granules 
of Xenopus are very large (organelle-sized) ribonucleoprotein (RNP) particles 
that are involved in anchoring localized RNAs at the posterior and vegetal 
poles of Drosophila and Xenopus oocytes, respectively. Several of the particles 
mentioned here contain not just proteins and mRNAs, but also non-protein-
coding RNAs (26, 90, 97, 134, 155). 
CIS-ACTING ELEMENTS THAT TARGET RNAs 
FOR LOCALIZATION 
In principle, there are two mechanisms by which an RNA molecule could 
be targeted for cytoplasmic localization. An RNA element or elements could 
be recognized by the localization machinery. Alternatively (only in the case 
of mRNAs), the polypeptide product of the RNA might be recognized and 
the RNA translocated intracellularly along with the polypeptide. The latter 
mechanism-through recognition of the signal peptide by the SRP apparatus-
may be used to bring mRNAs that encode secreted or transmembrane proteins 
into association with the endoplasmic reticulum (reviewed in 165). All other 
defined cytoplasmic RNA localization mechanisms involve recognition of RNA 
elements, particularly in the 3'-UTR of mRNAs. This section summarizes the 
methods used to map cis-acting sequence elements within localized RNAs. 
Generalities about the location of such elements within the RNAs are then 
drawn, and specific features of these elements are discussed. A subsequent 
section focuses on trans-acting factors that interact with these elements. 
Mapping of Cis-Acting Elements in Localized RNAs 
The general method used to map cis-acting sequences that function in RNA 
localization is to produce hybrid RNAs that include an exogenous reporter se-
quence (e.g. part of the E. coli {3-galactosidase RNA) and part or all of the 
RNA under study. These hybrid transcripts are introduced into the cell type of 
interest, and the reporter sequence is used as a tag to assay localization of the hy-
brid transcript. Initially the location of the transcripts was assayed by isolating 
parts of cells and carrying out RNase protection assays for the presence of the 
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transcripts (166). However, this method was replaced by the use of in situ hy-
bridization with antisense reporter RNA probes (e.g. antisense {3-galactosidase 
RNA probes) either in tissue sections or whole mounts. More recently-in the 
case of injected in vitro transcribed RNAs that have been ftuorescently tagged-
it has been possible to visualize the injected RNAs directly by fluorescence mi-
croscopy (159). Elements involved in various aspects of localization are then 
mapped further by testing a series of RNAs that carry deletions or mutations in 
the region that confers localization. Using these methods, cis-acting sequences 
sufficient (i.e. that are capable of conferring localization) or necessary (i.e. that 
when deleted result in failure of localization) can be mapped. Additional in-
formation may be gained by performing sequence alignments of the region of 
interest among different species. Conserved domains may represent important 
cis-acting elements required for localization (167). 
Methods available for introducing the hybrid RNA into the cell-type of inter-
est vary depending on the system. In Drosophila transgenic flies can be obtained 
that synthesize the hybrid transcripts in the correct cell type and often at the 
correct developmental stage. This can be accomplished using an inducible pro-
moter, a cell-type-specific promoter, or the promoter of the relevant endogenous 
gene. Thus there is seldom any question as to the in vivo significance of the 
results obtained. In many cases mutations exist that eliminate or reduce the func-
tion of the endogenous gene. This then enables one to test whether a trans gene 
carrying all of the endogenous regulatory and protein coding sequences rescues 
the mutant phenotype. If so, then transgenes in which specific RNA elements 
are deleted can be assayed for phenotypic rescue or lack thereof; thus both the 
effects on RNA localization, and the phenotypic consequences of disrupting 
that localization, can be tested simultaneously. 
A second common method for introducing the hybrid transcripts into the 
host cytoplasm is by injection of in vitro transcribed RNA. This has been done 
occasionally in Drosophila (60, 159) but is most common in Xenopus oocytes 
where transgenic technology is still rather primitive. In both Drosophila and 
Xenopus, the large size of the oocyte enables the injected RNA to be introduced 
at a specific location within the cell. 
A third method, used mostly for analyses of somatic cells in culture, is to 
transfect expression plasmids carrying the hybrid transcription unit into the 
cells, to wait for transcription and possible localization to occur, and then to 
assay the distribution of the hybrid RNAs. 
Cis-Acting Sequences for Localization Map 
to the 3'-Untranslated Region ofmRNAs 
Table 2 lists localized RNAs in which cis-acting localization elements have 
been mapped. For all mRNAs studied to date, sequences that are necessary for 
localization are found in the 3' -untranslated region (3'-UTR). In many cases, 
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Table 2 Cis-acting localization elements 
Sufficient subregions 
Species Transcript name Localization signal(s) (subelements) Reference 
Drosophila 
Add-hts 3'-UTR (345 nt) 345 nt sufficient _ a 
(ALEl = 150 nt) 
bicoid 3'-UTR (817 nt) 625 nt sufficient 166,176 
(BLEl = 53 nt) 
Cyclin B 3'-UTR (776 nt) 94nt+97nt 182 
(TCE = 39 nt) 
even-skipped 3' -UTR (190 nt) 163 nt (124 nt in UTR) 65 
fushi tarazu 3'-UTR (455 nt) Not defined 65 
hairy 3'-UTR (816 nt) Not defined 65 
Hsp83 3'-UTR (407 nt) 107 nt sufficient _b 
(protection) 
KJO 3'-UTR (1400 nt) 44 nt (TLS) sufficient 181 
nanos 3' -UTR (849 nt) 543 nt sufficient 43,141,185 
(localization) 
(TCE = 90 nt translational 
control) 
(SRE = 60 nt translational 
control) 
orb 3'-UTR (1200 nt) 280 nt sufficient 169 
oskar 3'-UTR(l043 nt) 924 nt sufficient 168, 184 
(localization) 
(BRE = 71 nt translational 
control) 
wingless 3'-UTR (1083 nt) 363 nt sufficient _c 
Mammals 
{3-actin 3' -UTR (591 nt) 54 nt or 43 nt sufficient 171 
(43 nt less active) 
BCJ 5' region ( 152 nt) 62 nt sufficient 173 
CaMKila 3' -UTR (3200 nt) Not defined 109 
tau 3' -UTR (3847 nt) 1395 nt sufficient 157,158 
(VgRBP-binding region 
= 624 nt) 
Xenopus 
Vgl 3'-UTR (1300 nt) 340 nt (V gLE) sufficient 170,183 
(85 nt repeat) 
TGF {3-5 3' -UTR (1102 nt) Not defined 198 
Xcat-2 3' -UTR (410 nt) 150 nt (mitochondrial 99 
cloud) 
120 nt (vegetal cortex) 
Xlsirt 3-12 repeat sequences 1\vo copies of repeat 97 
(79-81 nt) sufficient 
Yeast 
ASHJ 3'-UTR 250 nt sufficient 128 
"KL Whittaker, D Ding, WW Fisher, HD Lipshitz, manuscript in preparation. 
bSR Halsell, A Bashirullah, RL Cooperstock, WW Fisher, A Karaiskakis, HD Lipshitz, manuscript in prepa-
ration. 
cH Krause, personal communication. 
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these 3'-UTR elements are also sufficient for localization. Examples of mRNAs 
that contain such localization elements in Drosophila include anteriorly local-
ized transcripts such as bicoid, Add-hts, and KJO (22, 166; KL Whittaker, D 
Ding, WW Fisher, HD Lipshitz, manuscript in preparation), posteriorly lo-
calized transcripts such as oskar, nanos, orb, Cyclin B, and Hsp83 (43, 60, 
142, 168, 169; SR Halsell, A Bashirullah, RL Cooperstock, WW Fisher, A 
Karaiskakis, HD Lipshitz, manuscript in preparation), and apically localized 
pair-rule gene transcripts such as even-skipped,fushi-tarazu, hairy, and wing-
less (65). Xenopus also provides examples such as Vgl, TGF{3-5, and Xcat-2 
(99, 170). Interestingly, the rat tau RNA's 3' -UTR, which confers localization 
to the proximal hillock of rat axons, also mediates vegetal localization in Xeno-
pus oocytes (158). The chicken {3-actin 3' -UTR contains a cis-acting element 
sufficient for peripheral localization in chicken embryonic fibroblasts and my-
oblasts (171). The presence oflocalization tags in the 3' -UTR adds to the list of 
3' -UTR cis-acting elements involved in posttranscriptional mRNA regulation 
via control of stability, cytoplasmic polyadenylation, and translation (172). 
Cis-Acting Sequences for Localization Map Within 
Non-Protein-Coding RNAs 
Non-protein-coding RNAs also contain discrete elements that target the RNAs 
for localization (Table 2). Such elements have been mapped in Xenopus Xlsirt 
(97) and in neuronal BC-1 RNAs (173). 
Alternative Splicing Can Generate Localized 
vs Unlocalized RNA Isoforms 
Drosophila Cyclin B transcripts exemplify the importance of alternative splic-
ing of sequences that target localization (60). Alternative splicing within the 
3'-UTR generates two Cyclin B mRNA isoforms that differ by 393 nucleotides 
(nt). The shorter splice variant is synthesized preferentially during early oo-
genesis and is present throughout the pro-oocyte until stages 7-8. The longer 
splice variant is synthesized in the nurse cells later in oogenesis, during stages 
9-11. It is then transported into the oocyte, with an initially uniform distribu-
tion and is later concentrated at the posterior pole (60, 61). The transcript also 
exhibits perinuclear localization in the synctial embryo. Posterior localization 
of the long Cyclin B mRNA isoform is directed by the additional sequences 
spliced into its 3' -UTR relative to the short mRNA isoform (which is unable to 
localize) (60). 
Alternative splicing also plays a role in the localization of Add-hts tran-
scripts. Three classes of Add-hts contain unique 3' -UTRs introduced by alter-
native splicing (KL Whittaker, D Ding, WW Fisher, HD Lipshitz, manuscript 
in preparation). This alternative splicing also introduces variability in the 
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carboxy-terminal regions of the encoded Adducin-like protein isoforms (174; 
KL Whittaker, D Ding, WW Fisher, HD Lipshitz, manuscript in preparation). 
Only one of the mRNA variants, N4, exhibits transport into and localization 
within the oocyte (16; KL Whittaker, D Ding, WW Fisher, HD Lipshitz, 
manuscript in preparation). The N4 3'-UTR is necessary and sufficient for 
this transport and localization, suggesting that use of alternative 3'-UTRs is 
one mechanism by which different Add-hts protein isoforms are restricted to 
different subsets of the nurse cell-oocyte complex (KL Wittaker, D Ding, WW 
Fisher, HD Lipshitz, manuscript in preparation). 
Although not a consequence of alternative slicing, two actin RNA isoforms, 
encoding a"- and ,8-actin, possess isoform-specific 3'-UTRs that can confer 
differential intracellular targeting (175). ,8-actin transcripts are localized to the 
leading lamellae in both differentiating myoblasts and small myotubes, while 
a-actin transcripts associate with a perinuclear compartment. 
Discrete Localization Elements 
In the case of bicoid RNA, discrete elements within the 3'-UTR have been 
defined that confer distinct aspects of the RNA localization pattern. A decade 
ago a 625-nt subset of the bicoid 3'-UTR was found to be sufficient for anterior 
localization (166). At that time it was suggested that the secondary structure 
of the 3'-UTR, which can be folded into several long stem-loops, might be 
recognized by the localization machinery. Subsequent evolutionary sequence 
comparisons supported this hypothesis since the secondary structure appears 
to be conserved in distant Drosophila species (melanogaster, teissieri, and vir-
ilis) despite the fact that the primary sequence of these 3'-UTRs has diverged 
by up to 50% (167). Further, the 3'-UTR from one species can direct ante-
rior localization in a distant species (167). There is complementarity between 
two single-stranded regions predicted in the secondary structure, implying that 
tertiary base-pairing interactions might also be important (167). 
Subsequent analyses followed two different routes. In one set of experi-
ments, deletions were used to define an approximately 50-nt region, called 
bicoid localization element 1 (BLE1), which is necessary and sufficient (when 
present in two copies) to direct nurse cell-oocyte transport and anterior tran-
script localization during mid-oogenesis (176). However, anterior localization 
is lost later. BLE1 interacts with Exl protein, which might function in localiza-
tion to the anterior of the oocyte (177) (see below). In addition, linker scanning 
and point mutational analyses were used to define regions of the 3'-UTR that 
are important for anterior localization late in oogenesis and in the early embryo 
(163, 164). These regions interact with the double-stranded RNA-binding pro-
tein Staufen (178, 179), which functions to anchor bicoid RNA at the anterior 
of the late-stage oocyte and early embryo (see below). This is accomplished in 
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part by promoting quaternary (inter-3'-UTR) interactions via the complemen-
tary single-stranded regions mentioned earlier (164). 
Although not yet as well characterized as bicoid, it has similarly been possible 
to map discrete elements in other 3'-UTRs that direct subsets of the localization 
pattern. For example, the N4 isoform of Add-hts mRNA is transported from the 
nurse cells into the oocyte starting in the germarium, then localized cortically 
in the oocyte (stages 7- 8) and to the anterior pole (stage 9) (16, 44, 45, 180). In 
this case, a central (100-150 nt) element of the 3'-UTR, Add-hts localization 
element 1 (ALE1), is necessary and sufficient for nurse cell-oocyte transport as 
well as for cortical localization within the oocyte (KL Whittaker, D Ding, WW 
Fisher, HD Lipshitz, manuscript in preparation). The region that includes ALE1 
comprises the most extensive predicted secondary structure within the Add-hts 
N4 3'-UTR (KL Whittaker, D Ding, WW Fisher, HD Lipshitz, manuscript 
in preparation). When additional, adjacent parts of the N4-3'-UTR are added 
to ALE1, anterior localization is conferred starting at stage 9 (KL Whittaker, 
D Ding, WW Fisher, HD Lipshitz, manuscript in preparation). The KJ 0 3'-
UTR reveals several long inverted repeats, suggesting that it forms extensive 
secondary structure (22). A short region within the KJO 3'-UTR, TLS (trans-
port/localization sequence, 44 nt in length) is predicted to form a stem-loop 
structure and is necessary and sufficient for nurse cell-oocyte transport and 
anterior localization (181). Mutations that disrupt this structure block trans-
port and localization, while compensatory mutations that preserve the structure 
restore these processes. 
With respect to posteriorly localized RNAs, it has also been possible in some 
cases to map discrete localization elements. For example, as mentioned above, a 
181-nt element in the long isoform of Cyclin B mRNA is necessary for posterior 
localization (182). Similarly, a 107-nt element in the Hsp83 3'-UTR is neces-
sary and sufficient for association with the posterior polar plasm (SR Halsell, 
A Bashirullah, RL Cooperstock, WW Fisher, A Karaiskakis, HD Lipshitz, 
manuscript in preparation). 
Repeated/Redundant Localization Elements 
In the examples described above it was possible to define discrete, relatively 
small ( < 150 nt) localization elements that confer specific aspects of localiza-
tion. In other instances, while discrete elements have been identified that direct 
localization, there is some redundancy in the system such that more than one 
localization element capable of conferring a particular aspect of the localization 
pattern, is present in the RNA. 
An example comes from the Xenopus Vgl 3'-UTR. A 340-nt region within 
the 3'-UTR is necessary and sufficient for vegetal localization of Vgl RNA 
(170). Deletion analysis indicates that there is considerable redundancy within 
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this region but that critical elements can be defined that lie at each end (183). An 
85-nt subelement from the 5' end of the region, when duplicated, is sufficient 
to direct vegetal localization (183). 
A second example is in the orb 3'-UTR (169). In early oogenesis, orb.tran-
scripts accumulate preferentially in the pro-oocyte (stage 1). They localize 
transiently to the oocyte posterior (stages 2-7) and then to the oocyte anterior 
(stages 8-10). A 280-nt element is sufficient to confer oocyte accumulation, 
posterior localization, and then anterior localization. Further analysis has shown 
that when the element is split in two, each half on its own confers oocyte ac-
cumulation, although the level of accumulation is reduced relative to the intact 
element (169). Several possibilities could account for this result. Each element 
may constitute an independent binding site for the localization machinery, and 
the presence of both elements might recruit more localization factors. Alterna-
tively, the two elements may interact with each other to present a better binding 
site and recruit a single binding factor. 
A third example comes from analysis of the chicken {3-actin 3'-UTR (171). 
{3-actin mRNA is localized to the leading edge oflamellae in chicken embryonic 
fibroblasts and myoblasts. A so-called peripheral zipcode element consisting of 
the first 54 nt of the 3'-UTR is sufficient to direct localization of a heterologous 
transcript. When this element is deleted from the full-length 3'-UTR, the tran-
script is still able to localize, suggesting the presence of a redundant element. 
An inspection of the remainder of the 3'-UTR revealed a region of homology 
to the 54-nt zipcode within a more 3'-located 43-nt sequence. When this 43-nt 
region is present on its own, it is able to direct localization, albeit less effec-
tively than the 54-nt element. These data suggest functional redundancy, but a 
functional analysis gave complicated results. Transfection of oligonucleotides 
complementary to each element individually significantly reduced localization 
(171). This observation may suggest that both elements are required in their 
natural context to mediate localization and, therefore, that they are not fully 
redundant. However, each element can mediate localization in isolation. In 
addition, antisense oligonucleotides used may have recognized both elements 
(since they share sequence homology) and thus simultaneously inactivated both 
localization elements. 
A final case of repetition comes from the noncoding Xlsirts. These RNAs 
include repeated sequence elements flanked by unique sequences. The repeated 
element is 79-81 nt long and is tandernly repeated 3-13 times (97). Vegetal lo-
calization can be conferred by as few as two of the 79-nt sequence elements (97). 
Dispersed/Nonredundant Localization Elements 
In contrast to the aforementioned examples, in some cases it has been difficult 
to map discrete localization elements. For example, the nanos 3'-UTR contains 
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a 547-nt region that is necessary and sufficient to confer localization (43). 
Two overlapping subregions map within this larger region, either of which 
are capable of conferring localization. However, these subregions are 400 and 
470 nt in length, respectively, and cannot be subdivided without disrupting 
localization ( 43 ). Another possible example is the 1 043-nt oskar 3'-UTR (168). 
In this case deletions have been used to define elements necessary for distinct 
aspects of oskar RNA localization. However, it has been difficult to demonstrate 
sufficiency of individual elements for any specific aspect of localization (168). 
In principle, several scenarios might prevent definition of discrete and small 
( < 150 nt) elements sufficient for localization. For example, there might be 
several dispersed elements, each necessary for localization, distributed over a 
large region. Deletion of any one of these elements would disrupt localization. 
Alternatively, the arrangement of specific localization elements within the larger 
region or the secondary structure of the RNA might preclude the use of gross 
deletional studies to define subregions sufficient for localization. 
Additive Function of Localization Elements 
Implicit in much of the preceding discussion is the fact that different sub-
sets of the RNA confer different aspects of the localization pattern. In other 
words, localization elements act additively. Examples already mentioned are the 
bicoid 3'-UTR, which has distinct elements for early (BLE1) vs later (Staufen-
mediated) localization to the anterior pole, and the Add-hts N4 3'-UTR, which 
has an early transport and cortical localization element (ALE1) and distinct ele-
ments that function in anterior localization. In each case, the combination of the 
defined elements (with possible contributions from other undefined elements) 
directs localization with the correct spatial and temporal dynamics. 
Elements That Function in Translational Control During 
or After Localization 
Several localized RNAs in the Drosophila oocyte are not translated until they 
are localized. For example, oskar RNA is not translated until it is localized to 
the posterior pole of the stage 9 oocyte. Translation of unlocalized oskar RNA 
leads to major developmental defects. Thus there is an intimate and important 
link between localization and translational control of oskar RNA. Sequence 
elements for translational control are separable from those that function in lo-
calization per se. Elements known as Bruno response elements (BREs) have 
been mapped within the oskar 3'-UTR and are necessary and sufficient for pre-
venting translation of unlocalized RNA. Three discrete segments (A, B, and 
C) within the 3' -UTR bind an 80-kDa protein (Bruno) that mediates transla-
tional repression (discussed in the next section) (184). These segments share 
a conserved 7- to 9-nt sequence [U(G/A)U(A/G)U(G/A)U] that is present as a 
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single copy in elements A and B, and in two copies in element C. Mutation of 
this sequence abolishes binding of Bruno and thus translational repression of 
unlocalized oskar RNA (184). 
A second example comes from the nanos RNA. Unlike oskar RNA, which 
becomes tightly localized to the posterior pole of the oocyte, some unlocalized 
nanos RNA always exists in the embryo even after most of it is localized to 
the posterior. This unlocalized nanos RNA must be translationally repressed 
in order to prevent pattern defects in the early embryo (43, 139-141, 185). 
This translational repression is mediated by a 184-nt translational control el-
ement (TCE) in the nanos 3'-UTR (140) that contains two separable Smaug 
recognition elements (SREs), which bind a translational repressor to be de-
scribed in the next section (141). These elements map within evolutionarily 
conserved regions of the nanos 3'-UTR (185). SRE1 lies between nucleotides 
(nt) 25 and 40 (141) within a 90-nt region (nt 1-90 of the 3'-UTR), which was 
shown independently to confer translational repression (185). SRE2 maps to 
nt 130-144, downstream in the 3'-UTR (141), within an adjacent 88-nt region 
(nt 91-178), which independent analyses showed has limited ability to repress 
translation (185). The SREs can form stem-loops (14-23 nt in length) with 
a highly conserved loop sequence (CUGGC) while the stem sequence is not 
conserved. Point mutations in the loops abolish binding of Smaug protein and 
eliminate translational repression of nanos RNA. 
The BREs in the oskar 3'-UTR and the SREs in the nanos 3'-UTR are clear 
examples of discrete elements that are repeated within the 3'-UTRs and are 
largely functionally redundant. 
A translational control element has also been mapped within the Cyclin 
B 3'-UTR, to a 39-nt region distinct from the posterior localization element 
(see above) (60, 182). In this case, the translational control element represses 
translation of localized maternal Cyclin B mRNA until late stage 14, about 
11 h after fertilization. Deletion of the element results in premature translation, 
starting an hour after fertilization (182). The functional significance of this 
translational control has not been determined. 
Primary, Secondary, Tertiary, and Quaternary Structures 
A final question to be addressed here is the nature of the localization and 
translational control elements themselves. That is, is it the primary, secondary, 
tertiary, or quaternary structure that is recognized by the localization and trans-
lational control machinery? Instances of each of these possibilities have been 
mentioned in the preceding discussion. Several conserved primary sequence 
elements have been defined. For example, the SREs in the nanos 3'-UTR 
include a highly conserved loop sequence (CUGGC) recognized by Smaug 
(141), and the BREs in the oskar 3'-UTR contain a highly conserved sequence 
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[U(G/A)U(NG)U(G/A)U] important for Bruno binding (184, 186). Similarly, 
a conserved sequence in Vgl and several other 3'-UTRs (TGF{3-5, Xwnt-11, 
Xlsirt, tau, oskar, nanos, and gurken) has been implicated in localization (187). 
As mentioned above, the chicken {3-actin 3'-UTR contains two regions that 
confer peripheral localization (171); these regions each contain two conserved 
motifs (GGACT and AATGC). 
The importance of RNA secondary structure in localization has been clear 
for some time (e.g. bicoid 3'-UTR) (166, 167). Conserved primary sequence 
elements are often parts of a stem-loop (e.g. SREs) and are likely to be bound 
by factors that interact with single-stranded RNA. Other examples of important 
stem-loop structures are the KJO TLE (181) and, possibly, the Add-hts ALE1 
(KL Whittaker, D Ding, WW Fisher, HD Lipshitz, manuscript in preparation). 
Initially it was proposed that tertiary structure is also important for localiza-
tion based on the discovery of complementarity between two loops within stem-
loop III of the bicoid 3'-UTR (166, 167). These complementary regions actu-
ally undergo quaternary interactions (i.e. between different 3'-UTR molecules) 
mediated by the double-stranded RNA-binding Staufen protein (see below) 
(163, 164). 
TRANS-ACTING FACTORS INVOLVED IN RNA 
LOCALIZATION AND TRANSLATIONAL 
CONTROL OF LOCALIZED RNAs 
The previous section outlined the cis-acting sequences that function in RNA 
localization. It also discussed the sequences involved in localization as well 
as the elements involved in translational control of mRNAs during or after 
localization. Here, the focus is on trans-acting factors that function during 
RNA localization. These factors can function in RNA localization per se or in 
translational control during or after localization. The latter class of factors is 
included only if transhttional control is related directly either to the localization 
process or to the functional significance of RNA localization. 
Identification of Trans-Acting Factors 
Three strategies have led to the identification of trans-acting factors that func-
tion in RNA localization and/or translational control of localized RNAs. The 
first strategy, genetic definition of genes involved in RNA localization followed 
by molecular cloning of the genes and molecular biological and biochemi-
cal analyses of their encoded products, is restricted to D. melanogaster and 
S. cerevisiae. Examples are Drosophila Bicaudal-C, Bicaudal-D, Exuperantia, 
Homeless, K10, Squid, Staufen, Swallow, and Vasa. Although this strategy 
ensures that the gene product is involved in RNA localization, it cannot be 
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determined at the outset whether the effects on RNA localization are direct or 
indirect. 
A second strategy proceeds in the opposite direction by starting with bio-
chemical searches for factors that bind defined RNA elements involved in local-
ization and/or translational control. Ultimately, the gene encoding the identified 
factor is cloned and, in Drosophila, also mutated in order to assay function of the 
endogenous protein. With this method, it is known from the outset that the factor 
interacts directly with the target RNA; however, one has no assurance that the 
identified protein will indeed function in RNA localization/translational control 
rather than in some other aspect of RNA metabolism. Examples of trans-acting 
factors identified in this way are Bruno, Smaug, and Exl in Drosophila, and 
V gl RBP and Vera in Xenopus. 
A final approach (not so much a strategy) that has led to the identification 
of factors involved in RNA localization has derived from molecular screens 
for gene products (RNA or protein) with interesting intracellular distributions 
(e.g. localization) or with interesting molecular homologies (e.g. RNA-binding 
motifs). In this case, as for the second strategy described above, one has no 
prior indication that the gene product functions in localization or translational 
control. However, if it is present in the right place at the right time, and possesses 
the appropriate molecular properties, the gene product may have a function in 
the process of interest. Examples of gene products identified in this way are 
Oo18 RNA-binding protein (Orb) andPgc RNA in Drosophila, theXlsirtRNAs 
in Xenopus, and the YC RNA in ascidians. 
Factors That Interact Directly with Defined 
RNA Elements 
STAUFEN PROTEIN (DROSOPHILA) Alleles of the staufen gene were first recov-
ered as maternal effect mutations with defects in anterior and posterior (abdom-
inal) pattern in the Drosophila embryo (188). It was implicated in bicoid RNA 
localization to the anterior since bicoid RNA is partially delocalized in early 
embryos produced by mutant mothers (7, 32, 189). In staufen mutants oskar 
RNA is maintained at the anterior of the oocyte until stage 10 when it delo-
calizes (25) (in wild-type oocytes oskar RNA is transported from the anterior 
pole to the posterior by stage 9). Therefore, staufen is essential for initiation of 
posterior transport of oskar RNA. Moreover, weak staufen alleles show normal 
posterior localization of oskar RNA at stage 9, but the posterior localization is 
lost in later oocytes (stage 11) indicating that Staufen is also required to main-
tain posteriorly localized oskar RNA (190). During oogenesis Staufen protein 
first appears uniformly in stage 3-4 egg chambers, and by stage 8 it is present 
in a ring at the oocyte anterior as well as at the posterior of the oocyte (179). 
By stage lOB Staufen protein is at the posterior pole of oocyte; therefore, oskar 
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RNA and Staufen protein colocalize. In the early embryo, Staufen protein 
colocalizes with oskar RNA at the posterior pole and with bicoid RNA at the 
anterior pole (179). 
Staufen is a double-stranded RNA-binding protein (178). Varying the amount 
of the Staufen target RNAs (bicoid or oskar), or ofStaufen protein, indicates that 
the amount of Staufen protein recruited to the anterior or posterior pole depends 
on the amount of bicoid or oskar RNA present; thus the RNA targets rather than 
Staufen protein are limiting. Injected in vitro transcribed bicoid 3'-UTR RNA 
recruits Staufen protein into particles that colocalize with microtubules near 
the site of injection in the early embryo (163 ). The formation of these particles 
requires specific 3'-UTR elements previously defined as important for bicoid 
RNA localization (see above). Specifically, evidence suggests that two single-
stranded regions of stem-loop III within the bicoid 3' -UTR form intermolecular 
double-stranded RNA hybrids (i.e. via quaternary interactions) that are bound 
by Staufen protein (164). Staufen protein also interacts later in embryogenesis 
with the prospero 3'-UTR in neuroblasts and is necessary for basal localization 
of prospero transcripts (127). 
Given that Staufen interacts with the best-characterized 3'-UTRs oflocalized 
RNAs (those in bicoid and oskar RNAs), that it is an RNA-binding protein, and 
that mutations exist both in the staufen gene and in the genes that encode its 
target RNAs, Staufen is by far the best-understood trans-acting factor involved 
in RNA localization. 
EXL PROTEIN (DROSOPHILA) BLEl is a 53-nt element in the bicoid 3'-UTR 
that is sufficient (when present in two copies but not one) to direct early 
nurse cell-oocyte transport and anterior localization of RNA (see above) (176). 
2xBLEl was used in UV-crosslinking assay to search for directly interacting 
proteins (177). A single protein of 115 kDa (Exl) was found to bind 2xBLEl 
but not 1xBLE1, consistent with a role in localization. Definition of Ext-
binding sites within BLE1 and mutation of these sites gave results consistent 
with a role for Exl in BLE1-mediated anterior localization. Exl might inter-
act directly with BLE1 in the bicoid 3'-UTR during localization, and it might 
mediate Exuperantia protein interaction with bicoid RNA in the localization 
particles (177) (see below for discussion of Exuperantia). To date, the gene 
encoding Exl has not been cloned, and mutations in the gene have not been 
identified. 
BRUNO PROTEIN (DROSOPHILA) Bruno, an 80-kDa protein, was identified in 
a UV-crosslinking screen for trans-acting factors that bind the oskar 3' -UTR 
(184). There are three binding sites (BREs) in the oskar 3'-UTR that share a 
7- to 9-nt motif. Mutations in these elements abolish Bruno binding in vitro 
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(184). Endogenous oskar mRNA is translated only after the transcript is local-
ized to the posterior of the oocyte in stages 8-9 (184). An oskar [BRE-] trans-
gene results in premature translation of oskar RNA during stages 7-8, prior 
to oskar RNA localization, producing gain-of-function phenotypes (double-
posterior or posteriorized embryos) (184), consistent with spatially inappropri-
ate Oskar protein expression (75, 76). BRE elements can confer translational 
repression on a heterologous transcript (184). Bruno-mediated translational 
control of other transcripts is suggested by the ability of Bruno protein to bind 
gurken RNA (184). 
The gene encoding Bruno was recently cloned (186). The sequence reveals 
RNPIRRM-type ribonucleoprotein RNA-binding domains consistent with di-
rect interaction with RNA. The RNPIRRM-domain RNA-binding motif was 
first defined in yeast mRNA poly(A)-binding protein and mammalian hnRNP 
protein A1 (reviewed in 191). The gene encoding Bruno is a previously identi-
fied genetic locus, arrest, which is necessary for female as well as male fertility 
(192, 193). This observation, together with the fact that arrest mutants display 
defects in oogenesis prior to the time that Bruno binds oskar RNA, suggests 
that Bruno regulates other transcripts in addition to oskar RNA. 
Bruno also interacts with Vasa protein as assayed by far-Western analysis 
. (186). Vasa is itself an RNA helicase related to eiF-4A, which functions in 
translation initiation (194-196). This suggests a possible mechanism for Bruno; 
Bruno may protect oskar RNA from premature translational activation by the 
Vasa protein (186). 
Identification and cloning of Bruno, and its correlation with a previously iden-
tified genetic locus, is the first instance in which a trans-acting factor involved 
in translational control of a localized RNA has been identified biochemically 
and then studied both molecularly and genetically. 
SMAUG PROTEIN (DROSOPHILA) As described above, translational repression 
of unlocalized nanos mRNA (43, 140, 141) is accomplished through two ele-
ments that bind in vitro to Smaug, a 135-kDa protein (141). Mutation of these 
SREs abolishes Smaug binding in vitro. Embryos from nanos [SRE-] trans-
genic mothers lose head structures, which is consistent with translation of nanos 
RNA throughout the embryo rather than solely at the posterior (141). Smaug 
binding alone is sufficient to mediate translational repression since a trans gene 
containing three SREs but no other part of the nanos 3' -UTR is translationally 
repressed (141). The gene encoding Smaug has not been cloned. 
VOl RNA-BINDING PROTEIN (RBP) (XENOPUS) UV crosslinking has also been 
used to identify trans-acting factors that bind to the Vgl 3'-UTR, which func-
tions in vegetal localization of Vgl RNA in Xenopus oocytes (197). The cross-
linking experiments led to the identification of a 69-kDa protein called Vg1 
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RNA-binding protein (RBP). Vg1 RBP may also bind in vitro to the 3'-UTR of 
a second vegetal pole-localized RNA, TGF{3-5 (187, 197), but not toAn2 RNA, 
which is localized to the animal hemisphere. The precise role of Vg1 RBP in 
vegetal RNA localization is not clear. Evidence indicates that it mediates the as-
sociation of V g I RNA with micro tubules (199), which are necessary for vegetal 
RNA localization (see above). Based on the results of UV-crosslinking experi-
ments Vg1 RBP is likely to be a member of an RNP complex containing up to 
six proteins plus V g I mRNA (200). Six protein bands (one of which is likely to 
be V g1 RBP) were identified from stage ll-lli oocyte extracts, corresponding 
to the period during which Vgi RNA is localized (200). Fewer proteins were 
labeled in earlier and later stage oocyte extracts, at times during which Vgi 
RNA is not being localized. 
VERA PRarEIN (XENOPUS) In a search for trans-acting factors that bind the 
Vgi localization element a new 75-kDa protein, Vera, was purified (154). A 
mutant form of the Vgl localization element (deleted for three out of four 
repeated sequence motifs) that does not bind Vera in vitro exhibits impaired 
localization in vivo (154). Vera protein co-sediments with Trap-a, an integral 
membrane protein associated with the protein translocation machinery of the 
endoplasmic reticulum (ER) (154). Vera may link Vgl mRNA to the vegetal 
ER subcompartrnent while the ER (along with Vgl RNA) is transported via 
microtubules to the vegetal pole. 
Other Factors That Function in RNA Localization 
EXUPERANTIA PRarEIN (DROSOPHilA) The genetic analyses that led to the 
identification of staufen as functioning in bicoid RNA localization also led to 
the identification of exuperantia (188, 189). The first observable bicoid RNA 
localization defect in exuperantia mutants is loss of apical transcript localization 
in nurse cells (32) at a stage at which Exuperantia protein is localized around 
the nurse cell nuclei (201, 202). Exuperantia protein is highly concentrated in 
the anterior cortex of the oocyte between stages 8 and 10 (162, 201). In stage 10 
egg chambers mutant for exuperantia, bicoid RNA delocalizes from the anterior 
of the oocyte (7, 150). In late oocytes (stage 14) mutant for exuperantia, bicoid 
RNA is released from the microtubule-based cytoskeleton (147). However, 
Exuperantia protein is not present in late oocytes or in embryos, indicating 
that Exuperantia is involved in establishing but not in maintaining anterior 
bicoid RNA localization (201, 202). 
Visualization of an Exuperantia-GFP fusion protein in live oocytes (162) 
demonstrates that Exilperantia is present in large particles that are transported 
from the nurse cells into the oocyte through the ring canals (see above). Trans-
port of these Exuperantia-containing particles appears to be a multistep pro-
cess: Colchicine-sensitive steps are transport within the nurse cells and 
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anchoring at the anterior of the oocyte; whereas transport through the ring 
canals into the oocyte is insensitive to both microtubule and microfilament 
inhibitors (162; WE Theurkauf, TI Hazelrigg, personal communication). Ex-
uperantia may function in this microtubule-independent transport of bicoid 
transcripts through the ring canals into the oocyte (151). 
Taxol stabilizes microtubules and causes aberrant microtubule bundles in the 
oocyte that contain ectopically localized bicoid transcripts (150). Taxol-treated 
exuperantia mutant oocytes do not exhibit ectopic bicoid transcript localization 
(150). The microtubule networks in exuperantia oocytes are normal. These 
results are consistent with bicoid RNA association with ectopic microtubules 
requiring Exuperantia protein. 
Deletion of the cis-acting element BLE1 from the bicoid 3' -UTR mimics the 
bicoid transcript delocalization defects caused by exuperantia mutants (176). 
However, BLE1 specifically binds a protein called Exl (see above) and Exuper-
antia alone can bind RNA only nonspecifically (177). Exuperantia protein may 
interact with Exl protein in bicoid RNA localization particles. While Exuperan-
tia does not interact specifically with bicoid RNA, it does function specifically 
in bicoid RNA localization; other anteriorly localized RNAs such as Add-hts, 
Bicaudal-D. KJO, and orb are not delocalized in exuperantia mutant oocytes 
(16, 37). 
SWALLOW PROTEIN (DROSOPHILA) The third genetic locus initially shown to 
be necessary for bicoid transcript localization during oogenesis is swallow 
(7, 189). Subsequent analyses implicated it in the cortical and anterior localiza-
tion of a second RNA, Add-hts (16, 174; KL Whittaker, D Ding, WW Fisher, 
HD Lipshitz, manuscript in preparation). The swallow locus is not necessary for 
the transient anterior positioning of other RNAs such as Bicaudal-D. KJO, and 
orb (37). Swallow protein maintains cortical localization of transcripts such as 
bicoid and Add-hts as well as of RNPs such as the polar granules ( 44, 45). With 
regard to bicoid, Swallow appears to be involved in maintaining rather than 
establishing bicoid transcript association with microtubules since taxol-treated 
swallow oocytes exhibit ectopic bicoid transcript localization (150). The Swal-
low protein may possess a highly divergent RNPIRRM motif suggestive of a 
direct interaction with RNA (203). Swallow protein is distributed throughout 
the oocyte at stages 5- 7 and at its anterior cortex at stages 8-10, consistent with 
localization of Add-hts and bicoid RNAs to these regions (44, 45, 204). 
OSKAR PROTEIN (DROSOPHILA) Nonsense mutants such as oskar54 show ab-
normal oskar RNA localization (24, 25). In these mutants oskar RNA localizes 
to the posterior in stage 8 but subsequently delocalizes, indicating a role for 
Oskar protein in anchoring oskar RNA at the posterior. Directly or indirectly, 
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Oskar protein's role in oskar transcript localization is mediated by the oskar 
3'-UTR since a chimeric oskar 3'-UTR construct localizes to the posterior 
and is maintained there in wild type but fails to be maintained there in an 
oskar54 mutant (190). Further support for this scenario is the observation that 
in D. melanogaster, a transgenic D. virilis oskar RNA is able to localize to the 
posterior but fails to maintain its position at the oocyte posterior in the absence 
of D. melanogaster Oskar protein (205). D. virilis Oskar can direct posterior 
abdominal patterning but not pole-cell formation. This observation indicates 
that pole-cell formation may require a high concentration of Oskar protein and 
that this is provided for by anchoring high concentrations of oskar RNA at the 
posterior. Oskar protein nucleates the formation of the posterior polar granules, 
organelles that function in germ-cell formation and specification (see below). 
Oskar protein may interact directly with the oskar RNA's 3'-UTR to maintain 
transcript localization. Alternatively, Oskar function may be indirect in nu-
cleating formation of polar granules that in tum are needed for oskar RNA 
localization. 
VASA PROTEIN (DROSOPHILA) Vasa protein is a component of the perinuclear 
"nuage" material in the nurse cells and also of the polar granules at the posterior 
pole of the Drosophila oocyte (194, 196, 206-208). Loss of vasa function 
results in destabilization of the polar granules and delocalization of posteriorly 
localized RNAs (188, 194, 196, 206-208). Vasa protein is a founding member 
of the DEAD-box family of ATP-dependent RNA helicases (194, 207), and it 
binds duplex RNA (196). There is no evidence for specific binding of Vasa 
to any localized RNA; however, far-Western analysis has demonstrated that 
Vasa protein interacts directly with Bruno protein, which in tum binds directly 
to the BRE translational control elements in the oskar RNA's 3'-UTR (see 
above) (186). Transcripts encoding the zebrafish homolog of Vasa are localized 
subcellularly beginning at the two-cell stage and segregate into the primordial 
germ cells (209). This observation suggests likely evolutionary conservation 
of Vasa function in metazoan germ plasm. 
HOMELESS PROTEIN (DROSOPHILA) Homeless is another member of the 
DEAD/DE-H family of RNA-binding proteins (40). Its amino terminal por-
tion contains a region that bears homology to yeast splicing factors PRP2 and 
PRP16 and to the Drosophila Maleless protein (40). Transport and localiza-
tion of gurken, oskar, and bicoid transcripts are severely disrupted in homeless 
mutant ovaries, which also contain reduced amounts of Kl 0 and orb transcripts 
(40). In contrast, Bicaudal-D and Add-hts transcript localization is unaffected 
( 40). It is unknown whether Homeless protein interacts directly with any of the 
affected transcripts. 
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ORB PRarEIN (DROSOPHILA) Orb protein contains two RNP/RRM-type RNA-
binding domains and functions in antero-posterior and dorso-ventral patterning 
during Drosophila oogenesis (23, 149, 210). orb mutants affect the transport 
and localization of several RNAs including Add-hts, Bicaudal-D. Kl 0, gurken 
and oskar (149, 210). For example, in wild-type oocytes during stages 8-10, 
gurken mRNA is usually restricted to the dorsal side of the nucleus at the antero-
dorsal pole. In orb mutants, however, gurken transcripts are present throughout 
the entire anterior of the oocyte. In the wild type, oskar mRNA is localized to 
the posterior pole of the oocyte. In orb mutants oskar transcripts are distributed 
throughout the oocyte. Direct binding of Orb protein to either RNA has not 
been demonstrated. 
SQUID PRarEIN (DROSOPHILA) Squid is a member of the hnRNP family of 
RNA-binding proteins and was identified as functioning in dorso-ventral axis 
formation (211). There are three protein isoforms that share a common amino 
terminus containing two RNA-binding motifs. Two of these isoforms, Squid-A 
and Squid-B. are present in the oocyte. Squid is required for the correct dorsa-
anterior localization of gurken mRNA in the oocyte. In squid mutant ovaries, 
gurken transcripts are localized throughout the anterior of the oocyte rather 
than just antero-dorsally (211). Since gurken is unusual in that it is transcribed 
in the oocyte nucleus (R Cohen, personal communication), Squid's function 
in gurken transcript localization may initiate in the oocyte nucleus. It is unknown 
whether Squid interacts directly with the gurken mRNA or with the gurken pre-
mRNA. As for K1 0 (below), Squid may function in vectorial transport of gurken 
transcripts out of the oocyte nucleus. 
KlO PRarEIN (DROSOPHILA) KJO gene function is required during stage 8 of 
oogenesis for localization of gurken mRNA adjacent to the oocyte nucleus 
at the antero-dorsal tip of the oocyte (21, 212). K10 protein is restricted to 
the oocyte nucleus (213) but does not regulate gurken transcript production or 
stability (212). Since gurken is transcribed in the oocyte nucleus (R Cohen, 
personal communication) and becomes restricted to the oocyte cytoplasm dorsa-
anteriorly to the oocyte nucleus, K10 protein might function specifically in 
vectorial nucleo-cytoplasmic transport of gurken transcripts (R Cohen, personal 
communication). Whether this function is through direct interaction with the 
gurken mRNA is not known at present. 
BICAUDAL-C PRarEIN (DROSOPHILA) Mutations that reduce Bicaudal-C gene 
dosage result in defects in RNA localization in the oocyte: Most oskar RNA 
remains at the anterior pole of the oocyte and early embryo instead of being 
transported to the posterior by stage 9 ( 18). Possibly as a consequence, in these 
Bicaudat-e mutants, nanos RNA is localized ectopically near the anterior pole 
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in patches on the dorsal and ventral sides rather than at the posterior pole 
as in wild type (18). These embryos develop a bicaudal (double-abdomen) 
phenotype. Bicaudal-C mutations have no effect on gurken or orb transcript 
localization to the anterior pole. Females homozygous for strong Bicaudal-C 
alleles produce oocytes that do not form anterior chorion as a consequence 
of defects in follicle cell migration over the oocyte anterior. Bicaudal-C is a 
transmembrane protein that has two conserved cytoplasmic domains (18): an 
Eph domain that is present in transmembrane receptor tyrosine kinases and is 
involved in signal transduction, and a KH domain that has been implicated in 
binding of single-stranded DNA or RNA. Since Bicaudal-C RNA is localized 
to the anterior of the oocyte, it is reasonable to assume that the Eph domain 
functions in the intercellular signaling from oocyte to follicle cells that programs 
their migration (18). The KH domain might bind to and interact with the oskar 
transcripts during their localization, possibly functioning in their transfer to the 
machinery that transports RNA to the posterior (see above) (18). 
BICAUDAL-D PR01EIN (DROSOPHILA) Bicaudal-D function has been covered 
with respect to RNA transport and the oocyte cytoskeleton above. The Bicau-
dal-D protein includes a region with homology to the coiled-coil domains of 
several cytoskeletal proteins and is required for maintenance of oskar RNA 
localization at the posterior pole of the oocyte (160). 
EGALITARIAN PR01EIN (DROSOPHILA) In egalitarian mutants the Bicaudal-D, 
orb, and KIO RNAs do not accumulate in the oocyte (25). In addition, these 
RNAs no longer coprecipiate with the cytoskeletal fraction of oocytes as in the 
wild type (147). Egalitarian protein contains regions homologous to c10G6.1 
from Caenorhabditis elegans, an EST from Arabidopsis thaliana, and ribonu-
clease D from Haemophilus influenzae (20). It is also predicted to include a 
coiled-coil region. Egalitarian protein localization to and within the oocyte 
is dependent on microtubules (20). Further, the Egalitarian and Bicaudal-D 
proteins copurify (20). Egalitarian and Bicaudal-D may be components of the 
cytoskeletal apparatus involved in RNA localization. 
BULL WINKLE (DROSOPHILA) Mutations in the bullwinkle gene have several de-
fects in posterior body patterning (214, 215). The bullwinkle gene is required 
to localize oskar transcripts to the posterior of the oocyte, to maintain oskar 
RNA at posterior, and to regulate the level of oskar protein (214, 215). Cloning 
of the bullwinkle gene has not been reported. 
AUBERGINE (DROSOPHILA) While previously aubergine had been implicated 
in dorso-ventral body patterning (192), two new alleles were identified in are-
cent genetic screen for genes involved in posterior body patterning (214, 216). 
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Aubergine functions to enhance the translation of oskar mRNA in the ovary, 
mediated through the oskar 3'-UTR (216). Aubergine's enhancement of oskar 
translation is independent of Bruno-mediated repression of translation since an 
oskar [BRE-] transgenic RNA still requires aubergine function for its trans-
lation (216). Cloning and molecular analysis of aubergine have not been 
reported. 
XLSIRT RNA (XENOPUS) Xlsirts are a family of nontranslatable, interspersed 
repeat transcripts that localize to the vegetal cortex of Xenopus oocytes (see 
above) (97, 161). These RNAs are involved in the localization of Vgl but not 
Xcat-2 transcripts. It is unknown whether Xlsirt and Vgl RNAs interact directly . 
or whether Xlsirt RNA function in Vgl transcript localization is indirect via the 
cytoskeletal network or as part of a localization particle/organelle. 
PGC RNA (DROSOPHILA) In Drosophila a non-protein-coding RNA, Pgc, is a 
component of the posterior polar granules and is required for pole cells to 
migrate normally and to populate the gonad (26). Reduction of Pgc RNA at 
the posterior pole results in a reduction in the amount of posteriorly localized 
nanos and germ cell-less RNA and Vasa protein (26). It is unknown whether 
Pgc RNA interacts with other posteriorly localized RNAs and/or with protein 
components of the polar granules. 
YC RNA (STYELA) As described above, the noncoding YC RNA is localized in 
the yellow crescent of Ascidian eggs and embryos (101). The 3' -UTR of PCNA 
RNA contains a 521-ntregion of complementarity to YCRNA (100), while the 
5' -UTR of ribosomal protein L5 mRNA exhibits 789 nt of complementarity 
to YC RNA (102). YC RNA may interact directly with these two RNAs in 
vivo (100- 102); however, no such interaction has been demonstrated, and its 
function remains unclear (see above). 
Summary 
In summary, genetic and molecular strategies have identified a host of trans-
acting factors that function in transcript localization. To date, although many 
of these are homologous to known RNA-binding proteins, only a handful have 
been shown to interact directly with specific localized RNAs. Many localized 
RNAs have collections of discrete cis-acting localization elements that mediate 
distinct aspects of their localization. It might therefore be predicted that many 
different trans-acting factors will function during localization of any one RNA, 
each binding to a different type of element and each possibly functioning at a 
different time and intracellular location. RNA localization particles are likely to 
consist of these directly interacting factors in addition to numerous others that 
are involved in linking the RNA to the cytoplasmic translocation machinery 
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as well as anchoring it at its intracellular target site. It would be surprising 
if evolution has not also utilized the base-pairing capability of RNA in the 
translocation and anchoring process. 
DEVELOPMENTAL FUNCTIONS OF RNA 
LOCALIZATION 
The cellular functions of RNA localization have been reviewed extensively (see 
e.g. 1, 217) and so are considered here only briefly. First, for mRNAs, localiza-
tion directs high-level synthesis of the encoded protein at the site of localization. 
Thus if protein function requires a high ·concentration (e.g. Drosophila Oskar 
in the polar granules), this requirement can be met through mRNA localization. 
Second, localizing an mRNA also excludes protein synthesis from other parts 
of the cell, thus reducing the amount of protein present in those regions. Often, 
not only is local protein synthesis directed by mRNA localization, but trans-
lational control mechanisms actually prevent translation of unlocalized RNA 
either during RNA transit to the target site (e.g. Drosophila oskar RNA) or 
of unlocalized RNA that remains after transcript localization is complete (e.g. 
Drosophila nanos RNA). 
A third postulated function of mRNA localization is to direct specific protein 
isoforms to particular regions of the cell. Often this is accomplished by alterna-
tive pre-mRNA splicing such that different 3'-UTRs direct different isoforms to 
different cytoplasmic domains (e.g. DrosophilaAdd-hts RNA). Fourth, intracel-
lular localization is used as a mechanism to segregate RNAs unequally between 
the products of cell division, particularly when these divisions are asymmet-
ric (e.g. ASHJ transcripts during yeast budding, prospero transcripts during 
Drosophila neuroblast division). Fifth, certain non-protein-coding RNAs are 
localized (e.g. Xenopus Xlsirts or Drosophila Pgc RNAs). The detailed role of 
these RNAs and of their localization is currently under intensive study. These 
RNAs may serve as structural components oflocalization particles or organelles 
such as the germinal granules. Alternatively, they may function in the RNA 
localization or anchoring process, possibly through sequence complementarity 
to mRNAs that are being localized. 
Specification of the Anterior-Posterior and Dorsal-Ventral 
Axes of the Drosophila Oocyte 
As mentioned above, the gurken mRNA is unusual in that it is synthesized 
in the oocyte nucleus (R Cohen, personal communication). It is localized to 
the posterior pole of the oocyte at stage 7, then to both the anterior and pos-
terior poles at stage 8, and finally to the antero-dorsal pole from late stage 8 
through stage 10 (21, 218). Gurken protein is a TGFa-like secreted growth 
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factor (21). Establishment of the antero-posterior and dorso-ventral axes of the 
oocyte is accomplished between stages 7 and 9 of oogenesis through signal-
ing between the oocyte and the surrounding follicle cells (34, 35). The Gurken 
protein functions as a key signal from the oocyte to the follicle cells in both of 
these processes. First, due to posterior-localized gurken RNA, local produc-
tion of Gurken protein at the posterior of the oocyte signals to the posterior 
follicle cells. This signaling is essential for establishing the antero-posterior 
oocyte axis and the polarization of the oocyte microtubule-based cytoskeleton 
that plays a crucial role in RNA localization. Subsequently, antero-dorsallocal-
ized gurken RNA directs local Gurken protein synthesis, enabling oocyte-nurse 
cell signaling that establishes the dorso-ventral axis of the egg chamber. The 
dorsa-anterior localization of gurken mRNA depends on anterior migration of 
the oocyte nucleus on the polarized microtubule cytoskeleton. Thus the antero-
posterior axis is primary and the establishment of the dorso-ventral axis sec-
ondary (35). Both axes depend on localization of gurken mRNA for localized 
signaling. If gurken mRNA is mislocalized or delocalized, for example, by mu-
tating the KJO, squid, or orb genes, severe defects in the formation of both axes 
result. 
Specification of Anterior Cell Fates 
in the Drosophila Embryo 
Shortly after fertilization, bicoid mRNA is translated (219, 220). Since the em-
bryo is syncytial, Bicoid protein diffuses away from its site of translation at the 
anterior pole, forming an antero-posterior protein gradient with its peak at the 
anterior tip (219, 220). Since Bicoid is a homeodomain-containing transcrip-
tion factor, its function is to activate zygotic transcription of pattern-specifying 
genes in the syncytial nuclei in the anterior half of the embryo. It does this 
in a concentration-dependent fashion (221-223). For example, the hunchback 
gene contains high-affinity Bicoid-binding sites in its transcriptional control 
region, so its transcription is activated by low as well as high Bicoid concen-
trations throughout the anterior half of the embryo. In contrast, genes such 
as orthodenticle and empty spiracles have lower affinity Bicoid-binding sites 
and so are activated only by higher Bicoid protein concentrations in the more 
anterior part of the embryo. In this way, different combinations of zygotic 
pattern genes are activated in different subsets of the anterior part of the em-
bryo leading to different cell fates within this region (e.g. head more anteriorly, 
thorax more posteriorly). Bicoid mRNA localization controls the amount of 
Bicoid transcription factor in different regions and thus specifies distinct cell 
fates. Delocalization of bicoid mRNA can be accomplished by mutating genes 
that encode trans-acting factors that function in bicoid transcript localization 
(7, 32, 189) (e.g. exuperantia, swallow, staufen). Delocalization results in lower 
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levels of Bicoid protein at the anterior pole than in the wild type. As a conse-
quence, acronal and head structures cannot be specified. 
Localization of bicoid mRNA serves two additional functions. First, mis-
localization of bicoid RNA to the posterior pole can result in developmental 
defects in the posterior part of the embryo through cells mistakenly adopt-
ing anterior fates (224). Thus a corollary function of anterior bicoid transcript 
localization is to prevent Bicoid protein synthesis in the posterior of the em-
bryo. Translational control mechanisms also prevent Bicoid protein synthesis 
at the posterior (141, 205, 225). Second, the Bicoid homeodomain protein can 
function not only as a transcription factor but also can directly bind RNA and 
translationally repress mRNAs such as caudal through interaction with the 
caudal3'-UTR (226, 227). Thus anterior localization of bicoid mRNA and the 
resultant Bicoid protein gradient creates a reverse gradient of Caudal protein 
with its peak at the posterior pole. Caudal protein is involved in specifying 
pattern in the posterior of the early embryo (228, 229). 
Specification of Abdominal Cell Fates 
in the Drosophila Embryo 
A key player in abdominal cell fate specification is Nanos, a Zinc-finger-
containing protein (56, 230). The nanos mRNA is localized at the posterior 
pole of the late oocyte and early embryo, although some unlocalized RNA is 
present throughout the embryo (56, 231). After fertilization, the posteriorly 
localized nanos RNA in the syncytial embryo is translated (there is repression 
of unlocalized nanos RNA translation by Smaug protein). This translation 
leads to a gradient of Nanos protein with a peak at the posterior pole (139-141, 
185, 231). Unlike bicoid, which controls anterior cell fates by a combination 
of transcriptional control of target genes and direct translational repression of 
caudal mRNA in the anterior, all of the Nanos protein's effects in abdominal 
patterning derive from its translational repression of target RNAs. One tar-
get, hunchback maternal RNA, is distributed uniformly in the early embryo 
(232, 233) and encodes a Zinc-finger transcription factor that specifies anterior 
cell fates (234-236). Thus, if Hunchback protein were synthesized in the poste-
rior of the embryo, posterior cells would mistakenly adopt anterior fates. Nanos 
protein in the posterior of the embryo prevents this by translationally repress-
ing hunchback RNA. The Pumilio protein, previously shown to be important 
for abdominal patterning (237), specifically binds to Nanos response elements 
(NREs) in the hunchback 3'-UTR, recruiting Nanos through protein-protein 
interactions (140). If nanos RNA is misexpressed throughout the embryo by 
mutation of its SREs, head defects result, probably through repression of bicoid 
translation by Nanos protein since the bicoid 3'-UTR also contains NREs ( 141 ). 
Misexpression of high levels of Nanos protein in the anterior results in bicaudal 
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embryos (231 ). Thus the combination of posterior localization of nanos mRNA 
and the translational repression of unlocalized nanos transcripts plays a crucial 
role in patterning the abdomen of Drosophila. 
Assembly of Polar Granules and Specification of Germ 
Cells in the Drosophila Embryo 
oskar mRNA is localized to the posterior pole of the stage 9 oocyte. Trans-
lation of oskar RNA at this site nucleates the formation of the posterior polar 
granules and polar plasm (25, 75, 76). The polar granules and posterior polar 
plasm serve two functions . The first is the anchoring of nanos transcripts at the 
posterior (75, 76). Disruption of the polar granules results in delocalization of 
nanos RNA, translational repression by Smaug, and ultimately the production 
of embryos without abdomens. The second role of polar granules is to specify 
the formation of germ (pole) cells and to restrict their formation to the posterior 
tip of the embryo (25, 75, 76). Disruption of oskar function results in an inabil-
ity to nucleate polar granules and, consequently, absence of pole cells (238). 
Alternatively, misexpression of Oskar protein throughout the oocyte during 
oskar RNA localization (184, 186), overexpression of oskar RNA throughout 
the oocyte (75), or mislocalization of oskar RNA and protein to the anterior pole 
of the oocyte (76) all result in severe pattern defects. In the latter two situations 
ectopic pole cells form at or near the anterior of the embryo. The mechanisms 
by which the polar granules specify the formation and function of the pole 
cells in the early embryo are not yet fully understood but appear to require the 
function of several other posteriorly localized RNAs such as Pgc, mtlrRNA, 
nanos, and genn cell-less (26, 57, 133, 134,136, 137,239, 240). Thus, both the 
establishment of the polar granules, and their function in pole cell formation, 
require RNA localization. 
Signaling of Dorso-Ventral Axis and Mesoderm 
Induction in the Xenopus Embryo 
The animal-vegetal axis of the Xenopus embryo is established during oogen-
esis. The three germ layers of the early embryo (ectoderm, mesoderm, and 
endoderm) are established along the animal-vegetal axis (72, 73). The darkly 
pigmented animal hemisphere of the oocyte gives rise to ectoderm while the 
vegetal hemisphere cells become endoderm. The mesoderm is derived from 
animal hemisphere cells that lie adjacent to the vegetally derived mesoderm. 
Mesodermal development is not autonomous but is a result of inductive inter-
actions from the endoderm (72, 73). 
Asymmetrically distributed RNAs localized to the vegetal hemisphere that 
encode secreted growth factors such as Vg1 and TGF,B-5 have been implicated 
in mesoderm induction (5, 241-243). The secreted growth factor TGF-,81 can 
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act synergistically with another growth factor, bFGF, to induce mesoderm, 
whereas antibodies against TGF-.82 can reduce mesoderm induction when in-
jected into Xenopus embryos. Since Vg1 and TGF-,85 RNAs are localized to 
the vegetal hemisphere from which the inducing signal derives, and since Vg1 
and TGF-,85 proteins are related, respectively, to TGF-.B 1 and 2, these proteins 
are strong candidates for mesoderm-inducing signals (5, 241-243). Indeed, 
engineered processed V g 1 protein (in the form of BMP2/4-V g1 fusion protein) 
can function as a mesoderm inducer when ectopically expressed in embryos 
(241,242). 
The orientation of the dorso-ventral axis of the early embryo is not established 
prior to fertilization. Rather, the sperm entry point in the animal hemisphere 
establishes this axis in part by causing an oriented cytoplasmic rearrangement 
(72, 73). This rearrangement relocates interior cytoplasm (endoplasm) relative 
to the stationary cortical cytoplasm. Treatments, such as UV-irradiation, pre-
vent cytoplasmic rearrangement and ventralize the embryo (i.e. -prevent forma-
tion of the dorsal-most tissues). MatemalXwnt-11 mRNA is localized vegetally 
in oocytes and early embryos (98). Injection of Xwnt-11 RNA into embryos that 
have been ventralized by UV-irradiation substantially rescues the UV-induced 
defect by inducing formation of dorsal tissues such as somitic muscle and neu-
ral tube (98). This observation suggests that Xwnt-11 protein functions during 
normal embryogenesis in dorso-ventral axis formation and that localization of 
Xwnt-11 mRNA and protein may play a role in induction of this axis. 
The inductive events discussed previously are complex both at the level 
of inducing signals and at the level of mesodermal cell fate outcomes. The 
inability to genetically inactivate genes in Xenopus has been a major drawback 
in defining endogenous factors necessary (rather than sufficient) for induction. 
Thus the functions during normal development of Xwnt-11, Vg1, and TGF,B-5 
RNA localization and of their encoded proteins remain to be determined. 
Specification of Cell Fates During Asymmetric 
Cell Divisions 
During Drosophila neurogenesis, a stem cell called a neuroblast divides asym-
metrically to form a ganglion mother cell (GMC) and another neuroblast. The 
GMC then divides to form neurons. The Prospero nuclear protein is required 
for neuronal differentiation (244) and axonal pathfinding (245). The prospero 
mRNA and the Prospero protein are intially apically localized in the neuro-
blast at interphase but relocalize basally from prophase through telophase, thus 
segregating into the GMC (127, 246, 247). Basal localization ofprospero RNA 
requires lnscuteable and Staufen proteins (127), and Staufen binds directly 
to the prospero 3'-UTR (127). The Miranda protein functions as an adapter 
that links Prospero protein to the basal cell membrane during the asymmetric 
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neuroblast division (248). Thus RNA and protein localization are used to seg-
regate the Prospera protein into one product of an asymmetric cell division, 
conferring appropriate neuronal fates upon that cell and its progeny. 
Asymmetric segregation of cell fate determinants through rnRNA localiza-
tion has also been described in the budding yeast S. cerevisiae. In this case, 
during cell division the ASHJ mRNA is localized to the site of the bud and 
then into the daughter cell that forms there (128, 129). The ASHJ protein acts 
as a repressor of the HO endonuclease, which is responsible for mating-type 
switching (128, 129). Thus localization oftheASHJ rnRNA and its asymmetric 
segregation into the daughter cell ensures that the daughter cell cannot switch 
mating type while the mother cell (which does not inherit ASHJ mRNA) can 
switch. 
EVOLUTIONARY CONSIDERATIONS 
Many features of mRNA localization appear to have been conserved during evo-
lution, suggesting that RNA localization is an ancient mechanism for producing 
cytoplasmic asymmetry. For example, large stereotypic secondary structures in 
3'-UTRs that function in bicoid transcript localization are evolutionarily con-
served and functionally interchangeable between Drosophila species separated 
by over 60 million years (167). Further, the bicoid 3'-UTR, which directs ante-
rior RNA localization in the oocyte, can also direct apical transcript localization 
in epithelia such as the blastoderm (65). Consistent with this observation, bicoid 
RNA is localized apically in the nurse cells prior to its transport into the oocyte 
during normal development. Thus, at least within the same species, different 
polarized cell types appear to share localization signals and factors. 
More remarkable is the fact that the mammalian tau 3'-UTR, which directs tau 
transcript localization to the axons of neurons, can also direct vegetal transcript 
localization in Xenopus oocytes with a pattern and dynamics indistinguishable 
from Vgl transcripts (158). This result suggests that RNA targeting elements 
and localization machinery are conserved from Xenopus to mammals and from 
oocytes to neurons. Whether this functional conservation extends to the primary 
RNA sequence level remains to be seen; however, a small sequence element 
has been reported to be conserved in the 3'-UTR of tau, Vgl, and several other 
localized RNAs in mammals, Xenopus, and even Drosophila (187). 
Recently, RNA localization has been reported in the budding yeast, S. cere-
visiae (128, 129), and functions during budding to confer asymmetric fates on 
the mother and daughter cells. mRNA localization (e.g. of prospero transcripts) 
can serve a similar function in higher eukaryotes (127). This suggests that the 
process of RNA localization dates at least to the invention of single-celled or-
ganisms with specialized cytoplasmic domains and/or that undergo asymmetric 
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cell divisions. The demonstration that the yeast ASH I mRNA's 3'-UTR carries 
information for intracellular targeting implies that the position of cis-acting 
localization elements may be conserved in mRNAs from yeast to mammals. 
Future studies that focus on the identification and analysis of trans-acting fac-
tors that target RNAs for localization are likely to uncover additional conserved 
components of the cytoplasmic RNA localization mechanism. 
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Maternally synthesized RNAs program early embryonic 
development in many animals. These RNAs are 
degraded rapidly by the midblastula transition (MBT), 
allowing genetic control of development to pass to 
zygotically synthesized transcripts. Here we show that 
in the early embryo of Drosophila melanogaster, there 
are two independent RNA degradation pathways, either 
of which is sufficient for transcript elimination. How-
ever, only the concerted action of both pathways leads 
to elimination of transcripts with the correct timing, at 
the MBT. The first pathway is maternally encoded, is 
targeted to specific classes ofmRNAs through cis-acting 
elements in the 3' -untranslated region and is conserved 
in Xenopus laevis. The second pathway is activated 2 h 
after fertilization and functions together with the 
maternal pathway to ensure that transcripts are 
degraded by the MBT. 
Keywords: Drosophilalmidb1astu1a transition (MBT)/ 
localization/stability/Xenopus 
Introduction 
In animal embryos as diverse as echinoderms, insects, 
amphibians and mammals, the earliest stages of develop-
ment are programed by maternally synthesized RNAs and 
proteins (reviewed in Davidson, 1986). Subsequent phases 
of embryogenesis require products encoded by zygotically 
synthesized transcripts. The transition from maternal to 
zygotic control of development is referred to as the 
midblastula transition (MBT) which is defined by the first 
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developmental processes that require zygotic products. 
The MBT should not be confused with the onset of zygotic 
transcription, which initiates earlier. Prior to the MBT, a 
subset of the maternally synthesized transcripts is 
degraded. In mammals, maternal transcript degradation 
is complete by the two-cell stage, while in echinoderms, 
amphibians and insects it occurs prior to the MBT, 
when either several hundred cells (echinoderms), several 
thousand cells (amphibians) or several thousand syncytial 
nuclei (insects) are present. 
Genetic and molecular studies in Drosophila melano-
gaster have demonstrated that a subset of the maternal 
mRNAs encode proteins controlling the cell cycle, posi-
tional specification of cells or the morphogenetic move-
ments that drive gastrulation. These transcripts are 
eliminated during the syncytial blastoderm stage, shortly 
after zygotic transcription commences (reviewed in 
Cooperstock and Lipshitz, 1997; Bashirullah et al. , 1998). 
The subsequent cellularization of the blastoderm is the first 
developmental process requiring zygotic contributions and 
thus marks the Drosophila MBT (Edgar et al. , 1986; 
Merrill et al., 1988; Sibon et al., 1997). 
During early Drosophila embryogenesis, from egg-
laying until the MBT, there are 13 synchronous syncytial 
nuclear divisions (Zalokar and Erk, 1976; Foe and Alberts, 
1983; Campos-Ortega and Hartenstein, 1998). Sub-
sequently, the nuclei enter interphase of nuclear division 
cycle 14 and the somatic blastoderm cellularizes by 
concerted invagination of cell membranes from the peri-
phery. Blastoderm cellularization is followed by the first 
gastrulation movements and the first zygotically pro-
gramed mitosis, mitosis 14, which is no longer 
synchronous (Foe, 1989). It has been shown that this 
transition from synchronous maternally driven mitoses 
to asynchronous zygotically programed mitoses requires 
degradation of maternal string transcripts (string encodes 
a homolog of the cell cycle regulator, CDC25) (Edgar and 
O'Farrell, 1989, 1990; Edgar and Datar, 1996). 
While turnover of maternal transcripts was first reported 
more than 20 years ago, little is known of the degradation 
machinery or of the mechanisms by which specific classes 
of transcripts are targeted to it. Here we show that two 
transcript degradation pathways function in the early 
Drosophila embryo. The first, 'maternal', pathway is 
driven by maternally encoded factors that are recruited by 
cis-acting RNA degradation elements independently of 
whether the transcript is translationally active or trans-
lationally repressed. This maternal degradation apparatus 
is conserved in Xenopus oocytes and early embryos. 
The second 'zygotic' pathway becomes active 2 h after 
fertilization. Either pathway acting alone is sufficient to 
eliminate maternal transcripts; however, the joint action 
of both pathways is necessary for elimination of transcripts 
prior to the MBT. This dual degradation system is likely 
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to coordinate developmental events by ensuring the elim-
ination of maternal transcripts prior to the MBT. 
Results 
Degradation of maternally synthesized transcripts 
begins shortly after fertilization in Drosophila 
We analyzed the dynamics of transcript degradation in 
the early embryo focusing on three maternally encoded 
RNAs: Hsp83, string and nanos. Hsp83 transcripts are 
particularly abundant, representing I% of the poly-
adenylated transcripts in the early embryo (Zimmerman 
et al., 1983). RNA tissue in situ analyses demonstrated 
that maternal Hsp83 and string transcripts are no longer 
detectable by late stage 5, after completion of blastoderm 
cellularization (Figure I A-F); nanos transcripts are 
undetectable by stage 4 (Figure IG-I). RNA tissue in situ 
analyses are useful for defining when very low levels 
of transcripts are reached, but they are not sufficiently 
quantitative to be used to define the time course of 
degradation. Consequently, we carried out Northern blot 
analyses of RNA samples prepared from embryo collec-
tions spanning 30 min intervals during the first 5 h after 
Stogo4 
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Maternal transcript degradation in Drosophila 
ferti lization. These blots were probed for Hsp83, string, 
nanos and rpAI transcripts. 1pAJ served as an internal 
control since maternal 1pAl transcripts are stable beyond 
the MBT (Riedl and Jacobs-Lorena, 1996) (Figure lJ). 
Maternal Hsp83, string and nanos transcript levels 
decrease throughout the pre-MBT stages initiating within 
the first hour after fertilization (Figure IK). By the MBT 
(2.5- 3.0 h after fertilization), >96% of the maternal 
Hsp83 transcripts loaded into the embryo have disappeared 
(Figure IK). The Hsp83 transcripts present at and after 
this stage comprise undegraded maternal transcripts in the 
pole cells and zygotic transcripts. Ninety-five percent of 
long isoform string transcripts (Figure lJ and K; only the 
long isoform is strictly maternally synthesized and is 
shown in K, although quantitation was done on each 
isoform) and >99% of the nanos transcripts have been 
eliminated by the MBT (Figure lJ and K). The remaining 
nanos transcripts represent undegraded maternal tran-
scripts in the pole cells (Figure lH and I). These results 
demonstrate that maternal transcript degradation initiates 
at or shortly after fertilization, and that the vast majority 
of these transcripts have been eliminated by the MBT. 
Maternally encoded products direct transcript 
degradation, even in unfertilized eggs 
We used unfertilized eggs to ask whether maternally 
encoded products are sufficient to direct transcript 
degradation in the absence of both fertilization and zygotic 
transcription. In Drosophila, egg activation occurs when 
the mature oocyte passes from the ovary into the uterus. 
This process does not require fertilization. Egg activation 
re leases the female pronucleus from meiotic arrest at 
metaphase I, results in translation of various maternally 
encoded transcripts deposited in the oocyte, and induces 
Fig. 1. Degradation of maternal Hsp83, string and nanos transcripts 
begins at fertilization, and >95% of the transcripts are eliminated by 
the MBT. Whole-mount in situ analysis of transcript distributions in 
wild-type early embryos are shown in (A-1) while Northern blots and 
quantita tive analysis are shown in (J) and (K). All three species of 
transcripts arc present throughout the embryo at late stage 2 (A, D and 
G ; a t about nuclear cycle 8; 25 min- I h 5 min after fertilization). By 
stage 4 (nuclear cycle 13, 1 h 20 min-2 h 10 min after ferti lization), 
IWIIOS transcripts have been degraded in the somatic region (H ) while 
Hs[J83 and string transcripts are still present (B and E). By the cellular 
blastoderm stage (nuclear cycle 14, 2 h 10 min- 2 h 50 min after 
fertilization), Hsp83 and string transcripts have been degraded 
throughout the somatic region (C and F) while Hsp83 transcripts 
(arrowhead, C) and nanos transcripts (I) remain undegraded in the 
pole cells. The previously reported zygotic expression of Hsp83 RNA 
(Ding et a/., 1993a) can be seen in the presumptive head region 
(asterisk). Stages are according to Campos-Ortega and Hartenstein 
(1998). Embryos are oriented with the anterior to the left and dorsal 
up. This convention will be followed throughout. (J ) Northern blots 
are shown for Hsp83, string, nanos and rpAJ transcripts in developing 
embryos. For quantitation (K), amounts were normalized relative to 
rpAI levels since rpAI transcripts are stable. The time points shown in 
(J) also apply to (K). The ordinate in (K) presents [RNA] plotted on a 
logarithmic scale. A total of 96% of the maternally encoded Hsp83 
transcripts, 95% of the strictly maternally encoded string transcripts 
(' long isoform', upper band in J) and > 99% of the nanos transcripts 
have disappeared by 2.5 h after fertilization (arrows). The Hsp83 
transcripts present after 2.5 h in embryos comprise maternal transcripts 
present in pole cells and zygotically synthesized transcripts. The larger 
string transcript, which is strictly maternal in origin (Edgar and Datar, 
1996), was quantified. Details of the number of repetitions of each 
Northern blot experiment are given in Materials and methods. 
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depolymerization of cortical microtubules and cross-
linking of the vitelline membrane (Mahowald et al. , 1983 ). 
The transcripts which we analyzed, i.e. maternal Hsp83 
(Figure 2A-C), string (Figure 2D-F), nanos (Figure 2G-
I) and Polar granule component (Pgc; Figure 70), are 
degraded in unfertilized eggs. Northern blot analyses 
(Figure 21) indicated that 99% of the Hsp83 transcripts 
and 90% of the long isoform string transcripts have been 
degraded by 4-5 h after egg activation (Figure 2K), 
1- 2 h later than in developing embryos (Figure 21 and 
K). Over 99% of the nanos transcripts have been degraded 
by 3 h after egg activation (Figure 21 and K), 0.5 h later 
than in developing embryos but >I h earlier than Hsp83 
and string transcripts. rpAJ transcripts are stable through-
out this period (Figure 21). We conclude that maternally 
encoded factors are sufficient for degradation of Hsp83, 
string, nanos and Pgc transcripts. A second, superimposed, 
degradation pathway causes the more rapid elimination of 
transcripts in embryos than in unfertilized eggs (see 
below). 
Cis-acting elements in the 3' -UTR target 
transcripts for degradation 
To identify cis-acting sequences essential for transcript 
degradation, we focused on the 3 ' -untranslated regions 
(3' -UTRs) of Hsp83 and nanos transcripts. If an element 
targets transcripts for degradation, then absence of this 
element would be expected to stabilize the transcript. 
Unfertilized eggs were used for the analysis in order to 
identify those elements necessary for maternally encoded 
transcript degradation. 
For Hsp83, a series of reporter transgenes was con-
structed that contained a fragment of the Escherichia coli 
lacZ gene and either the full 407 nucleotides of the Hsp83 
3 ' -UTR or deleted versions (see Figure 3A for sequence, 
Figure 3B for transgenic constructs). By this analysis, a 
region in the 3' -UTR from nucleotide 253 to 349, which 
we refer to as the Hsp83 degradation element (HDE), 
proved necessary for maternally encoded Hsp83 transcript 
degradation (Figure 3C-F). Transcripts lacking the HDE 
(252D.350) are stable in unfertilized eggs for at least 6 h 
(Figure 3F). This contrasts with transcripts that include 
the HDE (endogenous Hsp83 transcripts or transgenic 
transcripts that include the HDE) which are fully degraded 
in unfertilized eggs by 4 h after activation (see Figure 2C, 
1 and K for endogenous transcripts; data not shown for 
transgenic transcripts). Elimination of either the 5' or the 
3' half of the HDE (252D.301 or 300D.35 1) results in 
incomplete degradation (data not shown; see Figure 3B). 
The first 186 nucleotides of the nanos 3' -UTR, desig-
nated the translation control element (TCE), have also been 
implicated in control of transcript stability (Dahanukar and 
Wharton, 1996; Smibert et al., 1996). In unfertilized eggs, 
this element is shown here to target the maternally encoded 
degradation machinery to nanos transcripts. Transcripts 
lacking the first 186 nucleotides (D.TCE) are not degraded 
by 2-4 h after egg activation (Figure 4C and D) whereas 
endogenous nanos transcripts have completely disappeared 
(Figure 4A and B). 
To study whether the Hsp83 HDE and the nanos TCE 
are functionally interchangeable, two additional transgenic 
constructs were made. In one, the HDE was added to a 
nanos transgene lacking the TCE (nos[D.TCE+HDE]) 
2612 
Fig. 2. Hsp83, string and nanos transcripts are degraded in unfertilized 
eggs. Whole-mount in s itu analysis of transcript distributions in 
unfertilized eggs are shown in (A-I) while Northern blots and 
quantitative analysis are shown in (J) and (K). Hsp83, string and 
nanos transcripts are present throughout the egg from 0 to 2 h after 
egg activation (A, D and G ). Between 2 and 3 h after egg activation, 
levels of Hsp83 and string transcripts have decreased (B and E), 
IIQnos transcripts are no longer detectable outside the posterior polar 
plasm (H ) and Hsp83 transcripts can be seen to be concentrated in the 
posterior polar plasm (B). By 3-4 h, all three classes of transcripts are 
undetectable (C, F and I) except for the posterior-localized Hsp83 and 
nanos transcripts (C and !). (J) Northern blots are shown for Hsp83, 
string, nanos and rpAJ transcripts in unfertilized eggs. Hsp83 and 
string transcripts (strictly maternal, upper band) reach minimal levels 
by 4-5 h, whereas nanos transcripts have disappeared by 3 h after egg 
activation. For quantitation (K ), amounts were normalized relative to 
rpAJ levels since rpA J transcripts are stable. The time points shown in 
(J) also apply to (K). The ordinate in (K) presents [RNA) plotted on a 
logarithmic scale. In unfertilized eggs, >99% of the nanos transcripts, 
99% of the Hsp83 transcripts and 90% of the string transcripts (strictly 
maternal, upper band in J) are degraded. Transcripts from unfertilized 
eggs are shown in gray (e ) while transcripts from embryos (taken 
from Figure 1) are shown in black <• > for comparison. Details of the 
number of repetitions of each Northern blot experiment are given in 
Materials and methods. 
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Fig. 3. Mapping of the Hsp83 degradation (HDE) and protection 
(HPE) elements. (A) Sequence of the Hsp83 3'-UTR with highlighted 
HDE (black) and HPE (gray). (B) Transcription of the transgenes is 
under the control of Hsp83 regulatory sequences fused to a 603 bp 
/acZ tag and followed by the 407 nucleotide Hsp83 3'-UTR (1.407) or 
the Hsp70 3'-UTR ('Hsp70') (see Materials and methods). 3', 5' and 
internal deletions within the Hsp83 3' -UTR are shown as a diagram. 
+,degradation or protection occur as in wild-type; +*,degradation 
incomplete; - , degradation or protection fail ; NA, protection cannot be 
assayed in the absence of degradation; NM, no maternal RNA present 
in the egg (Halsell, 1995). Black bars represent Hsp83 3'-UTR 
sequences; gray bars represent Hsp70 3'-UTR sequences. The HDE 
which maps from nucleotide 253 to 349 and the HPE which maps 
from nucleotide 350 to 407 are highlighted. (C and D) Endogenous 
Hsp83 transcripts visualized with an antisense Hsp83 RNA probe. 
(E and F) Transgenic 252t.350 reporter transcripts visualized with an 
antisense ~-galactosidase RNA probe. The age of eggs or embryos in 
hours is shown to the left. In contrast to endogenous transcripts (C and 
D), the 252t.350 transcripts persist throughout the egg until at least 
6 h after activation (E and F). 
(Figure 4E and F); in the other, the nanos TCE was added 
to an Hsp83- lacZ reporter construct lacking the HDE 
(Hsp83[!V!DE+TCE]) (Figure 4G and H). Addition of 
the Hsp83 HDE restores degradation to the otherwise 
stable nos[l'lTCE] transcript (Figure 4E and F) while 
addition of the nanos TCE similarly targets the stable 
Hsp83-lacZ[I'iliDE] transcript for degradation (Figure 4G 
and H). While our data demonstrate that the HDE and 
TCE are functionally interchangeable, we have been 
unable to identify any significant primary sequence or 
secondary structure conservation between these elements. 
Maternal transcript degradation in Drosophila 
These data support a model in which specific cis-
acting elements recruit a maternally encoded degradation 
machinery to both the Hsp83 and nanos transcripts. 
Relationship between translation and RNA 
degradation 
Our next goal was to study whether translational repression 
is a prerequisite for transcript degradation. Such a require-
ment had been postulated for nanos transcripts in early 
embryos since relief of translational repression (by deletion 
of the TCE) correlated with an increase in transcript 
stability (Dahanukar and Wharton, 1996; Srnibert et al., 
1996). Translation of nanos in the head region of the 
embryo causes repression of bicoid translation and thus 
head skeleton defects (Dahanukar and Wharton, 1996; 
Smibert et al., 1996). The severity of the defect serves as 
a sensitive readout of the Nanos protein level (Wharton 
and Struhl, 1991; Gavis and Lehmann, 1994) in the 
absence of a direct assay using anti-Nanos antibodies, 
which are no longer available. 
We examined the head skeleton of transgenic embryos 
carrying nos[l'lTCE] or nos[l'lTCE+HDE] transcripts. As 
previously reported (Dahanukar and Wharton, 1996; 
Srnibert et al., 1996), nos[l'lTCE] transcripts are translated 
and produce head skeleton defects (Figure 4J). Surpris-
ingly, even though nos[l'lTCE+HDE] transcripts are 
degraded (Figure 4F), they too produce head skeleton 
defects (Figure 4K). Furthermore, the severity of the head 
skeleton defects was greater in the case of 
nos[l'lTCE+HDE] than nos[l'lTCE]. In five independent 
nos[l'lTCE] transgenic lines, an average of 72:!:: 29% of 
the embryos exhibited defects and these were restricted 
to the dorsal bridge. In contrast, all four independent 
nos[l'lTCE+ HDE] lines resulted in 100:!:: 0% of the 
embryos exhibiting severe defects (Joss of dorsal bridge, 
dorsal arms, vertical plates and ventral arms). 
Thus, not only are the nos[l'lTCE+HDE] transcripts 
translated, but they are translated at higher levels than the 
nos[l'lTCE] transcripts, perhaps because the HDE includes 
a translational enhancer. We conclude that translational 
repression and transcript degradation are not causally 
linked; even highly translated transcripts are targeted 
for degradation. Moreover, non-protein-coding transcripts 
(e.g. Pgc) are also degraded in unfertilized eggs (Figure 
7G). Together, these data indicate that the transcript 
degradation machinery acts on transcripts that contain a 
degradation element independently of whether they are 
untranslatable, translationally repressed or translated. 
Discovery of a second, zygotically encoded or 
activated degradation pathway 
We next addressed why Hsp83 transcripts are eliminated 
more rapidly in embryos than in unfertilized eggs. We 
asked whether embryos contain an additional degradation 
machinery that acts independently of the HDE, by 
comparing the stability of transcripts containing or 
lacking the HDE. Degradation of endogenous Hsp83 
transcripts as well as HOE-containing transgenic tran-
scripts is initiated shortly after fertilization, and minimal 
transcript levels are reached by 2.5 h (Figure SA, B and 
F for endogenous transcripts; transgenic transcripts not 
shown). In unfertilized eggs, transcripts lacking the HDE 
are stable for well over 5 h (Figures 3E and F, and 5E). 
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Fig. 4. The Hsp83 HDE and the nanos TCE are interchangeable with respect to maternal transcript degradation, which is independent of translational 
repression. (A and B) Endogenous nanos transcripts are degraded by 2 h after egg deposition. (C and D) Deletion of the nan as TCE (na11os 3 '-UTR 
nucleotides 1-185) results in transcript stabilization. (E and F) Replacement of the IIWIOS TCE with the Hsp83 HOE (Hsp83 3' -UTR nucleotides 
253-349) restores transcript degradation. (G and H) Replacement of the Hsp83 HOE with the na11os TCE restores transcript degradation. 
nallos[IJ.TCE+HDE} transcripts are not translationally repressed even though they are degraded. Head skeletons are shown from wild-type (1), 
embryos from nanos[IJ.TCE] transgenic females (J) and embryos from llallos{t>.TCE+HDE} females (K). As previously reponed (Dahanukar and 
Whanon, 1996; Smibert et al., 1996), there is a reduction of the dorsal bridge in llanos[IJ.TCE] embryos (J). Surprisingly, although 
nanos[IJ.TCE+HDE] transcripts are degraded (F), they are not translationally repressed, as evidenced by the severe head skeleton phenotype (K) 
(note the loss of dorsal bridge, dorsal arms, venical plate and ventral arms). DBr, dorsal bridge; DA, dorsal arms; VP, vertical plate; VA, ventral 
arms. 
HDE-deleted EORO~PRMF transcripts are stable throughout 
the first 2 h of embryogenesis, after which degradation 
initiates, and 95% of these transcripts are gone by 4 h 
after fertilization (Figure SC, D, F and G). Thus, in 
addition to the maternally encoded degradation machinery, 
a zygotically synthesized or zygotically triggered degrada-
tion machinery is active starting 2 h after fertilization . 
Furthermore, since transcript degradation occurs at this 
stage in the absence of the HDE, this 'zygotic' degradation 
is independent of elements in the 3' -UTR that mediate 
the maternally encoded degradation. Zygotic transcript 
degradation occurs for all 3 '-UTR reporter constructs 
listed in Figure 3. 
Taken together, our analyses demonstrate that the joint 
action of both the 'maternal' and the ' zygotic' degradation 
pathways is needed to eliminate the bulk of maternal 
transcripts by the onset of the MBT. 
Elements in the 3' -UTR protect transcripts from 
degradation in the pole cells 
Certain maternal transcripts fail to degrade in pole cells 
of developing embryos or in the posterior polar plasm of 
unfertilized eggs. These include Hsp83 (Figures lC and 
2C), nanos (Figures lH and I, and 2H and I) and Pgc 
(Figure 7G) (Wang and Lehmann, 199 1; Ding et al., 
1993a; Nakamura et al., 1996). Our time course analysis 
shows that 1% of the total maternally loaded Hsp83 
transcripts and < 1% of the total maternally loaded nanos 
transcripts remain in the posterior polar plasm of un-
fertilized eggs (Figure 2K). Two possible mechanisms 
could lead to the absence of transcript degradation at the 
posterior: the degradation machinery might be excluded 
from the posterior polar plasm and thus also from the 
pole cells. Alternatively, the machinery could be active in 
2614 
the posterior polar plasm and pole cells, but certain classes 
of transcripts could be masked from the machinery by 
components of the polar plasm. 
To distinguish between these possibilities, we replaced 
the Hsp83 3 '-UTR in our reporter construct with the 3 '-
UTR from the Hsp70 transcript (Figure 3B). Transgenic 
reporter transcripts carrying the Hsp83 3 '-UTR are 
degraded normally in the soma but are not degraded in 
the pole cells (Figure 6A-C), mimicking the distribution 
of the endogenous Hsp83 transcripts (Figure lA-C). The 
reporter transcripts carrying the Hsp70 3' -UTR are taken 
up into the pole cells when they bud (Figure 6D and 
E) but are unstable and are degraded by the cellular 
blastoderm stage (Figure 6F; see figure legend for details). 
These results demonstrate that the maternally encoded 
degradation machinery is present throughout the egg 
and embryo. 
To identify 'protection' elements within the Hsp83 3' -
UTR, we assayed posterior protection of our reporter 
transcripts in unfertilized eggs (Figure 3B). Sequences 
sufficient for protection reside within the 3' -most 107 
nucleotides of the Hsp83 3' -UTR since transgenic RNA 
produced by the 301.407 construct is protected (Figure 
3A and B). Since transgenic RNA carrying only nucleo-
tides 351-407 is unstable during oogenesis (Halsell, 1995), 
it was not possible to determine whether the 3 '-most 57 
nucleotides alone are sufficient for protection. However, 
replacement of nucleotides 351-407 with the Hsp70 3'-
UTR results in failure of protection (Figure 3B), showing 
that nucleotides 351-407 are necessary for protection. We 
refer to nucleotides 35 1-407 as the Hsp83 protection 
element or HPE. Thus elements necessary for degradation 
versus protection map to distinct regions within the Hsp83 
3'-UTR. 
67 
StA9115 
(2 :1 0-2;50) 
pt~gCp 
(3:10·3 :40) 
E 
F 
G 
Fig. 5. Hsp83 transcripts lacking the HDE are degraded in embryos by 
a zygotically synthesized or activated degradation mechanism. (A and 
B) Endogenous Hsp83 transcripts visualized with an antisense Hsp83 
RNA probe. (C and D) Transgenic 252t.350 reporter transcripts 
visualized with an antisense f3-galactosidase RNA probe. The stage of 
embryos is shown to the left. In contrast to endogenous transcripts 
(A and B) which are degraded by the MBT and so are absent by stage 
5, the 252.6350 transcripts persist beyond stage 5 (C) and are degraded 
by stage 8 (D ). Zygotically synthesized transcripts accumulate in the 
head region and in the germ band (B and D). Northern blots are 
shown of unfertilized eggs ('UF' in E) and developing embryos ('F' in 
F). Quantitation is shown in (G). In unfertilized eggs, transgenic 
transcripts lacking the HDE (e , solid gray line) are stable, whereas 
they are degraded starting after 2 h and are gone by 4 h after 
ferti lization in embryos (A , dashed gray line). Endogenous transcripts 
in embryos arc shown for reference <•. solid black line; taken from 
Figure I K). For quantitation, amounts were normalized as in Figures I 
and 2. In embryos, the Hsp83 transcripts that persist after 2.5 h (black, 
endogenous) or after 4 h (dashed line, t.HDE) comprise maternal 
transcripts present in pole cells and zygotically synthesized transcripts. 
Details of the number of repetitions of each Northern experiment are 
given in Materials and methods. 
Identification of mutants that fail to undergo 
maternally encoded RNA degradation 
Since our data demonstrated that maternal factors are 
sufficient for transcript degradation prior to the MBT, 
we tested a collection of female sterile mutant lines 
(Schupbach and Wieschaus, 1989) to identify maternal 
effect mutants that fail to undergo degradation (see 
Materials and methods for list). Mutants were assayed 
for Hsp83 RNA degradation in unfertilized eggs aged 
well beyond the stage at which transcripts would have 
disappeared in the wild-type. The presence of protected 
Maternal transcript degradation in Drosophila 
Fig. 6. Degradation activity is present in pole cells but Hsp83 
transcripts are normally protected from it. (A and B) Stage 3 pole 
cells; (C and D) stage 4 pole cells; (E and F) stage 5 pole cells. 
(A-C) Hsp83 1.407 transgenic transcripts or (D- F) transgenic 
transcripts that replace the Hsp83 3'-UTR with the Hsp70 3'-UTR (see 
Figure 3A), visualized with an antisense f3-galactosidase probe. 
Transcripts that include the Hsp83 3'-UTR are protected from 
degradation in pole cells, whi le transcripts with the Hsp70 3'-UTR are 
degraded in both the pole cells and the soma by stage 5, indicating 
that degradation activity is present in pole cells. At stage 5, 82% of 
the embryos with the Hsp70 3'-UTR transgenic RNA had little or no 
detectable transcript in pole cells (11 = 39). At stages 6-8, 95% of the 
embryos with the Hsp70 3 '-UTR transgenic RNA had little or no 
detectable transcript in pole cells (n = 42). In contrast, 100% of the 
embryos carrying full-length Hsp83 3'-UTR transgenic RNA had high 
levels of transcript in their pole cells at these stages (11 = 50). 
transcripts at the posterior served as an internal control 
for the in situ hybridizations (if degradation occurs, then 
protected Hsp83 transcripts are visible at the posterior). 
Mutations in two loci, cortex and grauzone, result in 
failure of Hsp83 transcript degradation (Figure 78 and 
C). Failure of degradation was not specific to Hsp83 since 
nanos (Figure 7E and F), Pgc (Figure 7H and I) and 
string (Figure 7K and L) transcripts also failed to degrade. 
The cortex and grauzone mutants exhibit defective egg 
activation and cytoplasmic polyadenylation of transcripts 
(Lieberfarb et al., 1996; Page and Orr-Weaver, 1996). 
The maternally encoded degradation pathway is 
conserved in Xenopus 
Several maternal transcripts are localized during Xenopus 
oogenesis although it is not yet known whether the 
type of degradation-protection system described here for 
Drosophila functions in their localization (reviewed in 
Bashirullah et al. , 1998). Furthermore, as in Drosophila, 
many maternal transcripts are degraded prior to the 
Xenopus MBT (reviewed in Davidson, 1986). Thus, it 
was of interest to determine whether Xenopus oocytes 
and early embryos have a maternal RNA degradation 
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Fig. 7. The cortex and grt111l?ne mutants result in fai lure of maternally encoded transcript degradation. Assays were conducted in unfertilized eggs, 
aged for at least 3 h, from wtld-type females (A, D, G and J), cortex females (B, E, H and K) or grauzone females (C, F, I and L). Degradation of 
H>p83 (A-C), nanos (D- F), Pgc (G-1) and string (J-L) transcripts fails in eggs produced by the mutants. The defects in transcript localization 
(E, F, Hand I) may result from cytoskeletal abnormalities (Lieberfarb eta/., 1996; Page and Orr-Weaver, 1996). 
A B 
+HOE &HOE 
Fig. 8. The maternal transcript degradation pathway is conserved in 
Xenopus and Drosophila. (A) In vitro synthesized Drosophila Hsp83 
3'-UTR transcripts ( 1.407) that carry the HOE ('+HOE') are highly 
unstable in Xenopus ooeytes and are almost completely degraded 
within 6 h of injection. (B) In contrast, in vitro synthesized Drosophila 
Hsp83 3'-UTR transcripts that lack the HOE ('C.HDE' ; 252A350) are 
stable and can still be readily detected 24 h after injection. 
machinery similar to that identified here in Drosophila. 
We injected in vitro synthesized, digoxigenin-labeled 
transcripts comprising the full-length Drosophila Hsp83 
3 ' -UTR into stage 6 Xenopus oocytes or recently fertilized 
embryos. These transcripts are unstable and are degraded 
rapidly after injection (Figure 8A for oocytes; data not 
shown for embryos). We then injected in vitro transcribed 
Drosophila Hsp83 3'-UTR Ll.HDE transcripts into stage 6 
oocytes; these transcripts are extremely stable and are still 
readily detectable 24 h after injection (Figure 8B). We 
conclude that the Drosophila HDE functions as a degrada-
tion element in Xenopus oocytes and embryos. Thus, 
Xenopus must contain a transcript degradation activity 
highly related to the Drosophila maternal activity and 
capable of recognizing the Drosophila HDE. 
Discussion 
Passage from maternal to zygotic control of development 
is thought to depend on the elimination of a subset of 
maternal transcript classes from the early embryo. For 
example, degradation of ubiquitous maternal string tran-
scripts is necessary to permit zygotically driven, patterned 
domains of cell division after the MBT (Edgar and Datar, 
1996). Here we have shown that the joint action of two 
RNA degradation pathways controls maternal transcript 
degradation and its timing in the early Drosophila embryo, 
and that at least one of these pathways (the 'maternal' 
pathway) is conserved in Xenopus. 
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Two genetic pathways ensure RNA degradation 
prior to the Drosophila MBT 
The first degradation pathway is maternally encoded and 
does not require fertilization or zygotic gene transcription 
for its function. This 'maternal' pathway begins to function 
at or shortly after egg activation, and is sufficient for 
degradation of even abundant maternally loaded transcripts 
by 4-5 h after egg activation (Figure 9). The second 
'zygotic' pathway requires fertilization and becomes active 
1.5- 2 h after fertil ization. Acting alone, the zygotic 
pathway eliminates transcripts by 4 h after fertilization. 
Since the zygotic pathway can remove Hsp83 transcripts 
in 2 h, while the maternal pathway takes 4-5 h, the 
zygotic machinery is approximately twice as efficient as 
the maternal machinery. Under normal circumstances, 
relatively rare transcripts are degraded almost exclusively 
by the maternal pathway (e.g. nanos). In contrast, more 
abundant transcripts require the action of both pathways 
in order to be eliminated by the MBT (e.g. Hsp83, string). 
The maternal pathway initiates transcript degradation at 
or shortly after egg activation, while the zygotic pathway 
ensures degradation of abundant transcripts prior to the 
MBT. 
Our results predict four classes of maternal RNAs in 
the early embryo. The first class lacks both maternal and 
zygotic degradation elements and is stable (e.g. rpAl). 
The second class (if it exists-there are no known 
examples) would be degraded exclusively by the maternal 
machinery either because these transcripts lack zygotic 
degradation elements or because their low abundance 
enables them to be fully degraded by the maternal 
machinery prior to activation of the zygotic factors. A 
third class (if it exists-there are no known examples) 
would be degraded exclusively by the zygotic machinery, 
possibly because of a lack of elements that target the 
maternal factors. The fourth class (e.g. Hsp83, string and 
nanos) is degraded by the combined action of the maternal 
and zygotic machinery. 
The dual mechanism for transcript degradation dis-
covered here sheds light on two previously reported 
observations. First, it has been shown that modulation 
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Fig. 9. Maternal and zygotic degradation activities cooperate to 
eliminate maternal transcripts by the MBT. Below the time scale on 
the x-a~is arc shown the maternally driven mitoses (1-13) followed by 
interphase 14 (the MBT) duri ng which zygotic products take over 
control of the cell cycle before mitosis 14, the fi rst patterned and 
asynchronous mitosis. The y-axis represents the [RNA] plotted on a 
logarithmic scale. In unfertil ized eggs, an abundant transcript (e.g. 
Hsp83) lacking a maternal degradation clement but carrying a zygotic 
degrada tion element is stable (t.DE, blue). In contra<!, such a 
transcript is degraded in fertil ized, developing embryos by the zygotic 
degradation apparatus, starting -2 h after fertili7.ation, such that 
transcripts are fully degraded by 4 h after ferti liwtion (t.DE, green). I n 
the presence of both maternal and zygotic degradation clements, 
transcript degradation initiates at or shortl y after acti vation of 
unfertili zed eggs and is complete by 4 h afte r fertilization (+DE, 
black). In fertilized, developing embryos , transcripts carrying both 
maternal and zygotic degradation clements initiall y arc degraded solely 
by the maternal apparatus ( < 2 h after fertiliw tion) and then 
cooperatively by both the maternal and zygotic factors (> 2 h after 
ferti liwtion) (+DE, red). Only in this last case do abundant transcripts 
disappear by the MBT (2.0-2.5 h after fertilization). Rarer transc1ipts 
(e.g. nanos) are e liminated almost exclusively by the maternal 
machinery (yellow and grey). t.DE, no maternal degradation clement; 
+DE, maternal degradation clement present; UF, unfertilized egg; 
F, developing embryo. 
of the nuclear:cytoplasmic ratio affects the timing of 
disappearance of maternally synthesized string transcripts 
(Yasuda et al. , 1991). Changing the nuclear:cytoplasmic 
ratio would not affect the maternal degradation machinery 
since it would be pre-loaded into the embryo and its 
activity/concentration should be independent of that rativ. 
In contrast, changes in the nuclear:cytoplasmic ratio might 
be expected to alter the synthesis or local concentration 
of the zygotic degradation machinery, particularly if 
activation of this machinery is dependent on zygotic 
trdllscription. Thus, al tering the nuclear:cytoplasmic rdtio 
would alter the exact timing of string transcript dis-
appearance by modulating the zygotic pathway. Secondly, 
our resul ts explain why a -amanitin injection into embryos 
prior to nuclear cycle 6 causes a delay in degradation 
of maternal string transcripts (a-amanitin inhibits RNA 
polymerase II and thus zygotic transcription) (Edgar 
and Datar, 1996). If production or activation of the 
zygotic degradation machinery requires zygotic transcrip-
tion, a -amanitin would be expected to inhibit it while 
leaving the maternal degradation machinery unaffected. 
This would result in a delay in string degradation since 
only the maternally encoded degradation apparatus would 
be functional. 
In summary, while previous results suggested that 
turnover of transcripts at the MBT might be con~olled by 
zygotic products (O'Farrell et al., 1989; Yasuda et al. , 
Maternal t ranscript degradation in Drosophila 
1991), we have uncovered a dual maternal- zygotic 
degradation system that is likely to coordinate develop-
mental events by ensuring the e limina tion of maternal 
transcripts prior to the MBT. 
Cis-acting elements target t ranscrip ts for 
degradation or for protection 
We have shown that the maternal transcript degradation 
activity is present throughout the embryo and unfertilized 
egg. Deletion of specific cis-acting 3 '-UTR sequences 
results in failure of maternally encoded transcript degrada-
tion. These elements do not share any obvious primary 
sequence or secondary structure, nor do they include any 
previously defined degradation tags (reviewed in Jacobson 
and Peltz, 1996). Despite the lack of sequence conserva-
tion, our data demonstrate that the degradation elements 
are interchangeable (the Hsp83 HOE can substitute for 
the nanos TCE, and vice versa). The cis-acting elements 
defined here are not necessary for targeting tmnscripts to 
the zygotic degradation pathway since deletion of these 
elements has no detectable effect on the zygotic degrdda-
tion process; in fact, none of our Hsp83 3 '-UTR deletions 
abrogates zygotic transcript degradation. There are three 
plausible explanations for this result: (i) there are redundant 
'zygotic' degradation elements in the Hsp83 3 '-UTR; 
(ii) such elements reside in another part of the Hsp83 
transcript [given the structure of the reporter trans genes, 
this could be the 5' -UTR or the fi rst 333 nuclcotides of 
the open reading frame (ORF)]; or (iii) zygotic degradation 
is not a targeted event but is the default stale. 
For RNAs such as rpAJ, which are stable in the early 
embryo, we do not yet know whether there are specific 
stabilization elements or whether transcript stability is a 
default state. Indirect evidence in support of the latter 
possibility comes from analyses of a transcript instability 
element in the ftz 3'-VfR (Riedl and Jacobs-Lorena, 
1996). Addi tion of this clement (R E3) to rpAJ transcripts 
destabilizes them, suggesting that for rpAJ transcripts, 
stability is either the default state or tha t instabili ty 
elements such as R E3 are dominant to as yet undefined 
stability elements. 
Our data indicate that it is possible to differential ly 
stabilize transcripts carrying degradation tags in different 
regions of the cytoplasm and/or in different cell types. 
Speci fically, we have shown that the maternal degradation 
apparatus is active throughout the egg and embryo, but 
that transcripts such as Hsp83, nanos and Pgc are protected 
from degradation in the pole pla~m and pole cells. We 
have also been able to map sequences in the Hsp83 3'-
UTR thai arc necessary for this protection. The most 
likely candidate organelles for protecting transcripts in the 
polar plasm and pole cells are the polar granules them-
selves. First, one of the RNAs we have studied (Pgc) has 
been shown to be an integral component of the polar 
granules (Nakamura et a/., 1996). Secondly, i t has been 
shown that disruption of the polar granules results in 
failure of Hsp83, nanos and Pgc transcript protection in 
the polar plasm and pole cells, while ectopic assembly of 
polar granules at the anterior of the embryo results in 
ectopic protection of these transcripts anteriorly (Ephrussi 
and Lehmann, 1992; Ding et al. , 1993a; Nakamura 
et al., 1996). 
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Role of transcript degradation and protection in 
cytoplasmic RNA localization 
Differential stabilization of transcripts in specific regions 
of the cytoplasm represents one of several RNA localiza-
tion mechanisms (reviewed in Bashirullah et al., 1998). 
Hsp83 is the only example of a transcript localized by a 
degradation-protection mechanism (Ding et al., 1993a; St 
Johnston, 1995). However, we have shown that nanos, 
Pgc and Hsp83 transcript elimination in the somatic 
region of the embryo is accomplished by the same RNA 
degradation machinery. Further, our data suggest that 99% 
of the Hsp83 transcripts and >99% of the nanos transcripts 
reside in somatic region. This last result is very similar 
to the 96% value reported recently for somatic nanos 
transcripts (Bergsten and Gavis, 1999). We speculate that 
the differences in localization patterns of transcripts that 
are obviously localized prior to egg activation and those 
which only appear localized well after egg activation may 
be largely quantitative. 
Relationship of transcript degradation to 
translation and polyadenylation status 
The literature contains numerous examples of a correlation 
between translational repression of mRNAs and their 
degradation (reviewed in Jacobson and Peltz, 1996; 
Cooperstock and Lipshitz, 1997). In the early Drosophila 
embryo, the best studied example is nanos: nanos tran-
scripts outside of the posterior polar plasm are transla-
tionally repressed and are also unstable (Figure 4, and see 
also Dahanukar and Wharton, 1996; Gavis et al., 1996; 
Smibert et al., 1996). Deletion or mutation of cis-acting 
elements that mediate translational repression results in 
transcript stabilization (Dahanukar and Wharton, 1996; 
Smibert et al., 1996; this study). Despite this correlation, 
our data demonstrate that there is no obligatory link 
between translational repression and transcript degrada-
tion. Replacing the element from the nanos 3 '-UTR that 
mediates translational repression and degradation (the 
TCE) with the Hsp83 degradation element (the HDE) 
is sufficient to allow maternal degradation of nanos 
{!!..TCE+HDE] transcripts. However, at the same time, 
the presence of severe head defects demonstrates that this 
transgenic RNA is in fact highly translated. Thus, transcript 
degradation can be unlinked from translational repression. 
There are several examples of a correlation between 
polyadenylation status and transcript stability (reviewed 
in Jacobson and Peltz, 1996). In particular, long poly(A) 
tails are associated with translational activation and tran-
script stabilization, while short poly(A) tails are associated 
with translational repression and transcript destabilization. 
In the Drosophila embryo, it has been shown that several 
classes of maternal transcripts are cytoplasmically poly-
adenylated after fertilization, correlating with initiation of 
their translation (Salles et al., 1994). The cortex and 
grauzone mutations perturb cytoplasmic polyadenylation 
(Lieberfarb et al., 1996), but transcript stability was not 
assayed in those studies. We have shown here that maternal 
transcripts are stabilized by cortex and grauzone mutations. 
The primary cause of the defects in embryos produced by 
cortex and grauzone females is unknown; their phenotypes 
are complex and several aspects of egg activation are 
abnormal (Lieberfarb et al. , 1996; Page and Orr-Weaver, 
1996). Thus it is not yet possible to draw firm conclusions 
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from these mutants regarding a possible link between 
cytoplasmic polyadenylation status and transcript stability. 
Evolutionary conservation of transcript 
degradation pathways 
We have shown that Xenopus oocytes and early embryos 
contain an activity highly related to the maternal transcript 
degradation activity we have defined in Drosophila. 
Remarkably, the Drosophila HDE is recognized by this 
activity, and in vitro sythesized, injected transcripts are 
degraded rapidly, disappearing within a few hours. 
Removal of the HDE stabilizes these transcripts for at 
least 24 h. These results suggest that evolutionarily highly 
conserved pathways may control transcript degradation 
and localization throughout metazoa, opening up the 
possibility of exploiting the particular advantages of differ-
ent model systems for future mechanistic and functional 
analysis. 
Materials and methods 
Drosophila whole-mount RNA in situ hybridization 
RNA in situ hybridization with DNA probes was performed as described 
previously, with rrtinor modifications (Tautz and Pfeifle, 1989; Ding 
eta/., 1993a,b). Digoxigenin-labeled antisense RNA probes were made 
using the Megascript RNA transcription kit (Ambion, Inc.) according to 
the manufacturer's instructions, and included digoxigenin-labeled UTP 
(Boehringer Mannheim). The RNA probes were subjected to limited 
a lkaline hydrolysis by incubation in an equal volume of I 00 mM NaC03 
pH 10.2 for I h at 60°C followed by ethanol precipitation. Pre-
hybridization and hybridization were carried out at 55°C for RNA probes 
and at 48°C for DNA probes, and detection of the probe was as 
previously described (Tautz and Pfeifle, 1989). After hybridization, eggs 
or embryos were cleared in 50% glycerol followed by 70% glycerol. 
For exact staging, nuclei were visualized with I J.lg/ml 4' ,6-diamidino-
2-phenylindole (DAPI) in phosphate-buffered saline (PBS) for 5 min 
prior to clearing of the embryos. Eggs or embryos were then individually 
mounted in 70% glycerol and images were captured using a Spot cooled-
CCD camera (Diagnostic Instruments, Inc.) mounted on a Zeiss Axioplan 
rrticroscope. Adobe Photoshop software was used to process the images. 
For transgenic lines, at least two independently derived lines were 
analyzed for each construct. 
Drosophila RNA extraction and analysis 
RNA samples were isolated from staged egg collections by phenol 
extraction using Trizol (BRL). Equal amounts of total RNA were 
electrophoresed in I .2% agarose/formaldehyde/MOPS gels (Sambrook 
et al., 1989), and transferred onto nylon membranes (Amersham). Filters 
were pre-hybridized for at least I h at 63°C in hybridization buffer 
containing 0.5 M Na-phosphate/7% SDS. 32P-Labeled random primed 
DNA probes were added and hybridization was performed overnight at 
the same temperature. Filters were rinsed twice at 60°C in 30 mM Na-
phosphate/0.1% SDS, and exposed to Kodak XAR5 film at -80°C with 
an intensifying screen. Films were also exposed to a Molecular Dynarrtics 
phosphor screen, and quantitation was performed using ImageQuant 
software. Hsp83, string and mmos transcript levels were normalized to 
rpAI mRNA levels to control for variations in loading. The number of 
repetitions of each experiment was as follows: Hsp83 endogenous 
transcripts, fertilized = 3; Hsp83 endogenous transcripts, unfertilized = 
2; Hsp83 ll.HDE transcripts, fertilized = 2; Hsp83 ll.HDE transcripts, 
unfertilized = I ; string transcripts, fertilized = 2; string transcripts, 
unfertilized = 2; nanos transcripts, fertilized :::::: I ; nanos transcripts. 
unfertilized = I. 
Construction of transgenes for Drosophila germ line 
transformation 
Standard protocols were used (Sambrook eta/., 1989). 
Hsp83-lacZ transgenes. The following approach was taken to 
generate the series of /acZ--Hsp83 3 '-UTR constructs that include the 
5 ' -Hsp83 enhancer sequences and promoter (Figure 3B). Previous reports 
(Kim-Ha eta/. , 1993) suggested that a full-length /acZ ORF rrtight not 
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be completely transcribed in vivo. Therefore, we inserted the Hsp83 3 '-
UTR fragments downstream of a truncated lacZ tag. We accomplished 
this by constructing pB83Z, a Bluescript subclone that contains all of 
the Hsp83 5' upstream region, the first ex on, the intron and the first Ill 
codons of the ORF fused to 603 bp of lacZ sequence (Halsell, 1995). 
At the 3' end of the lacZ sequence are Aat!I, HindiD and KpnJ cloning 
sites for inserting the Hsp83 3 '-UTR fragments. The template for the 
PCR was Eco9, an 8 kb EcoRl fragment subcloned in Bluescript that 
contains the full-length Hsp83 transcription unit. 5' Fragments of the 
3'-UTR were PCR amplified and were flanked with Aatll and Hindll1 
restriction sites, while 3' fragments of the 3'-UTR were flanked with 
Hindll1 and Kpnl restriction sites. The position of the Hindiii restriction 
site within the amplified fragments allowed us to generate nested 5' 
deletion constructs, the 1.350hs 3' deletion construct and a series of 
internal deletions within the 3'-UTR. 3'-UTR constructs with internal 
deletions (the 'I!.' series) were generated by first subcloning an Aatli-
Hindll1 5' fragment into pB83Z and subsequently adding a Hindlli-
KpnJ 3' fragment. After subcloning into pB83Z, a Noti-Kpnl fragment 
was isolated and subcloned into NotJ-Kpnl-digested CaSpeR4 (Thummel 
and Pirrotta, 1991). As a control, the Hsp70 3'-UTR was also cloned 
independently of any Hsp83 3'-UTR sequence (Figure 3A, 'Hsp70'). 
The Hsp70 fragment was generated by PCR from a CaSpeR-hs template 
(Thummel and Pirrotta, 1991). 
11anos-Hsp8J hybrid transgenes. (i) nallos[I!.TCE]: a genomic 3' frag-
ment (Bglii-EcoRJ) containing a nanos 3'-UTR lacking the TCE was 
subcloned into pCaSpeR2 (Thummel and Pirrotta, 1991). Subsequently 
a genomic 5' fragment (BamHJ) extending from the nanos cis-regulatory 
sequences to the end of the ORF was inserted. (ii) nanos[I!.TCE + 
HDE]: a genomic 3' fragment (Bglli-EcoRJ) containing a na11os 3'-
UTR lacking the TCE was subcloned into pCaSpeR2. The Hsp83 HOE 
was PCR amplified incorporating 5'-BamHI and 3'-Bglll sites. This 
fragment was subcloned upstream of the 11anos 3' fragment. Subsequently 
a genomic 5' fragment (BamHI) extending from the nmws cis-regulatory 
sequences to the end of the ORF was inserted. (iii) Hsp83[ !!.HDE + 
TCE]: the 11anos TCE was amplified by PCR incorporating Hindiii sites 
at the ends, and inserted into lacZ-tagged pBS 1/'1>83[ !!.liD E) (2531!..350) 
at the 1/indiii site. 
Drosophila germline transformation 
Germline transformation was carried out using standard procedures 
(Rubin and Spradling, 1982). w1118 embryos were co-injected with 
500 ~tg/ml of the Hsp83-lacZ construct and I 00 ~tg/ml of pHS1t helper 
plasmid (Steller and Pirrotta, 1985). All transgenic insertions were 
homozygosed or balanced over CyO or TM3. 
Drosophila stocks and egg collection 
Drosophila mela11ogaster Oregon-R and wll/8 stocks are described in 
Lindsley and Zimm (1992). The following 'class 2' and 'class 3' maternal 
effect le thal mutants (Schupbach and Wieschaus, 1989) were assayed for 
transcript degradation in unfertilized eggs: celi-PK42, cell-RI/36, cortex, 
cribb/e, grauzone, luckellhaft, syn-HilO, presto, scraps, valois. For collec-
tion of unfertilized eggs, males of genotype T(Y;2)bw0 R<v#ll, en bw0 R<>·#JJ 
mr2/SM6a were crossed to appropriate females (Reed and Orr-Weaver, 
1997). Terminal duplication segregants are male sterile (Reed and 
Orr-Weaver, 1997). 
Drosophila embryo cuticle preparations 
For cuticle preparations, wild-type and mutant embryos were 
dechorionated, devitellinized and mounted as described previously (Raz 
and Shilo, 1993). 
RNA analysis in Xenopus 
Drosophila Hsp83 full-length 3'-UTR (1.407, see above and Figure 3) 
was transcribed from a pBiuescriptSK subclone using T3 RNA poly-
merase after linearization at the Kpni site. I!..HDE 3 '-UTR (2521!..350, 
see above and Figure 3) was transcribed from a PCR-amplified fragment 
that included the T3 RNA polymerase promoter at the 5' end of the 
3' -UTR sequence. Transcription was carried out in the presence of 
digoxigenin-11-UTP (Kioc et al ., 1996). For oocyte injections, ovaries 
were surgically removed from anaesthetized X.laevis females, 
stage 6 oocytes were manually defolliculated in calcium-deficient buffer 
(I X OR2) and were stored, injected and cultured for 0.5, 3, 6 or 24 h 
in 1 X modified Barth's buffer. For embryo injections , recently fertilized 
eggs were collected, injected and allowed to develop to stage 12 
(gastrula stage, - 24 h). For the time course in stage 6 oocytes (Figure 
SA), 500 ng of synthetic labeled RNA was injected into the cytoplasm 
Maternal transcript degradation in Drosophila 
whereas for comparative analysis of + HOE and !!.HOE 3'-UTRs (Figure 
BB), -100 ng of RNA was injected. Total RNA was prepared from 
injected oocytes or embryos, separated on a formaldehyde gel and blotted 
as previously described (Kloc et a/., 1989). The blot was blocked for 
1.5 h in 2% blocking solution (BMB, Genius kit) and was then incubated 
for 1.5 h with a 1:5000 dilution of anti-digoxigenin-alkaline phosphatase 
antibody in 2% blocking buffer. Subsequently blots were washed twice 
for 15 min each wash in G 1 buffer and stained in NBT/BCJP solution. 
All of the preceding used BMB Genius kit reagents and protocols. 
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Background: Drosophila numb was originally described as a mutation affecting 
binary divisions in the sensory organ precursor (SOP) lineage. The numb gene 
was subsequently shown to encode an asymmetrically localized protein which is 
required for binary cell-fate decisions during peripheral nervous system 
development. Part of the Drosophila NUMB protein exhibits homology to the 
SHC phosphotyrosine-binding (PTB) domain, suggesting a potential link to 
tyrosine-kinase signal transduction. 
Results: A widely expressed mammalian homologue of Drosophila numb 
(dnumb) has been cloned from rat and is refe rred to here as mammalian Numb 
(mNumb). The mNUMB protein has a similar overall structure to dNUMB and 
67% sequence similarity. Misexpression of mNumb in Drosophila during 
sensory nervous system precursor cell division causes identical cell fate 
transformations to those produced by ectopic dNUMB expression. In vitro, the 
mNUMB PTB domain binds phosphotyros ine-containing proteins, and SH3 
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full-length mNUMB in the multlpotential neural crest stem cell line MONC-1 
dramatically biases its differentiation towards neurons. whereas overexpresslon 
of the mNUMB PTB domain biases its differentiation away from neuronal fates. 
Conclusions: Our results demonstrate that mNUMB is an evolutionarily 
conserved functional homologue of dNUMB, and establish a link to tyrosine-
kinase-mediated signal transduction pathways. Furthermore, our results suggest 
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Introduction 
Many cytoplasmic signaling molecules that are targets of 
tyrosine kinases contain one or more SH2 (Src homology 
2) domains, which bind with high affinity to specific tyro-
sine-phosphorylated sequences [1,2]. Signaling enzymes 
often couple directly to receptor tyrosine kinases through 
their SH2 domains by binding to receptor autophosphory-
lation sites. In addition, a number of other conserved 
protein modules are found either alone or in combination 
with SHZ domains in cytoplasmic signaling proteins. 
These include SH3 and WW domains, which bind to 
proline-based peptide sequences [3,4], and PH (pleckstrin 
homology) domains, which may interact with protein 
targets or with phosphoinositides [5-7]. A family of mole-
cules composed solely of these conserved domains - for 
example, SHC, NCK, CRK and GRB-2 - and which 
exhibit no enzymatic activity have been termed adapters, 
representing an alternative mechanism by which cytoplas-
mic signaling molecules can be coupled to activated 
receptors. Many signaling adapters have been conserved 
throughout evolution; for example, Drosophila homologues 
of SHC (dshc), GRB-2 (drk) and NCK (dck) have been 
identified [8-11]. Genetic experiments have revealed the 
importance of these molecules in development: DRK is 
required to couple the SEVENLESS receptor tyrosine 
kinase to RAS for normal development of the Drosophila 
eye [9,10]; and mutations in the dck gene lead to a defect 
in axonal path-finding [11]. 
The PTB domain was described recently as an alternative 
phosphotyrosine-binding domain. The function of this 
domain was first demonstrated in the adapter molecule 
SHC [12-14]. and subsequently in the IRS-I molecule 
[15]. The SHC PTB domain has been shown to recognize 
phosphotyrosine in a specific sequence motif, NPXpY 
([16,17]; single-lette r amino-acid code, where X indicates 
any amino acid), found in several tyrosine kinase receptors 
and cytoplasmic proteins. A number of molecules contain-
ing pote ntial PTB domains have been identified by 
sequence homology, including the SHC-related protein 
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SCK, FE65, X11, Drosophila DISABLED and Drosophila 
NUMB (dNUMB) [18]. To date, the SHC, IRS-1, and the 
recently identified SHC-C [19] PTB domains have been 
shown to bind to tyrosine-phosphorylated proteins. 
Drosophila 11ttmb was originally described as a mutation 
affecting the binary division of the sensory organ precursor 
(SOP) lineage [20]. The numb gene was subsequently 
shown to encode an asymmetrically localized protein 
which is required for a binary cell-fate decision during 
peripheral nervous system development [21,22]. 
Drosophila NUMB protein is expressed in the SOP, and 
during cell division dNUMB is partitioned asymmetrically 
into the lib daughter cell and excluded from the Ila 
daughter cell [21,23]. The Ila cell then divides to produce 
a hair and socket, while the lib daughter divides to give a 
neuron and sheath. Loss of dNUMB function in this 
lineage results in the overproduction of hair and sockets at 
the expense of neurons and sheath cells [20]. Reciprocally, 
ectopic expression of dNUMB early in the lineage leads to 
an increase in sheath and neuron cells at the expense of 
hair and socket cells, whereas late expression converts 
both progeny of the II a cell into hair cells. 
Part of the dNUMB protein exhibits strong homology to 
the SHC PTB domain [18], suggesting a functional link to 
tyrosine-kinase signal transduction. Here, we describe the 
cloning and characterization of a mammalian Numb gene 
(mNumb). Furthermore, we establish that the PTB domain 
of mNUMB binds to phosphotyrosine-containing pro-
teins, suggesting that mNUMB functions as a signaling 
adapter molecule. We show that the cell-fate transforma-
tions caused by misexpression of mNUMB during devel-
opment of the Drosophila peripheral nervous system are 
identical to those produced by its Drosophila counterpart. 
Finally, we demonstrate that mNUMB biases the lineage 
determination of multipotent neural crest stem cells 
toward a neuronal phenotype, establishing a link between 
tyrosine-kinase signal transduction and cell-fate decisions. 
Results 
Cloning of a mammalian Numb gene 
In a search of expressed sequence tag (EST) libraries for 
novel PTB-containing molecules, one sequence was iden-
tified which contained a potential PTB domain and also 
showed high sequence similarity to the Drosophila ttumb 
gene. This DNA was used to screen an immortalized rat 
neural crest eDNA library to obtain a full-length eDNA. 
q~o cDNAs were isolated which coded for a complete 
open reading frame of 603 amino acids (Fig. la). In an itt 
vitro transcription/translation system, a 66 kDa protein was 
produced from the mNumb eDNA, which is consistent with 
the predicted molecular weight of the product of this open 
reading frame (see Fig. 3b). The sequence of the encoded 
protein is 67% similar to that of dNUMB (Fig. 1b), with 
the highest sequence homology in the putative PTB 
domain, where the two proteins are 70% identical. A com-
parison of SHC and NUMB PTB domains shows that 
amino acids critical for the binding of the SHC PTB 
domain to tyrosine-phosphorylated substrates are con-
served in the mNUMB protein [24-26] (Fig. l c). This sug-
gests that mNUMB may bind tyrosine-phosphorylated 
targets, and may play a role in a tyrosine-kinase-mediated 
signaling pathway. Examination of the mNUMB sequence 
also revealed that the carboxy-terminal half of the protein, 
which shows much lower homology to dNUMB, contains 
three potential SH3 binding sites. As for the Drosophila 
protein, no obvious catalytic domains can be identified in 
the mNumb sequence, suggesting that it may be a 
member of a group of signaling adapter molecules which 
include SHC, GRB-2, an9 NCK and their Drosophila 
homologues dSHC, DRK and DCK [8,9,11]. 
Expression pattern of mNumb 
The expression pattern of mNumb mRNA was examined 
by northern-blot analysis. The EST clone g116, which 
includes the amino-terminal 250 codons of mNumb, was 
used to probe a northern blot of poly(A)+ RNA isolated 
from adult rat tissues. A strongly hybridizi ng band of 
approximately 4.4 kb and a weaker band of approximately 
4 kb were detected in all tissues with the exception of 
skeletal muscle (Fig. 2). In addition, a similarly sized 
message was observed in multiple human cell lines, indi-
cating that mNumb mRNA is widely expressed in both 
rodents and man (data not shown). 
In order to examine the distribution of the mNUMB 
protein, a peptide corresponding to the carboxy-terminal15 
amino acids of mNUMB (Nb-C peptide) was used to gen-
erate polyclonal antiserum in rabbits (anti-Nb-C). Anti-Nb-
C antiserum immunoprecipitated three proteins, a doublet 
of 66 kDa proteins and a protein of 68 kDa (Fig. 3a). In 
vitro transcription/translation of the mNumb eDNA pro-
duced a 66 kDa protein doublet, which was recognized by 
the Nb-C antiserum (Fig. 3b). The 66 kDa protein doublet 
immunoprecipitated from R2 lysates co-migrated with the 
in vitro translated proteins, suggesting that these are the 
products of the mNumb gene itt vivo. The observed doublet 
may be due to phosphorylation of mNUMB both itt vitro 
and itt vivo, as treatment of anti-Nb-C immunoprecipitates 
with potato acid phosphatase collapsed this doublet into a 
single, faster-migrating band (data not shown). The 68 kDa 
species is likely to be the product of an alternatively 
spliced message O.V. and J.M, unpublished data). Follow-
ing cell fractionation, p66 and p68 were found primarily in 
the soluble cytoplasmic fraction, but were also detected in 
the particulate membrane fraction (data not shown). As 
shown in Figure 3c, the expression of mNUMB protein 
was not distributed evenly in adult tissues. Highest expres-
sion was evident in brain, liver and lung tissues, a pattern 
of expression that was consistent with, but more restricted 
than, the pattern of mRNA expression. 
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l TGGCGGCOGAGCTACAGTCTGAGGCGCCCOAG'I'TG'I'GCAGGGCCAGCGGCAGT'M'TCAGA 60 
. . . . . . 
61 TTTTAGAGCCAAAGMCATT'M'CCAGGGCAGACTGGCCACC"''TGGCMCCMGATCCTGA 1 20 
. . . . 
121 CCCATAACCACAGACTGGAGTACTGGTGGGCCACAGTCCTCAAATACCTGC'rl'AAGACI\G 18 0 
. . . . . . 
181 G'I'TGTA.AAACTTMCATGMCAAAC:rACGGCACAG'M"T'CAOOAGAAAGMAGATG'M'TAC 240 
M N X L R Q S F R R K K D V Y 15 
. . . 
241 GTCCCAGAGGCCAGCCGTCCACATCAGTGGCAGACAGATGAAGAGGGACTCCGCACTGGA 300 
16 V P E A S R P H Q W Q T D E E G V R T 0 35 
J 01 AACTGCAGC'M'CCCAGTTAA.GTACC'TTGGCCACGTAGAGGTTCATCACTCAAGAGGAATG J 60 
36 K C S F P V K Y L G H V E V D E S R G M 55 
. . ' . . . 
3 61 CACATCTCTCAACATGCCGTCAAAACAT'I'CAAAGCTOAAAGGAAGTTCTTCAAAGGC'M'C 4 2 0 
56 H I C B 0 A V X R L X A E R K F F X G F 75 
. . . . . . 
411 T'M'GGAAAAACQGGMAGAAAGCAGTGAAOGO:CI ICIGI'GGCTATCACCAGATGGAC'l'C' 4 80 
76 F C X T G K K A V K A V L W V S A 0 G L 95 
. . . . 
481 AGAG'M'GTGGATCMAAAACTAAOOACCTCATAG'M'GACCAGACMTACAAAAAGT'l.TCT 5 40 
96 R V V 0 E K T K D L I V D Q T I B K V S 115 
. . . 
541 qqCqdClCCCCCCAqAdCAA~CACAdCCDfDrMDCDfDqACAqAqdqCdAdAqCCCACC 600 
116 F C A P 0 R N F D R A F S Y I C R D G T 135 
. . . . 
601 AC'fCGGC'GATOGATC'I'CTCA'l"TGC"M'CATOGC'IC'I"CAAAGACAC'GGlGCGAAAGA.CTGAGC 1560 
136 T R R W I C H C P H A V K D T 0 E R L S 155 
. . . . 
661 CA"''GCCC'TGCGCTAGCCTGT'I'TACAGCCTAAACAGAAG GGAG 7:20 
156 H A V G C A F A A C L E R X Q JIC R E JIC E 175 
7:Zl 'l"GTCGAGTCACTGCTACTT'l"CCATGCCAGTAGM.CCACT'I'T'TAC.V.GAG.UGCATCATTC 780 
176 C G V T A T F D A S R T T P T R B G S F 195 
. . . . . 
781 CGTG'I'CACAACTGCCACAGAACAAGCTOAAAGAGAGGAGATCATGMACAGTTGCAAGAT 840 
196 R V T T A T E Q A E R E E I K K Q L Q 0 :215 
. . . . 
8 41 GCCAAGAAAGCTQAGACAGATAAGACCCT'I'GGTCCATCAG'l"GGC'l"CTGGCMCAGTGCT 900 
:216 A JIC JIC A E T 0 K T V G P S V A P G N S A :235 
. . . . 
901 CCATCGCCG'l'CCTCTCCCACcrccccMC'l"C'TGGATCCCACTGC'TTCTTTAGAGATGAAC 960 
:236 P 5 P S S P T S P T L 0 P T A S L E li N 255 
. . . 
961 AATCCTCATCCTATCCCACCCCCGCATGCACCAA'l"TGAACAGCTTGCTCCCCAACCCTCT 10:20 
:256 N P H A I P R R H A P I E 0 L A R Q G S 275 
. . . . 
1021 TTCCGGGGATI'TCCTGCTCTTAGCCAGAAGATGTCACCCTI'TAAACGCCAGCTGTCCCTA 108 0 
276 F R G P P A L 5 Q K M S P P X R Q L S L :295 
. . . . . 
1081 CGCATCAATGACCTGCCTTCCACTATGCAGACCAAGACTOAT'T'l'CCCAATAAAAAACACA 114 0 
296 R I N E L P S T H Q R X T D P P I X N T 315 
. . . 
1141 G'TGCCTGAGG'l"GGMGGA.GAGGCAGAAAGCATCAGCTCC'C'I'C'l'GCTCCCAGATCACCAGT 1200 
316 V P E V B G E A E S I S S L C S Q I T S 335 
. . . . 
1201 GCCTTCAGCACACCCTG'I'GAGGACCCCTTCTCC'I'C'roCCCCAATCACCAAACCAGTGACA 1260 
336 A F S T P C E 0 P P S S A P H T X P V T 355 
. . . 
1261 TTAG'I'OOCACCACACTCTCCTCTG'M'ACA.AGOOACTGA.GTGGGGTCACTCTTCTGGTGCT 1320 
356 L V A P Q S P V L Q C T E W C Q S S G A 375 
. . . . . 
13:21 GCCTCTCCAOOTCTCTl'CCA.GGCTOO"'"CACAGACGCACTCCC'l"CTCAGGC'' 1380 
376 A S P G L P Q A G H R R T P S B A 0 R W 395 
. . . . . . 
1381 TTAGMOAAGTATC.A.AAAAGTG'l'GCQGlGCCCAGCAGCCGCACGCCTCAGCCGCCCCTCTC 1440 
396 L E E V S K S V R A 0 Q P Q A S A A P L 415 
. . . . . . 
1441 CAGCCAG'M'CTGCAGCC'I'CCTCCGCCCGCTOCCATTGCCCCTCCAGCACCTCC'I'Tl'CCAA 1500 
416 Q P V L Q P P P P A A I A P P A P P P Q 435 
. . ' . . 
1501 dCACAqCCAqqCCqCACqqCqCAdC~CCCCqACAACCA 1560 
436 G H A P L T S Q P V P V G V V P P L 0 P 455 
1561 GC:C,T'IIMI:CG.,.,Ic:iircc,.rACCCAGTi:CTACCC'1"GTTOcc.uTGGGATCCCCTATCC.A.GCC'TCTAAT 16:20 
4 56 A P V S T Q S Y P V A N G M P Y P A S N 475 
. . . . . 
1621 G'l'CCC'l'CTAGTOGGCA.TCACCCCA'l"CCCAGATOGTAGCCAATC1'GT'l"''GGCCTCCAGGC 1680 
476 V P V V G I T P S 0 H V A N V P G T A G US 
. . . . . 
1681 CATCCTCAGOCCACTCATCCACATCAGTCCCCAAGCCTGGCCAAGCAOCAGACATTCCCT 17 4 0 
4 96 H P Q A T H P H Q S P S L A X 0 Q T F P 515 
. . . . . 
17 41 CAATA'l'CACACAJtCrAGTGCTACCACCAC'l"CCCT'AACCC'M'CTCCTCACACC'l'C 1800 
516 0 Y E T S S A T T S P P P JIC P S A 0 H L 535 
. . . . . 
1801 AA'l'GG'M'CTGCAGC'T'J"1'CAATGGTGTAGACA.ATAGCGGGCTACTCTCAGGAAACA.GACCT 1860 
536 N G S A A F N G V 0 N S G L V S 0 N R P 555 
18 61 dCACAAdqCC:crCCACdCACCqdCCCAdqdcAqCCqDf"MDdACdCCCAd~CqA 19 20 
556 A Q V P P G T C P V 0 P F E A Q W A A L 575 
. . . . . . 
19:21 GAAAGCA.AGCCCMGCAGCGCACCAACCCCTC'I'CCTACCAACCC'I."'"'J'CTCTGCA 1980 
576 E S It ! K Q R. T N P S P T N P F S. S 0 A . 595 
1981 CACA.AGGCA'l"'M'GAAATAGAGCTTl'AGA'i'GGTCC'ITATOA'I'OO'M"C'M"'lCTTAGC 2040 
596 0 J: A P E I E L • 603 
204 1 CAAKdddC~ciKKddA~dAqcicCACACqqqq 2100 
. . . . . . 
2101 CACTCATCCCAOTOGTCCCAACCAGCAAGTCCAAOCACACTCCAGOOAGGGCTGCTGTCC 2160 
21 61 cCAGAAGCOi..ooc.v.GCCT"i-cCTGG.AGAG<lACTGcCC'i'GCAGCTAGGCTAcAAACCAAG0 2220 
22 21 MGCATTGCCrrCTGGCccCTAACAAG'l"C'i-cTTGCAA00AGAGCCA.OMcAGCTGAAGA 2:280 
. . . . . . 
2:281 GG.AATCTG'TAT'J'CAAAGCACA'I"M'CC'TTGQATATAAAACAAAA.CAGCAACC'AAAATGATC 2 340 
. . . . . . 
2341 TTc:C<C:CC:TITirl'<C:'IITIT111M'ICAGGCCACTCACCGTCCCTCCCAGTAC'i'GCCC'TG'I'CACAGCTCCA 2400 
. . . . . . 
2401 'l"QG.AQAACAGTQ'I'OQC'I"GGT"CAGGCAGCCCA'I'GCTGC"l"GGGTTCACACGAGGGC :2460 
. . . . . . 
:2461 ATCAGCAGC'l'GCCCAGTAOA.GCTG'l'AGTCTGGGGATAAAGCTGAGCTTCCA.'M'TTGAGTT 25:20 
:2521 ACAlMqAAiqAqqAqAAKAi-AqAKqAKqAqAKfAqAqC~ 2564 
mNUHB 1 
..••••. . MNKLR 5 
···' I dNUMB 
(c) 
1 HGNSSSHTBEPLERGFTRGKFGDVKNGKSASFRFSKKSPKKMDRLRRSf'R 50 
6 QSFRRKKDVYVPEASRPHQWQTDEEGVRTGKCSFPVKYLGHVEVDESRGM 55 
' II II' II I l l . I ' IIIII . Ill ' II . '. I ll . IIIII Ill IIIII 
5 1 DSFRRRXDR. VPESSKPHOWQA.DEEAVRSATCSFSVKYLGCVEVFESRGM 99 
56 HICEDAVKRLKAERKFFKGFFGKTGKKAVKAVLWVSADGLRVVDEKTKDL 10 5 
"11' 1'1 1'··1 '"1'" 1 11, 1111111,.11,1 
100 QVCEEALKVLRQSR ••••.• ..••• RRPVRGLLKVSGOOLRWOOETKGL 138 
1 0 6 IVDQTIEKVSFCAPORNFDRAFSY ICRDGTTRRWICHCF'MAVKDTGERLS 15 5 
11111 111 111 111111 , 1,1111111 11111 1,11·1'1·1 1.11111 
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Figure 1 (facing page) 
(a) Sequence of mNumb. The nucleotide sequence or the mNumb eDNA and 
Its translation product are shown. The PTB domain is boxed, and putative SH3-
binding sites are underlined. (b) The amino-acid sequence or mNUMB and 
dNUMB were compared using the GCG GAP prograrn (c) A mu~lple sequence 
alignment of the PTB domains of Drosophila (d) and mammalian (m) 
homologues of SHC and NUMB. Arrowheads indicate the positions or 
conserved amino acids important for phosphotyrosine binding [24- 26]. 
Consistent with the western-blot analysis, immunohisto-
chemical staining of rat and mouse embryonic tissues with 
anti-Nb-C antiserum revealed that mNUMB was expressed 
widely (Fig. 3d-g). Tissue anti-Nb-C immunoreactivity 
was specific for mNUMB, in so far as preincubation of the 
antibody with the immunizing peptide prior to staining 
tissues essentially abolished all observed staining (Fig. 3e). · 
The strongest expression was observed in the nervous 
system, but was also detectable in non-neural tissue such as 
the branchial arches, lung, heart and liver (Fig. 3f). In the 
nervous system, mNUMB expression was especially promi-
nent in the ventricular zones of neuroepithelial tissue (neu-
rogenic regions) (Fig. 3d) and in developing neuronal 
ganglia (Fig. 3g). T he sensory neuron pools, including the 
dorsal root ganglia (Fig. 3g) and the trigeminal ganglia (Fig. 
3d) consistently showed the most intense staining. In two-
day-old primary rat neural crest cell cultures, a subpopula-
tion of cells was found to label intensely with anti-Nb-C. 
Furthermore, double-labeling of these cells with anti-13-3-
tubulin indicated that, at least in this model, mNUMB was 
expressed specifically in cells fated to the neuronal lineage. 
Surprisingly, it was also evident in these neural crest cell 
cultures that mNUMB was not distributed asymmetrically 
in crescents, as has been reported previously in Drosophila, 
but rather the anti-Nb-C immunostaining appeared to be 
cytoplasmic (Fig. 3i). 
Misexpression of mNUMB in Drosophila 
We misexpressed mNUMB in Drosophila sensory organ 
precursor cells in order to assay whether this would cause 
the same cell-fate transformations as those observed upon 
overexpression of dNUMB. Previous analyses of the effects 
of overexpression of the Drosophila numb gene by Rhyu et 
a/. [21] revealed a role for dNUMB at two successive cell 
divisions during peripheral nervous system development. 
During the first division of the SOP, dNUMB specifies the 
lib fate (neuron and sheath precursor) versus the Ila fate 
(hair and socket precursor). During the subsequent division 
of the lia cell, dNUMB specifies hair versus socket fate. 
Early misexpression of dNUMB causes both daughters of 
the SOP to adopt the lib fate resulting in excess neurons 
and sheath cells and the absence of hair (microchaete) and 
socket cells [21]. L ate misexpression of dNUMB results in 
twinning of hairs as a result of transformation of the socket 
cell into a hair cell [21]. 
Misexpression of mNUMB during the development of the 
Drosophila notum and the wings caused identical cell-fate 
Figure 2 
t:: c: 
m ·~ 
:I: CD 
kb 
Tissue distribution or mNumb mRNA In adult rat tissues. Northern blot 
containing 2 11-g of poly(A)• mRNA Isolated from a variety of rat tissues was 
analyzed for mNumb mRNA expression. Expression of a 4.4 kb transcript is 
noted in all lanes except skeletal muscle. 
transformations to those produced by ectopic expression 
of dNUMB. When misexpressed in the developing notum 
under heat-shock control prior to SOP cell division 
(10-14 hours after puparium formation; APF), mNUMB 
had no effect on subsequent cell-fate choice and the adult 
notum appeared wild-type (data not shown; see Fig. 4a for 
wild-type). Strikingly, however, in 100% of the flies, mis-
expression of mNUMB unde r heat-shock control at the 
time of the first division of the SOPs (14-18 hours APF) 
resulted in balding of the notum because of loss of 
microchaetes and associated sockets (Fig. 4b). Similarly, 
misexpression of mNUMB specifically at the presumptive 
dorsoventral margin of third instar larval wing disks under 
GAL4-UAS control (using the C96line; [27]) caused com-
plete loss of the marginal hairs in the wings (Fig. Sc,d). 
Misexpression of mNUMB in the notum 18--22 hours APF 
resulted in partial balding and also twinning of 
microchaetes. The latter phenotype occurred as a result of 
transformation of socket cells into hair cells at the division 
of the lia cells (Fig. 4c). Misexpression of mNUMB under 
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heat-shock control in the developing wing 14-18 hours 
APF caused twinning of the marginal hairs in I 00 % of the 
wings (Fig. Se,f). Misexpression after this division 
(22-26 hours APF in the notum, and 18-22 or 22-26 hours 
APF in the wing) had no effect (data not shown). T hus, 
mNUMB produces identical cell-fate transformations to 
those induced by misexpression of Drosophila 1111mb, and 
these effects are stage-specific relative to the cell division 
program of the SOPs. 
Figure 3 
(a) (b) In vitro 
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Identification and distribution of t he mNUMB protein 
using anti·Nb ·C antibody (aNb·C). 
(a) mNUMB from lysates of R2 cells was 
immunoprecipitated with preimmune serum (PQ or 
with anti-Nb -C plus or minus the immunizing peptide 
(20 fL9), separated by SDS·polyacrylamlde gel 
electrophoresis (PAGE), transferred to lmmobllon 
and immunoblotted with anti·Nb·C antibody. (b) 
mNUMB was immunoprecipitated from R2 cell 
lysates and from an in vitro transcription/ translation 
reaction (TNT) with anti-Nb-C plus or minus the 
Immunizing peptide (20 fL9) . separated by SDS· 
PAGE, transferred to immobilon and immunoblotted 
with anti·Nb·C. (c) mNUMB was lmmuncprecipitated 
from various rat tissue lysates using anti-Nb-C plus or 
minus the Immunizing peptide (20 fL9). separated by 
SDS·PAGE, transferred to immobllon. and 
immuncblotted with anti·Nb-C. In figures (a-c), 
mNUMB is indicated by an open arrow, and the non· 
specific immunoglobulin heavy chain band by a filled 
arrow. (d-g) Anti-Nb-C immunoreactivity in mouse 
and rat embryonic tissue sections. Scale 
bars = 200 ~gImK (d) Transverse section of rot E1 1 
shows predominant neuroepithelium (NE) staining in 
the third and fourth ventricle (3V and 4V), and 
trigeminal ganglion (TG) staining. (e) Anti·Nb·C 
staining was abolished when the antibody was 
pre incubated with the immunizing peptide 
R2 TNT 
a. a. 
"' "' a.. a..
+ + 
u u u u 
.6 .6 .6 .6 
z z z z 
tl tl tl tl 
The mNUMB PTB domain binds phosphotyrosine-
containing proteins 
Having shown that mNUMB is a functional homologue of 
dNUMB, we investigated the molecular mechanism of 
action of mNUMB and its role in mammalian develop-
ment. To date , although a number of molecules contain-
ing PTB domains have been identified, only the SI-IC, 
SHC-C and IRS-I PTB domains have been shown to bind 
tyrosine phosphorylated proteins. T herefore , we sought to 
(c) 
>, c: 
c: t 
"' :;; m "' 
·e "' c: c: "' 
"' 
u 
.2: ::> a. co I ;;z _J _J C/l 
kDa - + - + - + - + - + + :Nb·C 
200- peptide 
97-
68-•·-
.. • <J-
_ ....... 
• ~M 
~ 
43- ... 
~ 29- 1 
IP: aNb·C 
Blot: aNb·C 
(0.5 mg .ml- ': 30 min). <n Transverse section of rat 
E11 shows detectable mNUMB Immunoreactivity in 
the rostral neural tube neuroepithelium (NE), first 
branchial arch (8A) and heart walls (Hn. (g) Saggital 
section or mouse E1 3.5 shows predominant dorsal 
root ganglion (DRG) staining. (h-:i) Anti·Nb·C 
immunoreactivity of primary rat neural crest cells. 
Scale bar = 50 fUT1· (h) Phase·contrast image of cells 
in (ij). Cells were stained with DAPI to distinguish 
the cytoplasm and nuclei. (i) A subpopulation of cells 
In neural crest cultures express detectable 
cytoplasmic anti·NtrC immunoreactivity. 0) These 
mN UMB-expressing cells double stain w ith antePP~ 
tubulin, an early neuronal marker. 
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Figure4 
Misexpression of mNUMB during SOP 
development in the Drosophila notum causes 
cell-fate transformations. (a) Wild-type notum. 
(b) P[hs-mNumb] notum heat-shocked 
14-18 h after puparium formation. Note the 
absence of microchaetes.(c) P[hs-mNumb) 
notum heat-shocked 18- 22 h after puparium 
formation. Note the twinning of microchaetes 
(arrowheads}. 
establish whether the potential mNUMB PTB domain, 
located between amino acids 27 and 174, could indeed 
bind tyrosine-phosphorylated proteins. Amino acids 1- 183 
were expressed as a glutathione S-transferase (GST) 
fusion protein in bacteria, purified and immobilized using 
glutathione sepharose. T he immobilized fusion protein 
was incubated with cell lysates in order to assess its capac-
ity to associate with tyrosine-phosphorylated proteins. 
Figure 6a shows an anti-phosphotyrosine blot of proteins 
which bound to the GST -mNUMB-PTB protein or ro 
GST -SHC-PTB in either a v-sn·-transformed cell line 
Figure 5 
Misexpression of mNUMB during SOP 
development in the Drosophila wing margin 
causes cell-fate transformations. (a,b) Wild-
type wing. (c,d) Expression of mNUMB at the 
dorso-ventral margin of P[UAS-mNumb] 
transgenic larval wing imaginal disks results in 
loss of the marginal hairs. (e,f) Heat-shock-
induced expression of mNUMB in 
P[hs-mnumb] transgenic flies throughout the 
developing wing 14-18 h arter puparium 
formation results in twinn ing of the marginal 
hairs. 
( c) 
(e) 
(S7a) or its parental line RZ. The GST- mNUMB-PTB 
protein associated with a set of tyrosine-phosphorylated 
proteins that were similar in molecular weight to those 
that associated with the SHC PTB domain. GST alone 
(Fig. 6a) or a GST-fusion protein containing mNUMB 
amino acids 184-603 (data not shown) did not associate 
with these proteins. These data demonstrate that amino 
acids 1-183 of mNUMB function as phosphotyrosine-
binding domain. Both the mNUMB PTB domain and the 
SHC PTB domain associated with two pro[Cins of 90 kDa 
and 97 kDa in i\431 cells stimulated with epidermal 
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Figure 6 
(a) 
(b) 
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GST 
SHC 
PTB 
mNumb 
PTB aNb·C 
Blot: apY 
SHC mNumb 
PTB PTB aNb-C 
Blot: apY 
Association of phosphorylated proteins with the mNUMB PTB domain. 
Purified, immobilized GST, GST-SHC(1-209)PTB or 
GST -mNUMB(1-187)PTB fusion proteins were incubated with 
protein iysates from (a) R2 or S7a (v·src) cells, or (b) unstimulated(-) 
or EGF-stimulated (+) A431 cells. mNUMB was also 
immunoprecipitated from celllysates with anti-Nb-C antibody. Protein 
complexes were separated by SDS-PAGE, transferred to lmmobilon 
and immunoblotted with anti·phosphotyrosine antibody (apY). 
growth factor (EGF) (Fig. 6b). Unlike the PTB domain of 
SHC, however, the mNUMB PTB domain did not associ-
ate with the autophosphorylated EGF receptor (Fig. 6b). 
Therefore, the mNUMB PTB and the SHC PTB domains 
may share some cytoplasmic targets, but the mNUMB 
PTB does not recognize similar receptor autophosphoryla-
tion sites. In vivo, [3ZP]orthophosphate labeling of R2 cells 
has shown that mNUMB is a phosphoprotein (J.M., 
unpublished data). However, immunoprecipitated 
mNUMB was not detected by western blotting with anti-
phosphotyrosine antibodies (Fig. 6a,b), suggesting that 
mNUMB may be a substrate for serine/threonine kinases. 
mNUMB associates with SH3 domains in vitro 
The carboxy-terminal domain of mammalian mNUMB 
contains several proline-rich regions with sequences that 
match the minimal consensus motif for potential SH3 
binding (PXXP) (Fig. 1a). To test whether mNUMB asso-
ciates with SH3 domains i11 vitro, a series of GST -SH3 
domain fusion proteins was incubated with protein lysates 
from R2 fibroblasts. The resulting protein complexes were 
separated by 80S-polyacrylamide gel electrophoresis 
(PAGE) and immunoblotted with anti-Nb-C antiserum 
(Fig. 7). Of the different SH3 domains tested, only the 
SRC SH3 domain seemed to interact with mNUMB in 
vitro. With longer exposures, weaker interactions with 
ABL and FYN SH3 domains could be detected, suggest-
ing that, of those tested, mNUMB associated preferen-
tially with SH3 domains of Src family kinases. Consistent 
with this observation, we have found that tyrosine kinase 
activity is present in protein complexes precipitated with 
GST-mNUMB(l83-603), which contains these proline-
rich sequences (S.J. and R.S., unpublished data). The 
tyrosine kinase present in these in vivo protein complexes 
has not been identified, but is not SRC itself as 
immunoblotting with anti-SRC antibodies was negative. 
mNUMB overexpression influences cell-fate decisions in 
mammalian neural crest cell lines 
If the biological functions of mNUMB are similar to that of 
its Drosophila counterpart, as suggested by the phenotype 
caused by misexpression in Drosophila, then one might 
expect that overexpression of mNUMB would lead to an 
increase in the number of neurons formed from mammalian 
cells with neurogenic potential. Furthermore, suppression 
of mNUMB function should lead to a decrease in neuron 
formation. In order to test this hypothesis, mNUMB was 
overexpressed in the mouse embryonic carcinoma line P19 
and in the mouse neural crest stem cell MONC-1. 
When pooled stable transformants of P19 cells overexpress-
ing mNUMB were induced to differentiate (using retinoic 
acid) and stained for neurofilaments on day 6, 31.5 ± 3.6% 
of the total cells stained for the neuronal marker (n = 3 
independent experiments; Table 1). This represents a 
greater than 50 % increase over the proportion of control 
P 19 cells that stained positively for neurofilament (Table 
1). In an attempt to suppress mNUMB function, a trun-
cated form of mNUMB containing only the PTB domain 
was used. This construct could potentially act as a domi-
nant negative by uncoupling the PTB domain target from 
the tyrosine kinase or other downstream targets associated 
with the proline-rich carboxy-terminal region. P19 cells 
expressing the mNUMB-PTB protein showed a 23 % 
reduction in the percentage of neurofilament positive cells 
over control, a decrease from 20.2 ± 1.5% to 15.7 ± 2.5 %. 
This was a significant decrease, as more than 15 000 cells 
were counted per experiment, and similar results were 
obtained in all three independent experiments. 
Drosophila NUMB is necessary for two binary choices in 
the development of neurons from the SOP: first, it confers 
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Figure 7 
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Binding of mNUMB to SH3 domains in vitro. Purified, immobilized 
GST or GST-SH3(ABL, v·CRK. FYN, GAP, p85, SRC or Spectrin) 
were incubated with protein lysates of R2 cells. Protein complexes 
were separated by SDS-PAGE. transferred to lmmobllon and 
immunoblotted with anti·Nb·C antibody. 
the lib fate on one of the daughter cells of the SOP; and 
second, it specifies hair cell fate in one of the progeny of 
the Ila cell. To investigate whether mNUMB was 
involved in early lineage restriction during mammalian 
nervous system cell-fate determination, the gene was 
overexpressed in MONC-1 cells. These neural crest stem 
cells have the potential to form smooth muscle, neurons 
and glia in culture [28]. Retroviruses designed to express 
full-length p66 mNUMB, the mNUMB PTB domain 
alone or the bleomycin resistance gene alone were used to 
infect MONC-1 cells, which were then plated at clonal 
density and induced to differentiate by the addition of 
serum and forskolin. Of the clones containing the 
bleomycin gene, 79 % contained at least one neuron after 
48 hours (50 of 63 clones; Table 2 and Fig. 8). Strikingly, 
Table2 
Clonal analysis o f differentiated M ONC-1 cells. 
Experiment 1 
MONC-1 Bleo 
Number of clones 
examined 
28 
MONC-1 NUMB 43 
MONC-1 PTB 22 
Experiment 2 
MONC-1 Bleo 35 
MONC-1 NUMB 38 
MONC-1 PTB 32 
Neurons 
only 
0% (0) 
30%(13) 
0% (0) 
0% (0) 
36%(14) 
0% (0) 
Neurons/ 
smooth muscle 
43% (12) 
49% (21) 
10% (2) 
43% (15) 
21 % (8) 
6% (2) 
C lonal analysis of MONC-1 cells overexpressing full-length mNUMB. 
mNUMB PTB or the bleomycin resistance gene (Bieo). C lones were 
stained for neurofilament and smooth muscle actin and scored 
accordingly. Staining of only one cell per clone was sufficient to 
Table 1 
Neuronal different iation o f cells overexpressing m NUMB. 
% Neurofilament-staining cells 
Cell line Experiment 1 Experiment 2 Experiment 3 
P19·Bieo 
P19-NUMB 
p19·PTB 
20.9 
32.6 
16.9 
18.4 
34.4 
12.8 
21.2 
27.5 
17.4 
Presented are the percentages of neuralfilament·positive p19 cells 
after differentiation, induced by retinoic acid. at day 6. Each experiment 
originates from pooled stable transformants from independent retroviral 
infections of p 19 cells. Note that. in each experiment, stripes of cells 
were counted from triplicate plates - in excess of 1 5 000 cells were 
counted in each experiment 
96% of the clones (78/81) overexpressing mNUMB had at 
least one neuron, and 33% (27/81) of the clones contained 
only neurons (Fig. 8 and Table 2). In contrast, in clones 
expressing the mNUMB PTB domain, only 22% (12/54) 
produced at least one neuron after 48 hours and no clones 
of only neurons were observed. Remarkably, of the 42 
remaining clones, 31 contained only smooth muscle and 
the others were mixed clones of smooth muscle and cells 
that stained with GFAP (glial fibri llary acidic protein). To 
establish that this phenomenon was not a result of an 
effect on neuronal survival in the clones expressing the 
mNUMB PTB domain, 6 hour serial observations of these 
differentiating MONC-1 cells were undertaken. Cohorts 
of 30 identified clones were followed for 48 hours. It was 
observed that the neuronal cells (four cells in three clones) 
survived the 48 hours of the experiment, indicating that 
mNUMB does not alter neuronal cell survival but may 
function to bias the determination of neurogenic precur-
sors into a neuronal phenotype. 
Neurons/smooth Smooth Smooth muscle 
muscle/gila muscle/glia only 
36% (10) 14% (4) 7% (2) 
21% (9) 0%(0) 0% (0) 
0% (0) 23%(5) 68% (15) 
37% (13) 14% (5) 5% (2) 
34% (13) 8%(3) 0% (0) 
15% (5) 28%(9) 50% (16) 
categorize the clone. The total number of clones in two independent 
experiments stemming from independent infections is presented in 
column 1 . The other columns show the percentage of clones in each 
category. and the total number of clones is in parentheses. 
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Figure 8 
Overexpression of mNUMB leads to an increase in neurogenic capacity. 
Presented are immunomicrographs of MONC-1 cells expressing (a) full-
length mNUMB (NUMB), (b) a bleomycin resistance gene (BLEO) or (c) the 
PTB domain of mNUMB (PTB). Cultures were first s tained for neurofilament 
Discussion 
In a search for novel PTE-containing molecules, we have 
cloned a mammalian homologue of Drosophila tmmb by 
screening a neural crest eDNA expression library with a 
human EST. T he eDNA encodes a 66 kDa protein which 
is closely related to the Drosophila prote in. T he mam-
malian and Drosophila proteins share a high degree of 
homology in the amino-terminal 200 amino acids, and we 
have shown that this region contains a functional PTB 
domain. T he carboxy-terminal region of mNUMB con-
tains several potential SH3 binding sites. We propose, 
therefore, that NUMB is a component of a tyrosine-
kinase-mediated signal transduction pathway. We have 
established that this mammalian gene (mNttmb) is the 
functional homologue of Drosophila 1111mb, and have 
demonstrated that mNUMB functions as a neuronal cell-
fate determinant. On the basis of the wide tissue distribu-
tion of mN UMB, we suggest it may play a role in cell-fate 
decisions outside of the nervous system. 
mNUMB and dNUMB fulfil analogous roles in neuronal 
cell-fate choice 
T he biological role of mNUMB in mammals parallels that 
exerted by dN UMB during ne rvous syste m development. 
In Drosophila, dNUMB has been shown to be required for 
cell-fate determination at two successive divisions during 
sensory nervous system development. Remarkably, 
mNUMB, expressed under either heat-shock promoter or 
GAL4-UAS control, directed ide ntical cell-fate transfor-
mations to those produced by overexpression of dNUMB. 
We co nclude that mNUMB is a functional homologue of 
dN UMB. 
By analogy with the role NUMB plays in biasing the cell-
fa te determination of ITa and lib daughter cells in 
Drosophila, the overexpression of mNUMB in multi poten-
tial MONC-1 cells results in a strong biasing ~ the fate 
(NF; red) and smooth muscle actin (SMA; green). Note only NF-positive cells 
in mNumb-overexpressing clone and SMA in PTB-containing clone. Bleo 
controls stained for both NF and SMA. 
choices of these cells towards neurons. Reciprocally, sup-
pression of mNUMB function biases MONC-1 cells against 
neuronal lineages. This functional conservation has been 
seen in other signal-transducing pathways involved in 
Drosophila and mammalian neural development. For 
example, NOTCH function in neuronal cell-fate decisions 
is conserved between Drosophila and mouse [29,30]. 
In MONC-1 cells, suppression of mNUMB function leads 
to a dramatic increase in clones of only smooth muscle. 
T his should not be taken as evidence, however, that neural 
crest development involves a binary choice between neuro-
genic potential and myogenic potential. We suggest that 
mNUM13 strongly biases neuronal formation, and that sup-
pression of mNUMB function forces cells with neurogenic 
potential away from neuronal lineages. In our present 
culture system, MONC-1 cells give rise to smooth muscle; 
hence, a bias away from neuronal formation leads to smooth 
muscle determination. MONC-1 cells expressing the PTI3 
domain or overexpressing full-length mNUMB have never 
been observed to differentiate in standard medium. Differ-
entiation is only observed when the instructive or inducing 
factors are supplied through addition of serum. Thus, the 
bias toward or away from a given lineage is more likely to 
be the result of a change in the balance of competing; signal 
transduction pathways resulting from the ovcrcxprcssion of 
mNUMB or the suppression of mN UMB function. 
mNUMB is an evolutionarily conserved signaling adapter 
In order to understand the molecular mechanism by 
which mNUM B exerts its effects, it is necessary to 
analyze the signal transduction pathway in which 
mNUMB participates. T he structure of mNUMB sug-
gests that it is a member of a family of ada pter molecules 
which includes SHC, GRB-2 and NCK. The evolutionar-
il y conserved biological role of these molecules is shown 
by their functional conservation in invertebrates and 
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mammals, exemplified by our demonstration that 
mNUMB and dNUMB can direct identical cell-fate 
choices when misexpressed in Drosophila. The sequence 
similarity between the Drosophila and mammalian 
NUMB proteins is most striking in the PTB domain 
(70 % identity), suggesting that this domain plays a criti-
cal role in the biological activity of the protein. We have 
shown that the mNUMB PTB domain binds to tyrosine-
phosphorylated proteins in vitro, suggesting that both 
Drosophila and mammalian NUMB are involved in tyro-
sine-kinase signal transduction. It is interesting to note 
that another PTB-containing adapter molecule, SHC, and 
its Drosophila homologue, dSHC, have been shown to 
bind activated growth factor receptors through their PTB 
domains and to recognize a similar binding motif. We 
expect that the targets of the Drosophila and mammalian 
NUMB PTB domain will also be evolutionarily con-
served. This is suggested by the ability of mNUMB to 
signal when misexpressed in Drosophila, which may result 
from conservation of a specific PTB-binding site on an 
upstream or downstream target molecule. · A yeast two-
hybrid screen for sequences encoding proteins that inter-
act with mNUMB has identified seven in absentia (sino) 
[31] from a Drosophila library and a sitta-like eDNA from a 
rat brain library, supporting this hypothesis (R.S., S.J., 
J.V. and J.M., unpublished data). 
The binding specificity of the mNUMB PTB domain 
remains to be determined. On the basis of our observation 
that mNUMB PTB domain does not interact with the acti-
vated EGF receptor, it is likely that it recognizes and binds 
with high affinity a sequence motif different from the SHC 
PTB domain. The core sequence recognized by SHC and 
IRS-1 PTB domains is the motif NPXpY, which is pre-
dicted to form a tight 13-turn structure [17,32,33). Studies 
comparing the binding specificities of the SHC and IRS-1 
PTB domains have revealed that amino acids outside of 
this motif, in particular the -5 position relative to the phos-
photyrosine, appear to be important for binding specificity 
and affinity [17,15). It is also possible that the mNUMB 
PTB domain could have targets which are not phosphory-
lated on tyrosine, as both SHC and the PTB domain of 
FE65 have been reported to interact with specific target 
molecules in a tyrosine-independent manner [34,35). 
Outside of the PTB domain, the amino-acid sequence of 
Drosophila and mammalian NUMB proteins is much less 
conserved. We have identified several potential SH3 
binding sites in this region of mNUMB, and have shown 
that SH3 domains bind to mNUMB itt vitro. The dNUMB 
protein also has several minimal SH3-binding motifs 
(PXXP), and therefore this region may also be functionally 
conserved. In this respect, the overall structure of NUMB 
is similar to that of SHC: it possesses an amino-terminal 
PTB domain followed by a proline-rich region which con-
tains potential SH3 binding sites [12,36). 
The NUMB signaling pathway 
It will be necessary to identify proteins that interact with 
mNUMB in order to define the signal transduction 
pathway regulating cell-fate decisions. The PTB domain 
may couple NUMB to a receptor tyrosine kinase, or to 
another type of cell-surface receptor responsible for initi-
ating the instructive signal. That interaction could also be 
responsible for directing the asymmetric membrane local-
ization of NUMB which has been reported in Drosophila 
[21,22,37). To date, we have been unable to observe 
asymmetric localization of mNUMB by immunohisto-
chemical staining of either tissue culture cells or rat 
embryo sections, even in circumstances where dividing 
cells can be visualized. This result may suggest that mam-
malian and Drosophila NUMB proteins are mechanistically 
distinct in the way in which they localize within the cell. 
Alternatively, given the functional conservation between 
dNUMB and mNUMB, our inability to observe this phe-
nomenon could be a result of the recognition of multiple 
isoforms of mNUMB by our anti-Nb-C antibody. The 
generation of isoform-specific reagents should aid further 
studies to establish isoform-specific expression patterns 
and subcellular distributions. 
Recent work of Shah et a/. [38) demonstrates that, in 
primary crest stem cell cultures, bone morphogenic 
protein-2 (BMP-2) forces the majority of stem cells into a 
neuronal phenotype whereas TGF!3 directs cells to a 
smooth muscle fate. BMP-2 receptors signal via intrinsic 
serine and threonine kinase activity [39,40). In preliminary 
experiments, we have found that a protein with serine/thre-
onine kinase activity is associated with the mNUMB PTB 
domain (R.S., unpublished data). We speculate that 
mNUMB could act in the BMP-2 pathway or a similar par-
allel pathway. Although we have chosen to examine the 
role of mNUMB in neuronal determination, the expression 
pattern of mNUMB suggests that it may play a role in cell-
fate decisions outside of the nervous system. 
Materials and methods 
eDNA cloning 
A scan of EST databases Identified an 850 base-pair EST from a colon 
carcinoma cell line. This fragment was random primed and used to 
screen a rat neural crest library made from NeM-1 cells which have been 
described previously [41]. Nine positive clones were purified and two 
which contained 3.5 kb inserts were sequenced. Both clones contained a 
complete open reading frame of approximately 2.5 kb with high sequence 
similarity to Drosophila numb. 
Northern-blot analysis 
An 850 base-pair human EST eDNA corresponding to nucleotides 
205-1077 of the mNUMB-encoding eDNA was radiolabelled by random 
hexamer priming and used to probe a series of northern blots containing 
2 IJ.g of poly(A)• RNA isolated from a variety of rat tissues (elonetech). 
Blots were hybridized overnight at 42 •e in 50 % formamide, 4x SSPE. 
1 % SDS. 0.5% skim milk powder. 10% dextran sulphate and 10 mg ml- 1 
salmon sperm DNA. Blots were washed twice for 10 min at room tempera· 
ture in 2x SSe. 0.1% SDS, twice at 65 ·e in 0.1x SSe. 0.1% SDS. and 
then exposed to film. The blots were also probed with radiolabelled (3-actin 
eDNA (e lonetech) as an indicator of RNA loading. 
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Cell culture 
Rat fibroblasts (R2), R2 transformed by wild-type v-src (S7a) [42]. and 
human A431 cells were cultured in Dulbecco's modified Eagle's 
Medium (DMEM) containing 10% fetal bovine serum (FBS) and 1 % 
glutamine at 37 ·c unless otherwise indicated. P19 cells were cultured 
according to the methods of Rudnicki and McBurney [43]. In order to 
differentiate the P1 9 cells, cells were seeded at 1 00 000 cells per non-
tissue culture Petri plate and allowed to aggregate with 1 f.LM retinoic 
acid for 4 days. The cells were collected, trypsinized and plated back 
onto 60 mm Nunc plates in the absence of retinoic acid. Cultures were 
fixed two days later and stained for neural filament, or 6 days later and 
stained with GFAP. MONC-1 cells were cultured according to the 
methods of Sommers [28]. For analysis, transformants expressing 
NUMB or the NUMB PTB domain were plated at clonal density and 
allowed to reach sizes of 2-4 cells per clone. Differentiation was 
induced by the addition of 10% FBS and 5 f.LM forskolin to the stan· 
dard media. Neural (NF staining) and smooth muscle differentiation 
(smooth muscle actin staining) occurred within 36 h and glial differenti· 
ation (GFAP staining) within 1-3 days. Primary cultures of rat neural 
crest cells were prepared from day-11 .5 rat embryos and cultured 
essentially as described [28]. 
Production and analysis of transgenic Drosophila strains 
The complete rat open reading frame encoding rat NUMB from the 
mNumb eDNA (nucleotides 196- 2007) was inserted directionally into 
bcoof-pa~·digested pCaSpeR-hs [44] and EcoRI-Xhol·digested 
pUAST [45]. DNA-mediated transformation was according to standard 
methods [46]. Two transgenic lines were analyzed: P[hs·mNumb] and 
P[UAS-mNumb]. For analysis of the effects of ubiquitous expression of 
mNUMB, staged P[hs-mNumb] prepupae were collected over 4 h inter· 
vals and aged for an additional 12- 20 h at 25 ·c. Heat shock was 
according to Rhyu et a/. [21]. For analysis of localized expression of 
mNUMB, P[UAS-mNumb] flies were crossed to the GAL4 enhancer 
trap line C96 [27]. Wings and notums were dissected from adult flies, 
mounted in GMM [47], analyzed and photographed using a Zeiss Axio· 
plan microscope or a Leica M10 stereo dissecting microscope. Images 
were processed with Adobe Photoshop V. 3.0 software. 
Antibodies 
The polyclonal antibody (anti-Nb-C) was raised in rabbits to the peptide 
sequence TNPFSSDAQKAFEIEL, which corresponds to 14 amino-acid 
residues at the carboxyl terminus of mNUMB; an amino cysteine was 
added to facilitate conjugation to keyhole limpet haemocyanin. Anti· 
Nb-C was used at a dilution of 1 :200 in immunoblots and 1 :100 for 
immunoprecipitations. Anti·phosphotyrosine antibody RC20H (Trans-
duction Laboratories) was used at a dilution of 1:2500 in immunoblots. 
Anti-~-P tubulin monoclonal antibody (Accurate Chemical and Scien· 
tific) was used at 1 :500 for immunohistochemistry. 
Protein lysates, immunoprecipitation and western blotting 
Cell monolayers were lysed in 150 mM NaCI, 50 mM Tris-CI pH 7.5, 
1% Triton X-100, 1 mM Na3V04, with Pefabloc (Boehringer 
Mannheim), aprotinin and leupeptin at 1 0 f.Lg ml- 1. Rat tissue lysates 
were made by homogenizing the tissue with a polytron, followed by 
clarification by centrifugation at 12 000 x g for 15 min at 4 ·c. A 
protein assay was performed using a BCA kit (Pierce) according to 
manufacturers instructions. TNT-coupled Reticulocyte Lysate Systems 
from Promega was used to translate the mNumb eDNA cloned into 
pBSK in vitro, as described in the protocol. For immunoprecipitation, 
clarified lysates from a confluent 1 0 em tissue culture plate, or tissue 
lysate containing 500 f.Lg of total protein, were incubated with protein 
A-Sepharose and 1 0 f.LI of the polyclonal peptide sera at 4 ·c for 
60 min, and washed three times with lysis buffer. For western blotting, 
samples were separated by SDS-PAGE, transferred to lmmobilon-P 
(Millipore) with a semidry transfer apparatus, and immunoblotted as 
described previously. Primary antibodies w ere used at a 1 :200 dilution 
in Tris·buffered saline (TBS-T; 20 mM Tris-HC I, pH 7.5, 150 mM NaCI 
and 0 .05 % Tween 20) containing 5 % Carnation skim milk powder, or 
0 .01 M Tris, pH 7.5, 0 .1 M NaCI, 0.1% Tween 20 containing 1% 
bovine serum albumin (RC 20 antibodies) and developed using ECL 
(Amersham). 
GST-fusion proteins 
Bacteria expressing GST·fusion proteins were induced with IPTG and 
lysed by sonication in lysis buffer. GST-fusion proteins were purified 
using glutathione sepharose (Pharmacia). Fusion proteins immobilized 
on glutathione sepharose were quantitated, and 1 f.Lg of fusion protein 
was incubated with celllysates (prepared as described above) at 4 ·c 
for 90 min. The protein complexes were then washed in lysis buffer 
three times, the samples were then separated on SDS-PAGE, trans-
ferred to lmmobilon-P (Millipore) and immunoblotted. 
Generation of virus and retroviral infection of cell lines 
BOSC23 cells [48] were maintained in GPT selection medium until 
they were split and plated at a density of 2 000 000 cells per 60 mm 
dish in DMEM plus 10% FBS. Calcium chloride transfection was used 
to introduce pBABE [49] constructs into BOSC23 packing line. 10 f.Lg 
of precipitate per plate was added to the cells for 1 0 h in the presence 
of 25 f.LM chloroquin. The cells were then washed with medium, 2 ml of 
either P1 9 medium or standard medium were added, and virus col· 
lected for the next 48 h. Stable P19 and MONC-1 lines overexpressing 
the full-length mNUMB or the PTB domain of mNUMB were generated 
by retroviral infection. Briefly, cells were incubated for a period of 4 h 
with a viral supernatant containing 4 mg ml- 1 polybrene obtained from 
the transient transfection of BOSC23 cells with either pBABE-NUMB 
or pBABE-PTB retroviral constructs. The cells were allowed to recover 
for 12 h prior to the addition of 100 mg ml-1 (P19) or 25 mg ml-1 
(MONC-1) bleomycin for 5 days. The cells were then split onto fresh 
35 mm dishes and expanded in the presence of 25 mg ml-1 bleomycin 
or 10 mg ml-1 MONC-1. Cells were either stained with a polyclonal 
anti-HA antibody or analyzed by PCR using HA and mNumb-specific 
primers to confirm expression of the transgene before use. 
Immunohistochemistry 
Primary neural crest cell cultures and 1 4 I-'m sections of either mouse 
E13.5 or rat E11 embryos were fixed with cold acetone/methanol and 
stained with affinity-purified anti-Nb-C (5 f.Lg ml- 1) overnight at 4 ·c. 
Anti-Nb-C staining was detected with a donkey-anti-rabbit-biotin label 
(1 :100, Jackson) and strepavidin conjugated to CY2 (1 :50, Amer· 
sham). Neuronal cells were identified with a monoclonal anti· 
~-P-tubulin and detected with goat-anti-mouse conjugated to Texas 
Red (1 :100, Jackson). Cells were counter stained with DAPI 
(1 f.Lg ml- 1) to identify nuclei. Photographs were taken on inverted 
Leica fluorescence microscope. 
Cells used in the mNUMB overexpression experiments were fixed in 
4% formaldehyde in HBSS. Cells were blocked using 0.1 % NP-40 
and 1 % goat serum for 20 min at room temperature. Primary antibody 
was incubated in blocking solution overnight at 4 ·c. The primary anti· 
bodies used w ere mouse monoclonal anti-smooth muscle actin (1 :500 
Sigma), mouse monoclonal antl-neurofilament (1 :400 Sigma), mouse 
monoclonal anti·GFAP (1:25 Sigma), rabbit polyclonal anti·neurofila· 
ment. (1 :1000 Chemicon) and rabbit polyclonal anti·GFAP (1 :200 
Chemicon). Double labeling of P19 cells was performed using the 
mouse monoclonal GFAP and rabbit anti-neurofilament. For categoriz· 
ing MONC-1 clones, the cells were stained using Rabbit NF and 
mouse SMA and GFAP. Although the two monoclonals were both 
lgGs, the striking differences in morphology were used to d iscriminate 
the two cell types. The secondary antibodies conjugated to either nuo· 
rophor or phycoerythrin were used at a dilution of 1 :250 (Biosource 
International). Prior to photography, cells were counter-stained with 
1 f.Lg ml- 1 DAPI to help in visualization of the nuclei. Images were 
processed with Adobe Photoshop V. 3.0 software. 
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Fringe boundaries coincide with Notch-dependent 
patterning centres in mammals and alter Notch-dependent 
development in Drosophila 
Brenda Cohen1: , Arash Bashirullah2•3:, Lina Dagnino1, Christine CampbelP, William W. Fisher2, 
Ching Ching Leow1·4, Elisabeth Whiting1, David Ryan1, Dawn Zinyk2•4, Gabrielle Boulianne5·6•7, 
Chi-chung Hui2•4•5, Brenda Gallie1•4•5, Robert A. Phillips1•4•5, Howard D. Lipshitz2•3•4•5 & Sean E. Egan1•4•5 
In both vertebrate and invertebrate development. cells are 
often programmed to adopt fates distinct from their neighbors. 
Genetic analyses in Drosophila melanogaster have highlighted 
the importance of cell surface and secreted proteins in these cell 
fate decisions. Homologues of these proteins have been 
identified and shown to play similar roles in vertebrate 
development1-s. Fringe, a novel signalling protein, has been 
shown to induce wing margin formation in Drosophila6• Fringe 
shares significant sequence homology and predicted secondary 
structure similarity with bacterial giycosyltransferases7• Thus, 
fringe may control wing development by altering glycosyiation 
of ceil surface and/or secreted molecules. Recently, two fringe 
genes were isolated from Xenopus Jaevis8. We report here the 
cloning and characterization of three murine fringe genes 
(lunatic fringe, manic fringe and radical fringe). We find in 
several tissues that fringe expression b9undaries coincide with 
Notch-dependent patterning centres and with Notch-ligand 
expression boundaries. Ectopic expression of murine manic 
fringe or radical fringe in Drosophila results in phenotypes that 
resemble those seen in Notch mutants. 
To identify mammalian genes related to fringe, we searched the 
public data bases for sequences with similarity to the Drosophila 
fringe protein. One such human sequence was identified in the 
expressed sequence tag data base. Degenerate PCR followed by 
eDNA library screening was~ to done three mouse fringe, relat-
ed genes: lunatic fringe, manic fringe and radiCQ/ fringe. Their pre-
dicted amino acid sequence reveals that in each case anN-terminal 
signal sequence is present to target these proteins to the secretory 
pathway (Fig. 1). TheN-termini of the three mouse, two published 
Xenopus and single Drosophila friDge proteins. differ in both length 
and sequence6.S. In contrast, the C-terminal270 amino acids of all 
fringe proteins are very highly conserved. D· Fringe contains seven 
cysteine residues that are thought to form disulfide bonds in the 
native protein6• All vertebrate fringe proteins contain six of these 
cysteines at identical positions, suggesting that they may form an 
essential scaffold for this protein family. The mammalian fringe 
proteins, like the DrOsophila and Xenopus fringe proteins7, are high-
ly related to glycosyltransferases. The Drosophila fringe, Xenopus 
lunatic and radiall fringe and mouse lunatic fringe genes all encode 
proteins with a putative N-terminal 'pro region' followed bY a basic 
motif!~K In contrast, the predicted mouse manic and radical fringe 
proteins contain only a few amino acid residues between the leader 
sequence and the conserved C-terminal region, indicating that these 
two proteins may not require regulated proteolytic activation. 
Northern blot analysis of day 7 to 17 mouse embryos indicated 
that the three fringe genes are expressed throughout this period; in 
addition, they are widely expressed in adult tissues. Expression of 
fringe gene occurs at developmentally important boundaries in 
mesodermal, neuroepithelial, epidermal and haematopoietic tis-
sues (Fig. 2 and data not shown). Lunatic fringe is highly expressed 
during somitogenesis in two mesodermal stripes that generate 
boundaries a:t both the anterior and posterior margin of the form-
ing somite (Fig. 2a). These two stripes move towards the posterior 
of the embryo as new somites are generated, suggesting that lunatic 
fringe expression boundaries may be involved in the segmentation 
of mesoderm into somites. ln addition, lunatic fringe is expressed in 
the undifferentiated neuroblastic layers of the neural tube, brain 
and otic vesicle during central nervous system development 
(Fig. 2a-<). Lunatic fringe is also expressed in the myotome, which 
contains undifferentiated myoblasts (Fig. 2b), and in the interver-
tebral mesenchyme. Throughout development, lunatic fringe is 
expressed in proliferating cells in the ventricular zones of the ner-
vous system and in unconunitted neuroblasts in the retina. Expres-
sion is also observed in the basal cells of the skin and tongue 
epidermis; in the perichondrium, which contains proliferating 
chondroblasts; in the fetal heart; in haernatopoietic cells in the fetal 
liver; in S-shaped bodies of the developing kidney; and in a subset 
of splenic lymphocytes. Lunatic fringe is expressed in the thymic 
corteX but not the thymic medulla. This lunatic fringe expression 
boundary coil:tcides with the boundary between immature and 
mature thymocytes. 
In contrast to iunatic fringe, manic fringe and radiCQ/ fringe are 
usually expressed in cells that are undergoing or have completed 
terminal differentiation. Both of these-genes are expressed in the 
marginal zones. of the neural tube and brain throughout develop-
ment (Fig. 2d for radial! fringe), and both are expressed from day 
Ell.S to El3.5 in the dorsal root ganglia. These genes are also 
expressed in El2.5 fetal liver, and in the suprabasal epithelium of 
both tongue and skin. Strikingly, these genes are often expressed 
in cells directly juxtaposed with cells expressing lunatic fringe. The 
manic fringe gene is very highly expressed in megakaryocytes pres· 
ent in the adult spleen; these are the precursors of platelets. 
In many of the developing tissues described above, the undif-
ferentiated cells express high levels of lunatic fringe. Manic and rad-
ial/ fringe genes, on the other hand, are expressed in differentiated 
populations. To study this apparently conserved pattern at high 
resolution, we analysed two tissues in which stern cells and their 
differentiated progeny are physically separated. Sections through 
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0-Pringe 
X - Lunat.i c 
• - Lunatic 
a-Manic: 
•·Radical 
X- Rac:Ucal 
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Fig. 1 Comparison of the predicted fringe 
amino acid sequences. The red bar indicates the 
predicted cleavage site for Xenopus and mouse 
lunatic fringe proteins.. The blue arrows corre-
spond to the amino acid sequences from which 
degenerate oligonucleotide primers were 
designed for RT-PCR cloning of the mammalian 
fringe gene family and red arterisks denote con-
served cysteine residues. Identical residues are 
highlighted in yellow. Starting at residue 152 in 
the multiple sequence alignment. mouse and 
Xenopus lunatic fringe proteins are 77% identi-
cal; mouse and Xenopus radical fringe proteins 
are 59% identical; mouse lunatic. manic and rad-
ical fringe proteins are more than 50% identical 
to each other, and all vertebrate fringes are 
approximately 30% identical to D-fringe'·'· 
Manic fringe does not contain a basic cleavage 
sequence and encodes only 29 amino acids from 
the start codon to the region where lunatic 
fringe is predicted to be cleaved. These 29 amino 
acids code for little more than the leader 
sequence; thus, manic. fringe may be se<reted in 
an active form that does not require proteolytic 
cleavage. The mouse radical fringe protein also 
lacks a te trabasic cleavage site and contains a 
shorter N-terminus than the Xenopus radical 
fringe. From the start codon to the location of 
predicted cleavage in lunatic fringe, mouse radi-
cal fringe only has 44 amino acids. including the 
leader sequence. (Xenopus radical fringe has 71 
amino acids in the corresponding region.) Mouse 
radical fringe may thus also not require regulat-
ed proteolytic activation. 
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During somitogenesis, Notchl is 
required for proper segmentation of pre-
somitic mesoderm into somites but not 
to form somite-like tissue9• This observa-
tion suggests that activation of Notch may 
block differentiation of mesoderm into 
somite tissue at the boundary between 
adjacen t somites. Analysis of mouse 
Delta-like genel (DUl, a Notch-ligand) ex-
pression in mesoderm undergoing somi-
togenesis in ES-5 embryos reveals that 
Dill is highly expressed in p resomitic 
mesoderm and further induced in the 
forming somite (Fig. 3a)10• Despite this 
extremely high level of Dill expression in 
the forming somite, Notchl activation is 
probably restricted to the inter-somite tis-
sue9 _ Lunatic fringe is expressed at this 
stage in two bands that surround the 
forming somite (Fig_ 3b)- A mouse 
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the neural tube in day 10.5 embryos reveal that lunatic fringe is 
expressed in the ventricular zone, which corresponds to the neu-
roblast population, but not in the marginal zone, which contains 
differentiated neurons (Fig. 2e)- Adjacent sections probed with 
manic or radical fringe probes revealed a striking complementary 
expression profile for these two genes_ As neurons are born, they 
tum off lunatic fringe, leave the ventricular zone and tum on both 
manic and radical fringe genes (Fig_ 2f, g). Similarly, tongue epithe-
lium is continuously generated through division of basally locat-
ed stem cells that express lunatic f ringe (Fig_ 2h)_ As the cells 
differentiate, they move apically, tum off lunatic fringe and tum 
on both manic and radical fringe genes (Fig_ 2i, J)- Consequently, 
in neural tissue and in the epidermis, there is a boundary between 
stem cells, which express lunatic fringe, and their committed prog-
eny, which express the manic and radical fringe genes_ 
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homologue of the Drosophila Notch-lig-
and Serrate, /agged111 is also weakly 
expressed iil two bands that surround the forming somite (Fig-
3c)_ The thin domains of mesoderm, which fail to d ifferentiate 
into somite tissue but form inter-somite tissue under the influ-
ence of Notch I , occur at the Dill/lunatic fringe expression bound-
ary on either side of the forming somite_ DUI and /aggedi are also 
expressed in complementary domains within the developing neur-
al tube (Fig_ 3d, J)ll,ll _ Lunatic fringe is expressed in domains with-
in the neural tube which overlap the DUI expression domains (Fig_ 
3e); therefore, lunaticfringeexpression boundaries are coincident 
with Dlll/Jaggedl expression boundaries in the neural tube. A 
similar situation is found in the developing retina (data not 
shown)- The two cloned mammalian Serrate homologues are also 
differentially expressed in the epidermis13• Basal cells express 
/agged2, whereas differentiated suprabasal cells express /aggedl_ 
The lunatic versus manidradical fringe expression boundary in 
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Fig. 2 Expression of mouse fringe genes 
in embryonic and selected adult tissues as 
assayed by RNA tissue in situ hybridiza-
tion. (a,b,c,e,h) Lunatic fringe; (tl) manic 
fringe; (d,g,J? radical fringe. (a) Stage 
E8.5; (b) Et 1.5; (c,d) E12.5; (e-g) ElO. S; 
(h-J) adult. (a) shows a whole mount, 
whi le all others are dark-field views of t is-
sue sections. (a- d) are views of entire 
embryos while (e-g) are neural tube and 
(h-j) are tongue epithelium. ms, meso· 
derm; my, myotome; nt. neural tube; drg, 
dorsal root gang lia; vz, ventricular zone; 
mz, marginal zone; be, basal epithelium; 
sbe, suprabilsal epithelium. 
h 
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friuge. Thus, both manic fringe and 
radical fringe interfere with essential 
functions of endogenous D-fringe at 
the dorsal -ventra l (OV) compart-
ment boundary. Crosses combining 
GAL4P1<, UA S-mauic friuge and 
GAL41'1<, UAS-rndicnl [ri11gc are 
lethal, whereas increasing the expres-
sion of either of these mammalian 
fringe proteins through increasing 
GAL4 activity (at 29 °C). or by dou-
bling the dose of either mammalian 
[ri11ge, enhanced the wi ng pheno-
types. Manic and radical fringe, 
therefore, may inhibit d is ti nct func-
tions of 0-fringe, producing syn-
thetic lethality when assayed together 
in Drosophila. 
. ' . 
' . . , ~K 
be,._ . .. · sbe ~-· .· 
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skin (Fig. 2), therefore, corresponds to a fagged2-fagged I expres-
sion boundary. Thus, in mammalian tissues (somites, neural tube, 
retina and skin), as in Drosophila, a [ri11ge expression boundary 
coincides with a Notch-dependent patterning center and with a 
Notch-ligand expression boundary. 
In Drosophila, 0-fringe is expressed in the dorsal but not ven-
tral compartment of the developing wing disc. The 0 - fringe expres-
sion boundary produced in th is way is essential for formation o f 
the endogenous wing margin, and an ectopic 0 -fri nge expression 
boundary is sufficient to induce an ectopic margin 1'1• We assayed 
mammalian ma nic and radical fr inge functi o ns in transgenic 
Drosophila, since these do not possess N-terminal pro-regions and 
are probably synthesized in an active form. Spatially regulated 
expressio n was accomplished with the two component GAL4-
upstream activator sequence (UAS) system 15. Initially, we chose 
GAL41'" to drive expression in cells in wh ich the patched gene is 
expressed. In the wing imaginal disc, patched is expressed in a stripe 
of cells on the anterior side o f the AP compartnien t boundary1•1•16• 
Ectopic expression of D-[ri11gc by means of th is driver leads to a 
loss of wing margin tissue at the AP boundary and an ectopic wing 
margin on the ventral surface o f the wing6•1'1. In contrast, ectopic 
expression of either 111a11ic or rndical [ ri11ge causes the loss o f 
endogenous m argin tisstie without the generation of an ectopic 
margin on the ventral surface (Fig. 4b, c). 
The Drosopltila hypomorph ic _{1-i11ge allele [11g' 2 shows a weak wing 
vein-splitting o r 'delta' phenotype but a normal wins margin in het-
erozygotes6. A heterozygous [11g'2 muta tion enhanced wing defects 
produced by GAL41'1c, UAS-nw11ic jri11gc and GAL4P", UAS-mdicn/ 
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The GAL4c 96 Iine expresses GAL4 
at the dorso- ventral compartme nt 
boundary in the wing d isc, which 
represents the future wing margin !7. 
GAL4C96-driven 111allic fri11ge pro-
duced a dramatic loss of margin tissue and reduction o f wing size 
(Fig. 4d). In contrast, GAL4C96-driven rndicnl jri11ge had little effect, 
producing a small loss of margin tissue in only some of the nics (not 
shown). The GAL4cs enhancer trap line expresses GAL4 in all cells 
that will give rise to the wing blade1R. GAL4C5-driven I!WIIicfringe 
produced a dramatic loss of margin and wing blade tissue (Fig. 4c). 
In contrast, GAL4C5-driven rndiml [ri11gc produced wings with small 
vein deltas or vein splitting but no loss of margin (Fig. 4/). 
The effects of ectopic 11tn11ic jri11gc and mdical [ri11gc expression 
could also be documented in tissues o ther than the w ing, since 
GAL41'tc drives expression in other imaginal discs. GAL41'1"-driven 
manic frin ge induces a d ramat ic reduc t io n in s ize o f the eye 
( Fig. 4h) and fused ocelli (data not shown) . GAL41'1"-driven rad ical 
frin ge, on the other hand, had no effec t on eye (Fig. 4 i ) or ocellar 
developmen t, but an extra pair o f scutellar setae developed wi thin 
the normal proneural region (data not shown ). Loss of wing mar-
gin, vein spli tti ng, extra macrochaetae, fu sed ocelli and reduction 
in eye size are phenotypes previous! )' noted for mutants in Notch-
mediated s ignalling19- 27. We tested whether reduction o f No tch 
gene dosage (using Df( I Fk~f+ hemizygotes) affected GAL4P1<, UAS-
mallic and GAL41'1C, UAS- radicnl [ri11ge-induced phenotypes. In 
each case, the phenotypes were dramaticall)' enhanced (data not 
shown). A more direct assar o f the effects of ectopic mammalian 
fringe expression on Notch-mediated signalling in Drosop/,ila will 
require marker gene expression analrsis (fo r instance, wi•tgless at 
the dorso-ventral compartment bo undary o f imaginal wing d iscs) . 
Mammalian friuge expression boundaries coinc ide with tissue 
boundaries undergoing Notch-dependent patterning and also with 
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Notch-ligand expression boundaries. Ectopic expression of manic 
fringe and radical fringe in Drosophila produces phenotypes simi-
lar to those caused by disruption of Notch-dependent development. 
We speculate that-directly or indirectly-the fr inge proteins alter 
the sensitivity of Notch for its specific ligands. A direct test of this 
hypothesis will require biochemical assays that probe Notch acti-
vation by its ligands in the presence or absence of fringe proteins. 
During somitogenesis, lunatic fringe is strongly expressed in two 
stripes that surround the forming somite. Dil-l is expressed at 
extremely high levels in the forming somite, where Notch I is no t 
expected to be activated 111• Notch I activation is required between 
the forming somites in order to facilitate segmentation9 We 
hypothesize that 011- I can activate Notch I only between the form-
ing so mites because this is where Dil-l-expressing ·cells abut lunatic 
ji·inge-expressing cells. Lunatic fringe may therefore facilitate acti-
vation of Notch I by 011- I. In the developing neural tube a lunatic 
fringe expression boundary coincides with a Dll-1//aggedl expres-
sion boundary, suggesting that lunatic fringe may control devel-
b 
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c Fig. 3 Expression of mammalian Notch 
ligands and lunatic fringe during somi-
togenesis and neural tube patterning. 
Ea~bIcF Whole-mount in situ hybridiza-
tion with antisense probes to D//7(a), 
lunatic fringe(b) and Jaggedl(c) tran-
scripts in ES.S mouse embryonic posteri-
or mesoderm. Arrowhead points to a 
forming somite. {d,e, f) Dark-field view 
of a tissue-section in situ hybridized 
with antisense probes to D/11(d), lunatk 
fringe(e) and Jaggedl(f) genes in E10.5 
mouse embryonic neural tube. 
opment at this boundary. Ltmatic frirtge is expressed in the thymic 
medulla but not in the cortex. Notchl-mediated signals arc 
involved in lineage commitment of immature cortical thymocytes 
as they differentiate and move into the medulla2". Lunatic fringe 
may therefore function together with Notch I to control lineage 
commitment in the thymus. Finally, downregulation of 1111wtic 
ji-i11gc and upregulation of rtuutic and/or radical ji-ingc during dif-
ferentiat ion may be required to regulate Notch activation at the 
boundary between stem cells and their progeny in many tissues. 
As discussed above, biochemical analyses will be needed to address 
the postula ted role of mammalian fringe proteins in regu lating 
boundary formation and lineage commitment in these develop-
mental contexts. 
Note added in proof: Molecular cloning of avian fringe genes 
and their analysis in limb-bud development have been report-
ed29·30 In addition, the role of Dil-l in somite pa ttern ing has been 
demonstrated through genetic analysis31 . Results similar to those 
reported here by us have recently appeared32 
c 
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Fig. 4 Effects of ectopic expres-
sion of manic and radical fringe 
in Drosophila. a, wild-type 
w ing; b, wing from a GAL41l", 
UAS- manic fringe f ly; c. wing 
from a GAL4P1', VAS- radical 
fringe fly; d, wing from a fly 
expressing manic fringe from 
the GAL4C96 driver; e, w ing 
from a fly expressing manic 
fringe from the GAL4cs driver; 
f, wing from fly expressing radi-
cal fringe from the GAL4cs dri-
ver; g, eye from a wild-type fly; 
h, eye from a fly carrying 
GAL4Ptc, UAS-manic fringe; i, 
eye from a fly carrying GAL4P1' . 
VAS- radical fringe . 
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Methods 
RT-PCR. Mouse tissues were homogeniud in TRIZOL (Gibco BRL), total 
RNA extracted and poly(A)+ RNA prepared with Oligotex (Qiagen ). 
mRNA was heated to 95 •c for 5 min before eDNA synthesis, and reverse 
transcription was carried out at 37 •c for 1-2 h in xi First Strand Buffer 
(Gibco BRL), 10 mM DTT, I mM dNTPs (Pharmacia), 10 U RNasin 
(Pharmacia), 0.5 ~ pd(N)6 (Pharmacia) and 200 U of M-MLV reverse 
transcriptase. eDNA was then used in Taq polymerase PCR reactions con-
taining IX PCR Buffer (Perkin Elmer), I mM MgCl2, 0.2 mM dNTPs, 
0.01% gelatin and I mg of forward and reverse primers. Degenerate 
primers were as follows: Fringe upstream 5'-GCC GM :riC TGG TT(T/C) 
TG(T/C) CA(T/C) (GIT)TN GA(CIT) GA(CIT) GA(CIT) AA(CIT) 
TA(CIT)GT (codes for amino acids WFCH(VIF)DDDNYV with 5' &oR! 
site); Fringe downstream 5'-GCC!crMZ.t. CA (G/A)AA NCC NGC NCC 
NCC NGT NGC (G/A)AA CCA (G/A)AA (codes for anti-sense of amino 
acids FWFATGGAGFC with 5' Xbal site). PCR reaction conditions were as 
follows: initial denaturation at 96 •c for 7 min, followed by 2 cycles of 94 
•c for 50s, 50 •c for 2 min, 72 •c for 2 min, 35 cycles of 94 •c for 50 s, 55 
•c for 2 min, 72 •c for 1.5 min and a final incubation of72 •c for 10 min. 
PCR products (expected siZ< 216 bp, based on the human EST) were run 
out on 3% NuSieve agarose (Mandel) gels, purified with Qiaex II (Qiagen), 
digested with EcoRI and Xbal and subdoned into Bluescript (Stratagene) 
for dideoxy sequencing with Sequenase v2.0 (US Biochemicals). DNA and 
amino acid sequences were analysed with MacDNASIS software (Hitachi), 
and searches for related sequences were done through the BLAST network 
service provided by the National Center fc:>r Biotechnology Information. 
. Isolation of murine .fringe eDNA clones. Approximately I x 1()6 plaques of 
a mouse embryonic day 14 eDNA library (Stratagene) were transferred and 
ultraviolet light cross-linked to uncharged nylon membranes (Qiabrane, 
Qiagen), and screened with a mixture of 32P-labelled inserts from PCR 
clones of lunatic, manic and radical fringe. Hybridization was performed at 
48 •cfor24 h in 1MNaQ, 1% SDS,IO% dextran sulphate, 50 mMTris pH 
7.5, I X Denhardt's and 100 mglml denatured salmon sperm DNA. Filters 
were washed twice with 2X sse, 0.5% SDS, once with IX sse, 0.5% SDS, 
and once with IX sse, 0.5% SDS. All washes were at 48 •c for 30 min, and 
filters were exposed to Kodak BioMax film for 48 h. 'IWenty-two positively 
hybridizing plaques were identified and purified, and cycle sequencing was 
performed on 11 excised clones with an ABI Biotechnology Automatic 
DNA sequencer. Of these II clones, 8 were radica~ I was manic and 2 were 
lunatic fringe. The 5' ends of lunatic and manic fringe were cloned by 5' Race 
with 5'-AmpliFINDERTM Race Kit (Qontech) according to the manufac-
turer's specifications. The 3';pecific primer used for Race PCR synthesis of 
lunatic fringe was 5'-ATC AGT GAA GAT GAA CGT CKf ere CTT, and 
the 3'-specific primer used for Race PCR synthesis of manic fringe was 
5'-CTG CAG AAC AGT TGG TGA. 
Tl.ssue section in situ hybridization. In situ hybridization experiments were 
performed with 8 JUt1 paraffin or frozen sections from developmentally 
staged C.B.-17 embryos. Midday on the day of appearance of vaginal plugs 
was considered 0.5 dpc to time pregnancies. For paraffin sections, embryos 
were fixed overnight in 4% paraformaldehyde, dehydrated in ethanol and 
embedded in paraffin. For cryosections, embryos were protected by 
embedding in OCT compound (Miles) before freezing in liquid N 2• 
Pretreatments of frozen sections included fixing in 4% paraformaldehyde 
for I h, followed by proteinase K digestion (20 mg!ml, 7.5 min, 25 •C) and 
acetylation (0.1 M triethanolamine pH 8.0, 0.25% acetic anhydride, 10 
min, 25 "C). Subsequently, the sections were dehydrated with ethanol and 
air-dried before addition of hybridization solution. 
Rl'boprobes were synthesiZ<d with T7 RNA polymerase (Pharmacia, 
Boehringer Mannheim), T3 RNA polymerase (Pharmacia) and SP6 RNA 
polymerase (Pharmacia) according· to the protocol of the manufacturer. 
pBK-radicalliKpnl (done 16) was used to synthesiZ< sense (T3) and anti-
sense (T7) probes of709 bp, which span from nt418 of radical fringe to 118 
nt downstream of coding sequence. A probe for lunatic fringe was generat-
ed by PCR with the use of the following primers: s·~ CTG CTG 
TTC GAG ACC TGG ATC (contains &oR! site) and 5'- Mit.EJ: ACC 
AGG ATT GTA GAA GAT CGC (contains Bglll site) and pBK-lunatic 
(done 24) as template. The 756-bp PCR product, which spans nt 273 to nt 
1030 of the lunatic coding sequence, was subdoned into pGemT (Promega) 
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and sense and antisense riboprobes synthesized with SP6 and T7 polym-
erase, respectively. pBK-manic (clone 30) was digested with EcoRI and a 
426-bp &oRI fragment from 3' untranslated region of manic fringe (begins 
284 bp downstream of last coding nt) was subcloned into phosphatase-
treated &oRI-digested pBluescript vector (Stratagene). Sense and antisense 
manic riboprobes were synthesiZ<d from this plamid using T3 and T7 po-
lymerases respectively. A probe for mouse fagged! was generated with the 
following primers: 5'-TCC AGC TGA CAG AGG TTT CC and 5'-GAC 
CAG AAT GGC AAC AAA ACC TGC. The 937-bp PCR product, which 
covers nt 641-1578 of the rat sequence, was designed from a search for 
stretches of DNA identity between rat and chicken Serrate-I, which was pre-
dicted to be identical in mouse Serrate-I. This PCR product was subdoned 
into pGemT (Promega), and antisense riboprobes were generated by tran-
scription with T7 RNA polymerase. A 777 -bp Scal/Pstl fragment of mouse 
Delta-like! spanning nt 669-1446 was subcloned in pBK (Stratagene), and 
antisense riboprobes were generated with T3 RNA polymerase. 
Pre-treatment of paraffin sections and hybridization to [allp]UTP-
labelled sense and antisense probes (15,000-40,000 cpm/ml) were con-
ducted as described33, with the following modifications. The hybridization 
and washing steps omitted use ofDTT. After RNase treatment, the sections 
were washed sequentially with 2x sse, Ix sse and o.sx sse at 37 •c, 10 
min each, and with 0.1 xSSC at 65 •c for 30 min. Exposure of slides to 
emulsion was allowed to proceed for 1-3 weeks; after development, the tis-
sues were stained lightly with hematoxylin and eosin. 
Whole-mount in situ hybridization. Embryos were dissec ted into PBS and 
extra-embryonic tissues removed. Embryos were fixed overnight at 4 •c 
with 4% paraformaldehyde (PFA) in PBS, rinsed once with cold PBT (PBS 
with 0.1% 'IWeen-20) and dehydrated through an ascending methanol 
series (25%, 50%, 75%) in PBT and then stored in 100% methanol at - 20 
•c until further use. kttisense riboprobes were synthesiZ<d from the same 
DNA templates as described above for sections with a digoxygenin RNA 
labelling kit (Boehringer Mannheim). Embryos were rehydrated through a 
descending methanol series rinsed twice in PBT, and then bleached for I h 
at RT in 6% hydrogen peroxide in PBT. After three rinses with PBT, 
embryos were permeabiliZ<d with 10 J.lg/ml proteinase K (5 min for E9.5 
embryo and 2 min for E8.5 embryo), rinsed twice with PBT and then fixed 
with glutaraldehyde 0.2%/PFA 4%/PBT for 20 min at RT. After fixation, 
embryos were washed four times with PBT, washed once with hybridization 
buffer {50% formamide, Sx SSC (pH 4.5), 50 J.lg/ml yeast !RNA, I% SDS, 
50 J.lg/ml heparin), and incubated with 1.5 ml of fresh hybridization buffer 
for l hat 70 •c. Digoxygenin-labeled nboprobe (1.5 mg) was added direct-
ly and embryos were incubated overnight at 70 •c. 
After hybridization, embryos were washed twice for 30 min at 70 •c with 
solution I (50% formamide, Sx sse [pH 4.5] , 1% SDS), washed once for 
10 min at 70 "C with 50/50 solution !/solution 2 (0.5 M Naa, 0.01 M Tris 
[pH 7.5], 0.1% 1Ween-20), rinsed three times with solution 2 at RT, once 
with solution 3 at RT {50% fonnamide, 2x sse [pH 4.5]) and twice for 30 
min at 65 "C with solution 3. Embryos were then rinsed three times at RT 
with TBS-TI. (137 mM NaO, 2.7 mM KQ, 25 10M Tris [pH 7.5] plus 2 mM 
levamisole and 0.1% '!Ween, 20) and incubated for I h at RT with TBS-TI. 
containing 10% heat-inactivated (65 •c for 30 min) goat serum to prevent 
non-specific binding of antibody. Anti-digoxygenin Fab alkaline phos-
phatase conjugate {1/5000, Boehringer Mannheim) was pre-absorbed in 
TBS-TI. with 1% heat-inactivated goat serum and approximately 3 mg 
heat-inactivated embryo powder per mla!Jilbody. After an overnight incu-
bation at 4 •c with the pre-absorbed antibody, embryos were rinsed three 
times with TBS-TL, washed four times for I h with TBS-TI. at RT and then 
left overnight at 4 •c in fresh TBS-TI.. The buffer was exchanged by wash-
ing three times for 10 min with NTMT (0.1 M NaQ, 0.1 M Tris (pH 9.5], 
0.05 M Mg02, 0.1% 1\veen-20, 2 mM levamisole), and the antibody detec-
tion reaction was performed by incubating embryos with detection solu-
tion (NTMT with 0.25 mgtml nitroblue tetrazolium and 0.13 mg!ml 5-
bromo-4-chloro-3-indolylphosphate p -toluidinium). Detection reactions 
were complete within 15 min- I h, and then embryos were washed twice in 
PBT. Colour was intensified by dehydration/rehydration through ascending 
and descending methanoUPBT rinses. Embryos were then cleared through 
50% and 80% glycerol in CMFET (137 mM Naa, 3 mM KO, 8 mM 
Na2HP04, 1.5 mM KH2P04 ,0.7 mM EDTA, 0.1% EDTA,O.l% 1\veen-20) , 
and whole embryos were photographed under transmitted light with a 
Leica MZ12 microscope with Kodak Tungsten 160 ASA film. 
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Ectopic expression in Drosophila. An EcoRI fragment containing the entire 
radical fringe open reading frame was purified from pBK-phagemid vector 
(clone 89) and ligated with phosphatase-treated EcoRI digested transfor-
mation vector pUAST15• The 5' end of manic fringe was PCR-modified to 
contain Kozak consensus sequence (5' GAT CTA CCA~ G), and an Apal 
site was introduced by PCR at nt 304-309 to allow ligation with pBK-
phagemid vector manic fringe eDNA (clone 8). The entire manic fringe 
eDNA was then subcloned as a Bgni fragment into phosphatase-treated 
Bglll-digested transformation vector pUAST15• The recombinant plasmids, 
pUAST -radical fringe and pUAST -manic fringe, with the open reading 
frames in the correct orientation relative to the promoter, were used to 
transform Drosophila by standard procedures'W. For analysis of ectopic 
expression, transgenic flies carrying pUAST-manicand pUAST-radicalwere 
crossed to GAU enhancer trap lines. The GAU drivers used were 
GAUP"' 16; GAUcs, which is expressed throughout the wing disc pouch IS; 
and GA!AC96, which is expressed only along the DN boundary17• These 
crosses were repeated with several independent transgenic liAes for pUAST-
manic and pUAST-radicaL Progeny of such crosses were scored for defects. 
Wutgs were dissected from adult fiies, mounted in GMM35 and pho-
tographed with a Zeiss MC63 camera control system mounted on a Zeiss 
Axioskop microscope. Pictures of adult fly eyes were obtained by scanning 
electron microscopy by standard procedures36. 
1. m~rrK BA. & McMahon. A.P. Wnt genes and vrertebr11te development. Cun: Opin. 
denet~-- 4, 523-528(1994). 
2. 1ngtuom. P.W. SigMiing by hedgehog-family proteins In Drosophila and Yertebrate 
deYelopment. Curr. Opin. Gtnet ~vK 5, 492-498 (1995). 
3. Hogan. B.LM. Bone morphogenetk proteins: multlfunctioMI ~ulatcm of 
wrtebratedeY<Iopment. Genes O..V. 10, 1580-1594 (1996). 
4. lordell~ M. tilliam~ R. & iendah~ U. Notch..-elated genes In animal 
deY<Iopment.int J. O..V. Bioi. Jt, 76!1-780 (1995). 
5. Kopan. R. & Turner, D.L The Notch pathway: demoaacy and aristocracy In the 
selection of cell fate. Curr. Opin. Neurobloi. 6, 594-601 (1996). 
. 6. Irvine. K.D. & ttepcha~ E. Fringe, a boundary-<pedfic molecule, mediates 
Interactions between donal and ...ntral cells during Drosophila wing 
deYetopment. ~11T9I 59!>-606 (1994). 
7. Yuan. Y.P. 5chultt. J. Mlodzlk. M. & 8or1<, P. Secreted Fringe-like signoling 
mole<ules maybeglycosyttransferases. Cell88, !1-11 (1997). 
8. Wu. J.Y. Wen. L. Zluong. W.-J. & Rao, Y. The secreted product of XenoP<JS gene 
lunatk Fringe, a vertebrate signaling molecule. Science 273,355-358 (1996). 
9. Conlon. R.A.. Reaume, A.G. & Rossant, J. Notch1 Is required for the coordinate 
segmentatlonohomltes.o..w/opment1Z1,1533-1545(1995). 
10. Bettenhausen, B. Hrabe de Angells, M. Simon, D. Guenet, J.-L & Gossie<; A. 
Tronslentand restricted --">n during mouse emlxyogenesls of Dll1, • murine 
gene closely related to Dtwophilo ~ftaK o..w/opment121, O4MT~41U (1995). 
11. rndsel~ c.E.. Shlwber. CJ. Boulter. J. & Welnmaster, G. Jogge<j: a mammalian 
ligand tluotoctlvates Notch1. Ce/180, 90!1-917 (1995). 
12. Myat, A.. Henrique, D. ish-Horowkz. D. & Lewis. J. A chkk homologue of Serrate 
ond Its relationship with · Notch and Delta homologues during antral 
neurogenesls. Dev. Bioi. 174. 233-.147 (1996). 
13. 5hlwbe<; C.. lou~ J. rndsel~ C.E. & Welnmaster. G . .llgged2: A serrate-like gene 
expressed during rot emb<yogenesls. Dev. Bioi. 180, 371>-376 (1996). 
14. Kim, J. Irvine, K.D. & CMr~ 5.8. ~ff recogn111on, signal Induction. and 
l)'rnmelricol gene IC1Jvoticin at the donal-ventral boundory of the deY<Ioplng 
OroJoph/11 wing. Ce/1112, 795-«12 (1995)., 
15- Bra~ A.H. & Perrtmon. N. Targeted gene expression as a means of altering all 
. f-and generating dominant phenotypes. Dewlopment , .. 401-415 (1993). 
16. Hln<. u. Giebel. 1. & campos-()rtega. J.A. The bosk-heltx-loop-Mibc dO<noln of 
OroJoph/lllethll of ICUte protein Is wffldent for proneyral function and IC1Jy-
neurogenkgenes. Cen?i, n417 (1994). 
17. Gustofton. K. & 8oulianne, G.L Distinct expression patterns detected within 
Individual tissues by the GAIA enluoncer trop technique. Genome Jt, 174-182 
(1996). 
11. Yeh. e. Gustofton. K. & 8oullianne. G.L Green fluoresc.ent protein as a vital marker 
and reporter of gene expraslon In Drosophila. l'roc. ~ffK Aad. Sd. USA SZ. 
7036-7040 (1995). 
19. Fleming. R.J. Scottgale, T.N. Diederich. R.J. & Artlvonls-Tsokonas. s. The gene 
Serrate encodes a putatiYe EGF-IIke tronsmembrane protein essential for proper 
288 
Acknowledgements 
We thank K. Irvine, T. Vogt, E. LauferandR Flemingforccchangeof 
information and H.X Cheng, along with ACGT and the Centres of Exallence 
StijUtncingfacility. for DNA StijUtmcing. We are also indebted to 
K. Irvine, H. Krause and the Bloomington stock center for Drosophila stocks. 
Finally. we thankS. Cohen, W. Fu, A. Karaiskalds, T. Yager, f. oossan~ M. 
Crackower, D. Vander Kooy, E. wac~nhawI H. Schachter, members of our 
labs, C Kintner, Yi Rao and many other collegues either for advice, help, 
information or encouragement CC is a research fellow of the National 
Cancer Institute of Canada. This work was supported l1y grants to S.E.E. from 
the Medical Research Council of Canada, to H.D.L from the National ~na 
Foundation (USA) and the Medical Research Council of Canada, to RA.P. 
from The National Cancer Institute of Canada with funds from the Canadian 
Cancer Society. to B. G. from the National Cancer Institute of Canada with 
funds from the Terry Fox Run, to CCH. from the National Cancer Institute of 
Canada with funds from the Terry Fox Run and to G.B. from the Medical 
Research Council of Canada. 
Received 28 February; accepted 28 May 1997. 
ectodermal development in Drosophll• mel•nog~sterK GeMS ~vK 4, 2188-2201 
(1990). 
20. Thomas. u .. Speicher, SA & Knust. E. The Drosophil• gene Se"•te encodes an EGF-
Iike transmembrane protein with • complex expr-ession p.attem In embryos and 
wing discs. ~""iopment111I 74!1-761 (1991). 
21. Spekher, SA. qhorn~ u. Hln<, U. & Knust. E. The5errote locus of Drosophila ond 
Its role In morphogenesis of the wing Imaginal dlsa: control of cell proliferation. 
~""lopment1OMI RP~ (1994). 
22. ArUvanls-Tsakonas. s. Matsuno. K. & FortlnL M.E. Notch sign~llngK Science 268. 
2.25-232 (1995) . 
23. Vassln. H. Bremer. KA. Knust. E. & campos-Ortega. J.A. The neurogenk gene 
~fta of Drosophlll melanogaster Is expressed In neurogenk territories ond 
encodes 1 putative tronsmembrane protein with EGF-Iike repeats. EMBO J. 6, 
3431-3440 (1987). . 
24. Kopczynski, C.C.. Alton. A.K. cechte~ 1(. Kooh, PJ. & Musbvltch. M.A. T. ~ftaK 1 
Drosophila neurogenk gene, Is tronscriptlonally complex ond encodes a protein 
"'lated to blood coagulation factors and epidermal growth factor of Yertebrotes. 
Genes Dev. 2. 1723-1735 (1988). 
25. mo~ A.L & Muskavltch, M.A. T. Delta function Is required for bristle organ 
determination ond morphogenesis In Drosophila. Dev. Bioi. 157,484-496 (1993). 
26. Porody, T.R. & Musbvltch. MAT. The plelotropk function of Delta during 
postembryonk deY<fopment of Drosophila melanogaster. Genetics 135, 527-539 
(1993). 
27. Muskavltch. M.A.T. Delta-Notch signaling and OroJoph/la all fote choke. Dev. Bioi. 
166, 415-430(1994). 
28. Robey. E. et oL Ali actlvoted form of Notch Influences the choke between CD4 and 
CD8 T cellllneoges. Co/IWJ, 483-492 (1996). 
29. Rodrlguez.fsteban, C. et of. Radical fringe positions the apkll ectodermal ridge at 
the dor>owntral boundlry of the Yertebratellmb. ~tute 386, 360-366 (1997). 
30. tKKoufe~ E. et al. Expreulon of Radical fringe In limb-bud ectoderm regulates apkll 
ectodermal ridge formation. ~lrre 386, J66-373 (1997). 
31. de Angells. M.H.. Mcintyre a, J. 6 Gassier, A. Maintenance of somite borden In 
mkerequlrestheDelta '->ologueOIII.Natutel86. 717-n1 (1997). 
32. Johnston. 5-H. et oL A family of mammaliln fringe geneslmplkoted In boundary 
determlnatlonandthekotdtpathwoyK~lopment1O4KOO4~E199T}K 
33. eu~ C.<. Slusarskl. D. Plott. KA. Holmgren, R. & Joynet; A.L Expression of thnte 
mouse homologs of the Drosophila segment polarity gene aJbllus /nlwnlptus, Gli, 
Gll-2, and Gll-3, In ectoderm- and mesodemHieriYed tissues suggests multiple 
roles during postlmplantatlo deY<Iopment. Dev. Bioi. 152,402-413 (1994). 
34. Spradling. A.C. m~lement-medloted tronsfonnatlon,ln Orosophllo: A prKtial 
opproach (ed. Roberts, D.BJ 175-197 ~ol Press, Oxford. 1986). 
35. Lawrence. P.A.. Johnston. P. & Morota. G. Methods of maridng cells. In Drosophila: 
A l'rKtlcol Approach. (ed. Roberts, D.B.) 229-242 ~oimr-Oxford. 1986). 
36. Tomlinson. A. & Ready, D.F. ~ff fote In the Drosophila ommatidium. Dev. Bioi. 123, 
264-275(1987). 
nature genetla volume 16 July 1997 
93 
